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Abstract 
The aim of this research was to investigate the phytochemistry of two species 
Sanicula europaea and Teucrium davaeanum which are traditionally used in 
treatment of wounds. Four compounds were isolated from the 80% 
methanolic extract of S. europaea; bis-(2-ethylhexyl) phthalate (1), palmitic 
acid (2), rosmarinic acid (3), saniculoside N (4). Compounds 1 and 2 were 
isolated for the first time from this species.  The structure elucidation of the 
isolated compounds was on the basis of 1D, 2D NMR spectroscopy and 
mass spectrometry measurements. Two compounds were isolated from the 
crude glycosides extract of T.davaeanum; 6 is a phenylethanoid glycoside 
and 8 is an iridoid glycoside, from the data available these may be new 
compounds for which the names davaeanuside A and davaeanuside B are 
proposed respectively." 
 
The total polyphenol content of S. europaea L, T. davaeanum leaves-flowers 
and T. davaeanum stem were found to be 5.0, 1.20 and 0.65 mg per 100 mg 
dried plant material respectively. A study of the antioxidant activity of the 
50 % ethanol extracts of S. europaea and T. davaeanum showed that on a 
mg/mg basis S. europaea and T. davaeanum  have approximately 5%, 8 %  
antioxidant capacity of Trolox respectively. 
 
A study of the cytotoxic activity of davaeanuside A (6), iridoid glycoside (7), 
davaeanuside B (8) and saponin compound (10) isolated from the crude 
glycosides extract of T.  davaeanum revealed that saponin compound (10) 
inhibited the growth of Hela cells by 50 % at  50 µg/ml, P< 0.001, but the 
other compounds did not show activities against the tested cell lines at 100 
µg/ml. The results of this work provide some basis for the traditional use of 
these species in the treatment of wounds. 
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      Introduction 1
 
1.1  The use of natural products in drug discovery 
 
Natural products, of animal, plant and mineral origin, have been the roots 
of therapy of human illnesses and infections. The use of medicine 
essentially dates back basically to the beginning of human culture. Modern 
therapeutics have progressed over centuries’ through systematic research 
of scientists. Recently, the most significant base of prospective drug leads 
was natural products, secondary metabolites (Bhushan et al., 2004). 
 
Natural products, of animal, plant and mineral origin, have been the roots 
of therapy of human illnesses and infections. The use of medicine 
essentially dates back basically to the beginning of human culture. Modern 
therapeutics have progressed over centuries’ through systematic research 
of scientists. Recently, the most significant base of prospective drug leads 
was natural products, secondary metabolites (Bhushan et al., 2004). 
 
The Egyptian pharmaceutical Ebers Papyrus (2900 B.C.) detailed over 
700 plant based drugs for production of gargles, pills, infusions and 
ointments. The clay tablets found in cuneiform from Mespotamia (2600 
B.C.) were the earliest records of natural products. They mentioned uses 
of oils from Cupressus sempervirens (Cypress) and Commiphora species 
(myrrh) which are traditionally used as cure to coughs, cold and 
inflammation. The Chinese Materia Medica Wu Shi Er Binb Fang (1100 
B.C.; recipes for 52 prescriptions). While natural scientist and Greek 
philosopher, Theophrastus (back to 300 B.C.) is a collection of medicinal 
herbs and the  Shennong Herbal (100 B.C.;  recorded the uses of 365 
drugs (Bhushan et al., 2004). 
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The Greek physician, Dioscorides (100 A.D.) and Tang Herbal (659 A.D.;  
850 drugs)  are all mentioned the uses of medicinal herbs (Bhushan et al., 
2004).   
    
The Western knowledge of treatments (including England, Ireland, France 
and Germany) was conserved in monasteries during Dark and Middle 
Ages, while the Arabs maintained the Greco-Roman knowledge and 
expanded the uses of their resources. Arabs were the first who privately 
owned pharmacies (8th century) (Bhushan et al., 2004). 
 
 Many glycosides containing plant species are used in traditional medicine. 
For example Sanicula europaea and Teucrium davaeanum were used in 
treatment of wound. Therefore the aim of this study was to isolate and 
identify the main constituents of crude glycoside extracts of both species 
and test the isolated compounds in treatment of wound.    
 
1.2 The genus Sanicle 
 
Sanicle is a genus of the family Apiaceae or Umbelliferae (Wiersema, 
2007). Both names are approved by the ICBN (International Code of 
Botanical Nomenclature). The Apiaceae family is a large family with about 
250 to 455 genera and between 3300 and 3700 species. It is generally 
distributed in the temperate region of both hemispheres, mostly in Eurasia 
and especially in Asia; 100 genera ( ten endemic and 614 species of 
which 340 are found in China (Zipcodezoo.com, 2013, Marquina et al., 
2001). 28 genera and 137 species are native in southern Africa.  In North 
America there are 91 genera; of these, about 20 are found in Quebec.  
 
 The most characteristic features of this family is that the plants have 
hollow stems named umbellifers, a characteristic small, in addition to, they 
have inflorescence in the form of compound umbel,  flowers with five 
petals, and white, yellow or pink not blue colour  (Michael, 2010). 
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The species belonging to the Apiaceae family are herbaceous, biennial or 
perennial plants, although some grow rough stems and there are a few 
wooded, tree-like or shrubby species in temperate areas. They have 
substitute and usually compound leaves, frequently simple, often fern-like 
or feather-divided; the leaves extend at the base into a sheath that clasps 
the stem. The stems are hollow between the leaf-joints, often furrowed, 
The cluster crystal of calcium oxalate, which are found distributed in 
abundant frequency in the mesophyll. The idioblasts, which are rarely 
found, are composed of parenchymatous cells densely packed with 
microsphenoidal crystals of calcium oxalate. These present in the spongy 
mesophyll and are frequently damaged, so that the crystals are scattered 
when seen under the microscope.  The acicular crystals of calcium oxalate 
which are found in underlying parenchyma in surface view of the leaf their 
appearance are regular (Lindley, 1836). 
 
The genus Sanicula  has about 40 species worldwide, (Marquina et al., 
2001). Table 1.1 shows the Sanicula species and subspecies with their 
botanical and common names (Lindley, 1836). 
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 Table 1.1  S. europaea species and subspecies with their botanical names, common names and distribution.  
No.  Species  Common name  Distribution  
1 S. apiifolia  - United States 
2 S.arctopoides  Footsteps of spring  United States (California ,  Oregon , Washington , Mexico 
3 S. arguta  Sharptooth Blacksnakeroot   United States (California ) , Mexico 
4 S. artopodoides - Temperate zone . 
5 S. astrantia  - Temperate zone  
6 S. astrantiifda  - - 
7 S. azorica - Portugal , Turkey . 
8 S. bipinnata  Poiso Sanical . United States ( California ) , Mexico . 
9 S. bipinnatifida Purple Snakeroot .  United States ( California , Oregon , Washinton ) . 
10 S. brasiliensis  - - 
11 S. caerulescens   Blue sanicle . United States . 
12  S. canadensis  Canadian Black snakeroot . United States . 
13  S. canadensis var canadensis  - - 
14 S. canadensis var. grandis Fern .  - United States , Maxico . 
15 S. canadensis var. canadensis .  Canadian Blacksnakeroot .  North America .  
16  S. canadenis var. genuine  Canadian Blacksnakeroot .  United States . 
17 S. canadensis var. grandis  Canadian Blacksnakeroot . United States . 
18 S. canadensis var. marilandica  Canadian Blacksnakeroot . United States . 
19 S. canadian var. marilandica . Canadian Blacksnakeroot . United States . 
20  S. capensis . - - 
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Table 1.1 continued 
 
21 S. chinensis  - China , Japan . 
22  S. coerulescens .  - Qatar , Sudia Arabia , United Kindom , United States .  
24 S. crassicaulis  Pacific Blacksnakeroot. United States , Canada , Chile , Mexico .  
25  S. crassicaulis Var. crassicaulis  Pacific Blacksnakeroot. United States . 
26 S. crassicaulis Var. menziesii Western Snakeroot .  United States ( Oregon , Washinton ) . 
27 S. crassicaulis Var. tripartite  Pacific Blacksnakeroot. North America , United States .  
28  S. costata  - - 
29 S. crassifolia - Chile . 
30 S. deserticola  - Mexico 
31 S. dielsiana  - - 
32 S. diversiloba  - - 
33 S. elata - China , Japan , Cameroon , Equatorial , Indonesia . 
34 S. elongata  - - 
35 S. epipactis .  - - 
36 S. erythrophylla .  - - 
37 S. europ  - - 
38 S. europaea L.  European Sanicle .  United States , Austria , Azerbaijan , Finland , France , Germany , 
Creece , Hungary , Ireland . 
39  S. europaea elata  European Sanicle  -  
40 S. europea  - Norway , Spain , Sweden .  
41 S. floridana - - 
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Table 1.1 continued 
 
42 S. floridana Var. Canadensis  - United States . 
43 S. giraldii  - - 
44 S. giraldii Var. ovicalycina  - - 
45 S. graveolens  Western Snake-Root United States , Canada , Chile , Mexico .  
46 S. gregaria  - - 
47 S. hacquetioides  - - 
48 S. henryi - China . 
49 S. hermaphrodita -  United States . 
50 S. hoffmanii - United States . 
51 S. hoffmannii  Hoffmann’s Blacksnakeroot  United States . 
52 S. howelli - - 
53 S. ichangensis - - 
54 S. javanica - Indonesia . 
55 S. kaiensis  - - 
56 S. kauaiensis  Kauai Blacksnakeroot  United States . 
57 S. kurilensis  - - 
58 S. laciniata  Coastal Black snake root  United States , Mexico . 
59 S. lamelligera  - China . Japan , Taiwan  
60  S. liberta  - United States ( Colorado , Florida ) , Argentina , Colombia , Ecuador , 
Guatemala , Guinea .  
61  S. macrorrhiza  - - 
62 S. marilandica  Maryland Black Snakeroot  Canada , Mexico , United States  . 
63  S. marilandica Var. borealis  Black Snakeroot  - 
64 S. marilandica Var. Canadensis  Black Snakeroot - 
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Table 1.1 continued 
 
65 S. maritima  Adobe Snakeroot  United States . 
66 S. mariversa  - United States . 
67 S. marylandica  - United States . 
68 S. menziesii - United States . 
69 S. menziesii Var. foliacea  - - 
70 S. menziessii Var pedata  - - 
71 S. mexicana  - Guatemala . 
72 S. montana  - - 
73 S. moranii - Mexico . 
74 S. nanchuanensis  - - 
75 S. natalensis  - - 
76 S. nemoralis  - - 
77 S. nevadensis  - - 
78 S. nevadensis Var. glauca  - - 
79 S. nudicaulis  - - 
80 S. obtuse - - 
81 S. ordorata Clustered Black Snakeroot United States , Canada , Mexico . 
82 S. officinalis  - - 
83 S. officinarum - - 
84 S. orthacantha  - China , Viet Nam . 
85 S. orthacantha Var. Costata  - - 
86 S. oviformis  - - 
87 S. palmate - - 
88 S. patagonica - - 
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Table 1.1 continued 
 
89 S. peckiana Peck’s Blacksnakeroot United States . 
90 S. pengshuiensis - - 
91 S. petagnioides - Taiwan . 
92 S. potaninii - - 
93 S. purpurea Purple flower Blacksnakeroot  United States (Hawaii) . 
94 S. rubriflora - Japan . 
95 S. sandwicensis Hawaii Black snakeroot  United States  (Hawaii , south Georgia , South sandwich 
Islands . 
96 S. satsumana  - - 
97 S. saxatilis Devil’s Black Snakeroot  United States . 
98 S. septentrionalis  -  - 
99 S. serpentine  - United States . 
100 S. serrata  - China . 
101 S. smallii Small’s Black Snakeroot . North America Mexico .  
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1.2.1 Sanicula europaea L.  
 
S. europaea root stock (underground stem from which every year’s new 
stalks grow up) is shortly creeping and fibrous, with a small number of 
thick brownish scales at the top. The stem erect 8 inches to 2 feet high, 
often leafless or with a single leaf. The radical leaves are on stalks 2 to 8 
inches long, the leaves themselves palmate three to five partite, the leaves 
are heart shaped at the base near the stalk and toothed like a saw. The 
flowers are in umbels, each little collection forms a semi-circular head. The 
umbel is irregular, the flowers pinkish-white, they may flower in May or 
June and are succeeded in August by spherical seeds which are covered 
with prickles, the plant is glabrous and clear green, the leaves paler 
beneath and the stems often reddish (Grieve, 1998).  
Figure 1.1 and figure 1.2  shows the flowers and leaves in  S. europaea 
respectively (Blaich, 2013a). Figure 1.3  shows distribution of S. europaea 
in the world (Zipcodezoo.com, 2013).  
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Figure 1.1   Flowers of  Sanicula europaea L (Blaich, 2013b) . 
 
 
 
Figure 1.2  Leaves of Sanicula europaea L (Blaich, 2013b). 
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Figure 1.3  Distribution of S. europaea L. 
 
1.2.2    Distribution of S. europaea in the world 
 
S. europaea is found in the following countries; Austria,  Azerbaijan,  
Belgium,  Bosnia and Herzegovina,  Bulgaria,  Burundi, Congo,  Czech 
Republic,  Denmark, Equatorial Guinea, Finland,  France,  Germany,  
Greece,  Hungary,  Ireland,  Italy,  Kenya, Morocco  Netherlands, Norway, 
Poland, Portugal, Romania, Serbia and Montenegro, Slovenia, Spain, 
Sweden, Switzerland, Tanzania, Turkey, Ukraine,  United Kingdom, United 
States (Zipcodezoo.com, 2013)  
 
1.2.3               Traditional uses of S. europaea . 
 
    Use of S. europaea  for wound healing  1.2.3.1
 
The Middle Ages were a time when several treatments for wound healing 
were vigorously used. Books remaining from this age and much later 
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argue in careful detail, the preparation and use of many plants specifically 
for wound healing. For example Sanical is a plant that is generally stated 
which is known today as S. europaea (Corke, 1912). 
 
People in the Middle Ages used to say of Sanicle , “Celui qui Sanicle a De 
mire affaire il n’a” which means “He that hath Sanicle needeth no 
surgeon”.  In reference to its medical virtues the name comes from the 
Latin word sano (I heal or cure). In the Middle Ages there was not one 
system approved for the naming of plants and spelling was not constant. 
This plant has many names. Such as, senikyl, senicle, senigle , 
wodemerche , wodeworte    and siwariswort. This led  the identification in 
the manuscripts a problem but the plant certainly grew and still grows in 
England today (Corke, 1912). 
 
 Many medical works record the use of S. europaea although when it was 
first introduced is unknown. The work written by Lanfranchi who is one of 
the well-known Italian surgeons of the Middle Ages, is the earliest 
example. He trained in thirteenth century Paris (Corke, 1912). 
 
“Another powder is the viscous juice from the root of mallow, which some 
individuals called Sanicle, while other called ungaria, it is prepared by 
wash and dry the root in oven in such a method it does not burn, then 
grind it into a powder and apply a good amount to the hollow type of ulcer. 
Because of its inborn properties it encourages new tissue formation, either 
used by itself or mixed with other things” (Corke, 1912).  
 
Many medical receipts that have been found in manuscripts from the 
thirteenth century mentioned the use of S. europaea  . For instance, S. 
europaea  is mentioned in the ̋ Lettre d’Hippocrate ̏ which was the most 
significant group of vernacular medical receipts before 1300 (Tony, 1994).  
It is also found in the versified receipts known as the ̋ Physique rime ̏  
where sanicle is stated in a receipt for staunching the blood of wounds and 
in another for the therapeutic of wounds (Tony, 1994)  
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 In the fifteenth centry S. europaea.  was still being used in many 
treatments. For example, the ̋ Liber de Diversisor Medicinis ̏ which is a 
collection of remedies for various ailments written somewhere between 
1422 and 1454 , point out S. europaea  on many occasions (Ogden, 
1938).  
 
In an unpublished manuscript of 1446 S. europaea  is mentioned in a 
number of recipes. For example “Also, through the use of certain drinks 
you can determine whether the wounded man shall live or die. For if he 
coughs it up again it is a sign of death and if he keeps it down it is a sign 
of life. One such drink is this one. Take 3 penny weights of bugle and S. 
europaea  and crush them and mix them with 6 spoonfuls of old stale ale. 
Filter it and give it to the patient to drink” (Thomas, 1446). 
 
“A good syrup for wounds..... or take equal quantities of herb John , herb 
Robert , Piggle , Bugle , Sanicle , Millifolie , Consolida major / minor , 
Plantain , Avence , use the juices ” (Thomas, 1446). 
 
As late as 1794 an English dictionary was still able to comment upon it’s 
healing properties. “S. europaea  – an evergreen plant , that grows wild in 
woods on hilly grounds , and is esteemed for it’s great vulnerary quality ” 
(Thomas,  1794). Where vulnerary = the proper cure of wounds and ulcers 
(Kanzaki et al., 1998). 
 
1.2.4      Other uses of S. europaea   
 
The uses of S. europaea as a medicinal treatment have been found in 
manuscripts dating as far back the 13th century (Grieve, 1998). It uses 
have been reported in treatment of blood disorders in combination with 
other herbs, as an internal remedy for chest and lung complaints, chronic 
cough and catarrhal infection, Inflammation of the bronchi, spitting of blood 
and infection of the pulmonary tissues, as an astringent gargle in sore 
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throat, in scald head of children and all cases of rash, for plentiful bleeding 
from the lungs, bowel and other internal organs and for examination 
dysentery. 
 
1.2.5      Albarello drug jar for Sanicle , Italy , 1601 – 1800  
 
Figure 1.4 shows a drug jar used to stock syrup of Sanicle which in Latin 
was called (Sciroppo di Sannicola). The syrup was composed of a mixture 
of Sanicle and sugar, this syrup was used to treat the inner ulcers, 
particularly in kidneys and bladder (museum.org.uk, 2013).  
 
 
 
 
Figure 1.4.  Jar used for syrup of Sanicle. 
   
1.2.6 Phytochemistry of S. europaea  
 
On reviewing the literature on S. europaea it was found that it contains 
many classes of compounds including saponin glycosides, tannins, volatile 
oils and mucilage-metabolic products, a summary of reported data is 
detailed below.  
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    Volatile oil  1.2.6.1
 
Identification of the essential oil contents of S. europaea prepared by the 
hydrodistillation method from leaves of S. europaea was carried out by 
Pavlovic et al (2006).  The plant was collected from two diverse regions, 
Montenegro and Serbia. The GC (Gas Chromatography) and GC-MS 
(Gas-Mass Chromatography) of the volatile oils revealed that the oils were 
composed mainly of sesquiterpene hydrocarbons (59.5-63.8%). The main 
constituents were β-selinene  (40.4-44.2%), cayophyllene oxide  (17.9-
19.2) and α-selinene (3.7-4.0%), their structures are shown in Figure 1.5 
(Pavlovic et al., 2006).  
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Figure 1.5.  α-selinene, β-selinene and caryophyllene oxide. 
 
 Saponin glycosides 1.2.6.2
  
Arda et al. (1997) isolated a new triterpene saponin glycoside,21-β-
(angeloyloxy)-3-O-[β-D-arabinopyranosyl(1-4)-β-D-glucopyranosyl(1-3)-β-
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D-glucuronopyranosylpropyl-ester-3β,15,16,22α,28β-pentahydroxy-∆12–
oleanene named saniculoside-N from S. europaea, Figure 1.6 (Arda et al., 
1997).   
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Figure 1.6.  Saniculoside N. 
 
 
Saniculoside R-1 Figure 1.7 is another triterpenoid saponin from S. 
europaea was isolated by Schopke et al (1998). The structure was 
elucidated from NMR and MS data as 21-O-[2-methyl butanoyl]-
3β,15α,16α,21β,22α,28-hexahydroxyolean-12-ene-3-O-[α-L-
arabinopyranosyl(1-3)]β-D-glucopyranosyl(1-2)-β-D-glucuronopyranoside  
(Schopke et al., 1998).    
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                              Figure 1.7  Saniculoside R-1. 
 
 
Saponins have been found in some other species of Sanicle for example 
Sanicula elata Ham. Var. chinesis Makino. Matsushita et al. (2004) 
isolated eleven new oleanane type triterpenoid saponins, 
saniculasaponins (I-XI) and the known saponin sandrosaponin (IX) Figure 
1.8 from the methanol extract of the total plant of Sanicula elata Ham. Var. 
chinesis Makino. The new compound structures were elucidated on the 
base of chemical and spectroscopic data (Matsushita et al., 2004).   
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Figure 1.8  Saniculasaponins I-XI  and sandrosaponin. 
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                                  Figure  1.8.  Continued. 
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     Phenolic acids 1.2.6.3
  
The known phenolic acids, rosmarinic acid, and caffeic acid were isolated  
from S. europaea as major compounds Figure 1.9 (Arda et al., 1997).  
 
O
O
OH OH
OH
O
OH
OH  
                                       Rosmarinic acid  
 
COOH
OH
OH
 
                                          caffeic acid 
        
Figure 1.9.  Rosmarinic acid  and caffeic acid. 
 
1.2.7 Pharmacological actions of S. europaea 
 
The antiviral effect of aqueous extract of S. europaea leaf on influenza 
virus-infected cells was studied by Turan et al. (1996). Authors 
investigated the effect of aqueous extract of S. europaea on influenza 
virus growth in Madin Darby Canine Kidney  cells (MDCK). Fractions I, II 
and III isolated from aqueous extract of S. europaea with Sephadex 
column chromatography were stated to be non-toxic toward MDCK cells at 
(100 µg/ml). The growth of influenza A/PR/8/34 (strain A/Puerto 
Rico/8/1934) was totally inhibited by these fractions, while that of influenza 
B/Lee/40 (strain B/Lee/1940) was not affected. Fractions II and III have 
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been shown not to have a direct virucidal activity on influenza A/PR/8/340 
at (100 µg/ml) (Turan et al., 1996).  
 
The effect of S. europaea aqueous extract on the virus multiplication was 
carried out by plaque inhibition assay. The results revealed that, plaque 
formation by influenza A/PR/8/34 was completely inhibited by fractions I. 
II, III at (100 µg/ml); thus, fraction IV was not effective at concentration of 
(50 µg/ml). According to plaque formation assay the same extracts were 
not effective against influenza B/Lee/40 multiplication. Influenza A/Vic/1/75 
(strain A/Vic/1/1975) produced microscopic plaques in the presence of 
extract (no concentrations were mentioned) (Turan et al., 1996). 
 
The RNA synthesis in vitro assay was also carried out. Preliminary 
experiments showed that the RNA polymerase activity of influenza A virus 
measured in vitro is inhibited by the addition of aqueous extracts (no 
concentrations were mentioned) 
(Turan et al., 1996).  
 
The antiviral activity of the aqueous extract of S. europaea leaf on the 
bacteria-bacteriophage system was studied by Turan et al (1996). They 
found that the plant extract inhibited the adsorption and/or penetration of 
phage infection without any toxic effect on Escherichia coli B2 host 
bacteria (no concentrations were mentioned). The high molecular weight 
fraction that eluted first from the gel filtration column was found to be 
accountable for this inhibition (Turan et al., 1996).  
           
The antiviral activity of S. europaea aqueous extracts on multiplication of 
HPIV-2 (human parainfluenza Virus type 2) was studied by Karagoz et al. 
(1999). They prepared the aqueous extract from the leaf of the plant and a 
fraction isolated from the crude extract with gel filtration chromatography 
was shown to inhibit HPIV-2 reproduction without any toxic result on Vero 
cells. The acidic fraction (100 µg/ml) obtained from the crude extract of S. 
europaea leaf was found to be the most effective fraction in the plaque 
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inhibition assay at non-cytotoxic concentrations. Unfortunately, antiviral 
activity was not detected in the molecules purified from the crude ethanol 
extract of S. europaea (Karagoz et al., 1999).  
 
Newton et al. in 2002 found that the herb part of S. europaea has weak 
antimycobacterial activity [Mycobactenium aurum MIC > 500 µg/ml, M IL 
smegmatis > 500 µg /ml] (Newton et al., 2002).  
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1.3 Teucrium davaeanum species 
 
The studied species T. davaeanum belongs to the family Labiatae. The 
species grows in Wadi Telal, Sirte region, Libya, it is an endemic species. 
The aqueous extract of the T. davaeanum is used in folk medicine in 
treatment of wounds and as an antidiabetic agent. The reason of this 
study was to identify the main constituents of crude glycosides extract 
which might have wound healing activity, which may have potential in the 
treatment of wounds. Identification of T. davaeanum was reported in 
(section 2.1). 
 
The Labiatae is a family of flowering plants, with approximately 220 
genera and 4000 species  widely distributed (Khoshnood-Mansoorkhani et 
al., 2010). Most of the species of the Labiatae are aromatic square 
stemmed herbaceous annuals or perennials, while some tropical species 
are trees. Many species of Labiatae have been used in medicinal practice, 
manufacture of perfumes, spices and as flavouring agents (Pettit et al., 
1966). 
 
The Labiatae is represented by 22 genera and 65 species in Libya 
(Siddiqi, 1985). The genus Teucrium is a large genus with about 340 
species worldwide (Bosabalidis, 2013). 
 
1.4 Botanical description of  Teucrium davaeanum L. 
 
Suffrutose shrub, stem decumbent, subterete, much branched, younger 
branches covered with soft spreading branched hairs. Leaves ± sessile 
oblong - lanceolate, attenuate at base, tricrenate in the middle, obscurely 
nerved above, prominently nerved and densely bullate beneath, revolute 
margined, densely villose and woolly on both sides. Verticils forming 
dense ovate - subglobose terminal spikes. Calyx subsessile, 
membranous, tubular- campanulate, 10-nerved, teeth subequal, triangular, 
acute, Corolla pale yellowish, tube subincurved, villous, upper lip lobes 
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oblong, suberect, lower lip trilobed, lateral lobes oblong-lanceolate, middle 
one 1.5 longer than lateral ones, deebly concave and almost conduplicate. 
Stamens arcuate, filaments sparsely villose. Nutlets black, smooth and 
rugose (Siddiqi, 1985). Figure 1.10. illustrates Teucrium davaeanum. 
 
 
 
 
 
 
1.5 Phytochemistry of Teucrium genus 
1.5.1 Volatile oils 
 
Volatile oils were identified in many Teucrium species: T. arduini (Vukovic 
et al., 2011), T. persicum (Miri et al., 2012), T. orientale subsp. Taylori 
(Amiri, 2010b) , T. polium, T. polium ssp. Aurasiacum (Jaradat, 2015), T. 
libanitis and T. turredanum (Blázquez et al., 2003), T. cyprium ssp. 
 
Figure 1.10  Teucrium davaeanum. 
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Cyprium, T. micropodioides, T. divaricatum and T. kotschyanum (Arnold et 
al., 1991), T. marum (Ricci et al., 2005). The major constituents were 
monoterpenes and sesquiterpene: 1,4-Cadinadiene, limonene, 
germacrene-D and Beta-pinene. Figure 1.11 shows compounds identified 
in the volatile oils prepared from some Teucrium species. 
 
 
1,4-Cadinadiene Limonene
Germacrene-D Beta-pinene 
 
Figure 1.11 Shows compounds identified in the volatile oils prepared from some 
Teucrium species. 
 
1.5.2  Diterpenoides compounds  
 
Neo-clerodane and 19-nor-neo-clerodane diterpenoids compounds are 
very common in Teucrium genus. More than 200 neoclerodanes have 
been isolated and identified. Because of their biological activities, 
especially antifeedant activity, a large number of studies were carried out.  
Table 1.2 shows some diterpenoid compounds isolated from Teucrium 
species. Figure 1.12 shows diterpenoide compounds isolated from some 
Teucrium species. 
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Table 1.2 diterpeniode compounds  isolated from Teucrium species. 
Species name Diterpeniodes References 
T. abutiloides Teubutilin A, B, Montanin C  and 12-
epiteupolin II. 
(Ricci et al., 2005) 
T. africanum Tafricanin A, B. (Hanson et al., 1982) 
T. asiaticum Teuflin, auropolin. 
Teucrasiolide  acetylauropolin. 
(Camps et al., 1987) 
T. botrys Teucvidirn, teuchamaedryn C, montanin D  
and teubotryn. 
(María et al., 1986a) 
T. barbeyanum Teucrin A, F  and G. (Bruno et al., 1985) 
T. brevifolium Teubrevins A  and B. 
Teubrevinc C, D, E, F, G, H  and I. 
(Rodríguez et al., 1994) 
T. bicolor (12R)-epi-teuscordonin, montanin C, teucvin, 
teucrin H2  and teuscordonin   . 
(Labbe et al., 1989) 
T. canadense Teucvidin, teuflin), teucvin, 18-
acetylmontanin. 
(Bruno et al., 1989) 
T. capitatum Lolin  and 19-acetylgnaphalin (Marquez et al., 1981) 
 
 
 
T. chamaedrys Teucrin A, teugin and 
dihydroteugin.Teucroxide. Teuchamaedrin C, 
6α-hydroxy teuscordin and dihydroteugin. 
Teuchamaedryn A. Isoteuflidin, teuflidin, 
teucvin, teucvidin 
, teucrins F  and teucrins G. 
(Savona et al., 1982). 
(Garcia-Alvarez et al., 
1983). 
(Malakov and Papanov, 
1985). 
(Lekehal et al., 1996). 
(Rodríguez et al., 1984)       
T. chamaedrys ssp. 
Syspirense 
Syspirensins A  and Syspirensins B. (Calis et al., 1996) 
T. cubense Eugarzasadone. (Domíguez et al., 1974) 
T. flavum sub flavum Teuflin  and teuflidin (Bruno et al., 1981) 
T. flavum sub glaucum Teuflin, teuflidin, teuflavin and teuflavoside. (Savona et al., 1984c) 
 
T. fragile Teugin. (Bruno et al., 1981) 
T. creticum Teucretol  and 6,19-diacetylteumassilin. (Savona et al., 1987) 
(Bruno et al., 1992) 
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 Table 1.2   Continued. 
 
Species name Diterpeniodes References 
T. gnaphalodes  Gnaphalin and 19-acetylgnaphalin. 12-
acetylteugnapholodin. 
(Savona et al., 1979) 
(María et al., 1985) 
T. japonicum Teuponin. (Zhi-Daz et al., 1991) 
T. kotschyanum Teucvidin, teuflin, tuscorodin, 12-epiteucvidin, 
12-epiteuflin, teukotschyn, montanin D  and 
teucrin H2. 
(Simoes et al., 1989) 
 
T. maghrebinum 12-epi-teucjaponin A, 12-epi-montanin D, 12-
epi-montanin B, teusalvin C, teucjaponin A, 
montanin D, 19-deacetylteuscorodol  and 
montanin B. Teukotschyn, 12-epi-teukotschyn, 
teughrebin  and 12-epi-teughrebin. 
(Bruno et al., 2000) 
(Bruno et al., 2001) 
T. marum  Teumarin  and acetyl teumarin. (Savona et al., 1984b) 
T. massiliense Deacetylajugarin, Ajugarin, teumassilin, 6,19-
diacetylteumassilin and triacetylteumssilin. 
(Savona et al., 1984a) 
T. montanum  Montanin A  and B. (Malakov et al., 1978) 
T. montbretii subsp. 
Libanoticum 
3β-hydroxyteututilin A, 12-epimontanin G, 20-
epi-3, 20, di-O-deacetylteupyreinidin, 6-
ketoteuscordin, teuscordinon, 6β-
hydroxyteuscordin, montanin D, 3,20-di-O-
deacetylteupyreinidin  
, montanin G, 3-O-deacetylteugracilin A. 
(Bruno et al., 2002) 
T. Oliverianum Teucrolivins A, B  and C. Teucrolivins G  and H. 
Teucrolins A, B, C, D  F, G  and E, 12-O-
methylteucrolivin A, 12-O-methylteucrolin A.  
(Bruno et al., 1991) 
(María et al., 1991) 
(Al-Yahya et al., 1993) 
(Al-Yahya et al., 2002) 
T. oxylepis subs marianum  
 
Isoteucrin, teucroxylepin, 12-O-
acetylteugnaphalodin, diacetylteucroxylepin  
and teucjaponin A. 
(Cuadrado et al., 1991) 
T. orientale Teucrolivin A, B, C  and H. 6-deacetyl-
teucrolivin A, 8β-hydroxy-teucrolivin B. 
(Bruno et al., 2004) 
T. pernyi Teupernin D. (Xie et al., 1992) 
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Table 1.2  Continued. 
 
Species name Diterpeniodes References 
T. pyrenaicum Teupyrenone, teupyreinin, teupureinidin, 
teucrin P1, 3β-acetoxyl-teupyreinin  and 
gnaphalidin. Teupyrin A, B  and teumassilin. 
(García-Alvarez et al., 
1982) 
 
T. polium Teupolin IV), teupolin V  and teucrin P1. 
Teulolins A  and B. Teupolin III. 
(Malakov and Papanov, 
1983). 
(Bedir et al., 1999) 
(Malakov et al., 1982) 
T. polium subsp aureum Auropolin) and eriocephalin. (Eguren et al., 1981) 
T. polium subsp capitatum  Picropolin, 7-deacetylcapitatin, picropolinol, 20-
epi-isoeriocephalin  and capitatin. 
(Fernández et al., 1985) 
T. salviastrum  Teusalvin A, 18-acetyl teuscorodin, 
teuscorodin, teusalvin B  
,teuscorodol, teusalvins D, E  and F. 
(María et al., 1986b) 
T. scorodonia  Teuscorolide-2-hydroxyteuscorolide, 
teuscorodin  
and teuscorodonin.  
(Marco et al., 1983) 
T. scordium 2-keto-19-hydroxyteuscordin  . (Papanov and Malakov, 
1985) 
T. viscidum var miquelianum Teucvidin, methyl teucvate and methyl 
teucvidinate.Teucvin  and teufin. 
(Node et al., 1981) 
T. webbianum Teuflidin, teucrin A, 2β-hydroxyteucvidin, 
teucvidin, teucvin, teuflin, teucrin H4  and 
isoteuflidin. 
(Savona et al., 1986) 
T. yemense 6β-O-acetyl-3β-hydroxy teucroxylepin, 
teucryemin, 19-acetyl teucryemin, 3β-19-O-
diacetylteucryemin  and teucryeminone. 
(Sattar et al., 1995) 
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Figure 1.12 Shows diterpenoide compounds isolated from some 
Teucrium species. 
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1.5.3   Iridoid glycosides from Teucrium species 
 
The iridoid glycosides harpagide and 8-O-acetyl harpagide are common in 
Teucrium species. The two compounds were reported in T. polium in 
addition to teucardoside and teuhircoside (Jaradat, 2015) (Rizk et al., 
1986) . Acetyl harpagid and teucardoside  were isolated from T. arduini L 
(Ruhdorfer and Rimpler, 1981). Figure 1.13 shows iridoid glycosides 
isolated from some Teucrium species. 
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Figure 1.13 Iridoid glycosides isolated from some Teucrium species. 
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1.5.4        Flavonoids  
 
Kawashty et al (1999) isolated five flavonoids from the leaves and stems 
of T. polium. The compounds were named apigenin 7-glucoside, vicenin-2, 
luteolin 7-glucoside, apigenin 5-galloylglucoside and cirsimaritin 
(Kawashty et al., 1999). 
Rizk et al (1986) isolated and identified luteolin, luteolin-7-O-glucoside and 
6-methoxygen-kwanin from T. polium. Oganesyan (2007) isolated the 
eupatorin (5,3-dihydroxy-6,7,4`-trimethoxyflavone) from the aerial part of 
T. orientale (Oganesyan, 2007). Barberan et al (1985) isolated luteolin and 
apigenin from the aerial part of T. gnaphalodes (Barberan et al., 1985). 
Figure 1.14 shows flavonoids isolated from some Teucrium species. 
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Figure 1.14 Shows flavonoids isolated from some Teucrium species. 
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1.5.5        Biological activities of  some Teucrium species 
 
Teucrium polium showed antidiabetic activity (Tatar et al., 2012), T. arduini 
L. exhibit antioxidant and antimicrobial  activities (Šamec et al., 2010), T. 
persicum Boiss showed antioxidant activity (Miri et al., 2012), T. orientale 
showed antioxidant activity (Amiri, 2010a). T. chamaedrys showed 
antioxidant and antimicrobial activities (Vlase et al., 2014), hepatotoxicity 
(Lin et al., 2009), (Gori et al., 2011), treatment of wound (Chiej, 1984), 
treatment of digestive, respiratory disorders, abscesses and gout 
(Stankovic et al., 2010).   
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1.6 Aim of the study  
 
The overall aim of this work was to investigate the phytochemistry of two 
plant species: Sanicula europaea and Teucrium davaeanum and to 
determine their total phenol contents as well as evaluate their antioxidant 
and cytotoxic properties. 
  
 
1.7 Objectives  
 
 Prepare the plant extracts, using solvent extraction. 
 
 Isolation of the major constituents using open column 
chromatography (CC), preparative chromatography (PC) and high 
performance liquid chromatography (HPLC). 
 
 Elucidate the chemical structures of the isolated compounds using 
spectroscopic techniques (MS, 1D & 2D NMR). 
 
 Determine the total phenol contents of 50 % ethanol extract of the 
two plants species via Folin-Ciocalteu’s method. Evaluate the 
antioxidant activity of 50 % ethanol extracts of both plants using 
ABTS radical scavenging activity. 
 
 Evaluate the cytotoxic activity of some isolated compounds from T. 
davaeanum  according to the method published in (Fatokun et al., 
2013).  
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     Materials and Methods 2
 
2.1 Plant materials  
 
Dried cut herb of S. europaea was supplied by the Herbal Apothecary 
Company (Leicester). 
Teucrium davaeanum was collected from Wadi Telal. Sirt region, in April 
2013 during the flowering stage, the plant was kindly identified by Dr 
Mohammed ElSherif, Biology Department, Faculty of Science, Garyounis 
University-Benghazi, Libya.   
 
2.2  Solvents 
 
The solvents (reagent grade and HPLC grade) were purchased from 
Fisher Scientific. 
 
2.3  Chemicals  
 
Chemicals were purchased from Sigma Aldrich Scientific unless otherwise 
stated.  
 
2.4  Extraction procedures 
 
2.4.1     Preparation of non-polar constituents of S. europaea  
 
This procedure was carried according to the method of Alla et al. (2013). 
Dried and crushed plant material of S. europaea  was defatted in a Soxhlet 
extractor at 50 oC using petroleum ether for 5 hours. The extract was dried 
over anhydrous sodium sulphate, filtered and evaporated in vacuo at 45 oC 
until dryness to yield a yellow material (4g) (Alla et al., 2013).  
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The petroleum ether extract was then dissolved in boiling acetone (300 ml) 
and left at room temperature for 24 hours. The solution was filtered and 
the precipitate washed first with cold acetone and then with cold 
chloroform:methanol (1:1) to yield a white precipitate (216 mg) of acetone 
insoluble fraction (fatty alcohols). The acetone soluble fraction (fatty acids 
+ hydrocarbons) was evaporated to dryness (1.5 g) (Alla et al., 2013). 
  
 Preparation of hydrocarbons mixture  2.4.1.1
 
The acetone soluble fraction after evaporation in rotary evaporator (2.8 g) 
was saponified by refluxing with 60 ml 0.5 M methanolic KOH (5.6 g KOH 
in 100 ml MeOH) for 6 hours. The mixture was concentrated to about 30 
ml and diluted with distilled water (40 ml). The unsaponifiable fraction was 
extracted with ether (3 × 100 ml). The combined ether extract was washed 
with distilled water, dried over anhydrous sodium sulphate and 
concentrated in vacuo to dryness to yield a yellow semisolid residue of 
unsaponifiable fraction (e.g. hydrocarbons mixture) (2.3 g). 
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1.5 Kg dried crushed plant material
Hexane Soxhlet extraction at 50 
o
C for 5 hours.
Hexane extract Defatted plant 
material.Filtration.
Dried in vacuo at 50 
o
C
 
until dryness.
Dissolved in hot acetone (300 ml).
Left at room temperature for 24 hours
Acetone soluble fraction (fatty acids and hydrocarbons. Acetone insoluble 
fraction 
(precipitate).
Total fatty alcohols
Filtered, washed 
with cold acetone 
then with 
chloroform : 
methanol 1:1
Evaporated to dryness.
Alcoholic potassium hydroxide (60 ml) was added.
Refluxed for 6 hours at 45
o
C.
The mixture concentrated to (30 ml) then diluted with distilled water.
Extraction with ether (3 x 100ml). 
 Concentrated in vacuo to dryness.
Total hydrocarbons 
mixture.
The hydroalcoholic soap solution mixed with 5% H2SO4.
Extracted with CHCL3(3 X 300 ml).
Chloroform extract concentrated in vacuo to dryness.
Total fatty acids
Dissolved in 40 ml MeOH containing 4 % HCL.
Refluxed on a boiling water bath for 3 hours.
Extraction with CHCL3 (3 X 50 ml).
Concentrated in vacuo to dryness.
Total fatty acids methyl 
ester.
Aqueous phase.  
 
Figure 2.1.  Extraction of non-polar constituents of S. europaea.  
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 Extraction of glycosides from S. europaea  2.4.1.2
 
The defatted dried plant material (section 2.4.1) was Soxhlet extracted 
using 80% methanol at 45 oC for 5 hours. The solution was filtered using 
filter paper Whatman No 1. The methanol in the solution was removed 
using a rotary evaporator at 45 oC. The remaining aqueous solution was 
extracted several times with chloroform (3 × 250 ml), followed with ethyl 
acetate (3 × 250 ml) then butanol (3 × 50 ml).  
 
The combined butanol layers were concentrated to dryness (using a rotary 
evaporator at 70 oC, methanol was added to reduce the boiling point of the 
butanol) i.e. forming a eutectic mixture. The dried butanol extract was then 
dissolved in methanol, and then dropped slowly into diethyl ether. The 
whitish precipitate obtained from the above procedure was filtered using a 
sintered glass Buchner funnel. The precipitate was dried under vacuum for 
18 hours. 
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1.5 g of dried crushed deffated plant material.
80% Methanol sohxlet extraction.
80 % Methanol extract. Marc
1- Concentration of 
extract untill dryness 
dissolve  in distilled 
water.
2- leave  overnight at 4C
o
, then filter.
Aqueous solution of extract.
Extraction with hexane(3 x 100 ml).
Hexane extract. Aqueous phase.
Extraction with ethyl acetate (3 x 100 ml).
1- Concentration of extract
 to dryness and left at 4C
o
.
Concentrated hexane extract.
Chloroform extract.Aqueous phase.
Extraction with Chloroform (3 x 100 ml).
Aqueous phase.
Concentration of extract
 to dryness and left at 4C
o
.
Extraction with butanol (6 x 
20  ml).
Aqueous 
phase.
Butanol extract.
Concentration of extract  then dissolve in methanol and
add 50 ml diethyl ether to precipitate crude glycosides.
Ethyl acetate  extract
Concentration of extract
to dryness and left at 4C
o
.
Crude glycosides extract.  
 
Figure 2.2.  Extraction of crude glycosides of S. europaea. 
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     Aqueous extraction 2.4.1.3
 
Dried and crushed plant material of S. europaea (10 g)  was added to 200 
ml of distilled water and  the mixture was shaken strongly for 30 minutes, 
filtered and divided into two portions in thick walled pear-shaped flasks 
(100 ml each). The samples were frozen using dry ice acetone and freeze 
dried in the Institute of Cancer Research with the help of Dr Bradley.  
 
2.5    Chromatographic Techniques 
 
2.5.1    Normal phase silica gel chromatography 
 
Fractionation of plant extracts was carried out using positive pressure 
column chromatography (PPCC). The column was packed with normal 
phase silica gel for column particle size 0.02-0.04 mm - 0.04-0.06 mm 
Silica gel for thin layer chromatography particle size 12 µm was also used. 
The mobile phase used was a gradient system of hexane:chloroform: 
methanol. 
 
2.5.2         Reverse phase silica gel C-18 chromatography 
 
Reverse phase silica gel C-18 type (LiChrospher R 100 RP-18E 12 μm) 
was used. The column (30cm length and 2.5 cm diameter). was packed 
with a slurry in methanol: water, 50: 50 and allowed to settle under gravity. 
The crude glycosides extract was dissolved in a minimum amount of 
methanol and added to the column; then it was continually eluted with the 
selected mobile phase. Fractions were collected with a volume ranging 
between 15-20 ml.  
 
 
 
  
40 
 
2.5.3       Preparative thin layer chromatography  
 
Preparative chromatography of plant extracts was performed using two 
types of plates, thin layer chromatography (silica gel 60 F254 aluminum 
sheets 20 × 20 cm plates) and thick layer chromatography plates (silica 
gel 60 F254 glass plates 20 × 20 cm, 2000 microns). The mobile phase was 
Chloroform: Methanol: water 60:40:10 for both plates. Capillary tubes (5 
µL) were used to apply the extract as a band across the plate; four 
applications were placed on each plate. The mobile phase was developed 
through the plate three times.     
 
Plates were allowed to dry and covered with glass except for the edge. 
The edge was sprayed with vanillin sulphuric acid. The plates were 
visualised under UV light at wavelengths 254 and 375 nm. The bands 
were marked by pencil and collected using a small spatula. The combined 
bands were collected in small vials, dissolved in methanol, sonicated for 
15 minutes and filtered. The methanol was evaporated using a rotary 
evaporator.   
 
2.5.4       Gel filtration chromatography    
 
Fractionation of plant extract was carried out using Sephadex LH20. The 
slurry was prepared in chloroform or methanol. Mobile phases used were 
Methanol (100%), Chloroform:Methanol gradient system, Methanol:water 
50:50. 
 
2.5.5 Thin layer chromatography (TLC) 
 
Analytical (TLC) was performed using silica gel 60 F254 on aluminium 
sheets 20 x 20 cm, 0.25 mm layer (Merck Ltd). The resulted from 
fractionation of crude glycosides was applied on TLC by 2 μm, 5 μm 
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capillary tubes. The most commonly used mobile phase was chloroform: 
methanol:water (6:4:1) tanks with different sizes were used.  
2.6        Gas chromatography-Mass spectrometry (GC-MS)  
 
Instrument                       AGILENT 7890 GC with 5975 EI/CI MSD. 
Temperature program   Injector: 250°C, Detector: 300°C.  
   Oven program                 initial temp 100°C for 0.5min, ramp 1: 5°C/min to 
220°C, 
                                          no hold, ramp 2: 10°C/min to 275°C hold 5 min. 
Run time                          35min. 
Carrier gas                       Helium at 1ml/min. 
Column                            Capillary column SGE BP5, length 
                                          25m, film  thickness  0.5 µm, internal diameter  
                                               0.32mm.                  
Detector                          Flame ionization detector. 
Sample volume              1µl. 
 
 
2.7     High performance liquid chromatography (HPLC) 
 
2.7.1      Analytical High performance liquid chromatography (HPLC)     
      
                                                                                                                                                                         
Model                             Millipore Waters-510 
Detector                         Linear UVIS 200 
Wavelength                   254 nm 
Loop                              20 μl, 100 μl 
Pump                             510-Solvent system pump 
Column                         Reverse phase silica gel C-18 (10 × 100mm)  
                                       Normal phase silica gel (10 × 225 mm) 
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2.7.2            Preparative high performance liquid chromatography 
(PHPLC) 
Model                              Perkin Elmer Series Autompter 
Detector                          Series 200 Diode Array Detector 
Wavelength                     (200, 290 and 330) nm 
 Loop                                100 μl          
 Pump                              Perkin Elmer Series 200 pump                                                            
Column                            Reverse phase silica gel C-18 
 
2.8    Spray reagents 
 
2.8.1     Anisaldehyde reagent 
 
0.5 ml anisaldehyde was mixed with 10 ml glacial acetic acid, followed by 
85 ml methanol and 5 ml concentrated sulphuric acid (Wagner, 2001). 
 
2.8.2      Vanillin sulphuric acid reagent 
 
 2 g vanillin was dissolved in 100 ml of methanol; 2 ml of sulphuric acid 
were  added (Wagner, 2001).   
 
2.8.3     Ferric chloride reagent  
 
Ferric chloride was prepared by dissolving 5 g of ferric chloride in 100 ml 
methanol. 
 
2.8.4     Dragendorff’s reagent     
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Solution A was prepared by dissolving 0.85 g of basic bismuth nitrate in 10 
ml glacial acetic acid; 40 ml of distilled water was added. Dissolution may 
be encouraged by heating. 
 
Solution B was prepared by dissolving 8 g potassium iodide in 30 ml of 
distilled water. Stock solution was prepared by mix equal volumes of 
solution A and B Dragendorff’s reagent was prepared by mixing 1 ml of 
stock solution with 2 ml of glacial acetic acid and 10 ml of water.  
 
2.9         Spectroscopic methods 
 
2.9.1         Mass spectrometry 
 
       Electro spray ES+ and ES- mass spectrometry 2.9.1.1
 The instrument used was a Micromass Quattro Ultima Spectrometer. 
Ionisation was carried out using electro spray (ES+) and (ES-). Samples 
were dissolved in methanol and infused at 10μl / min using a Harvard 
syringe pump. 
 
       Accurate mass spectrometry 2.9.1.2
 
Mass spectrometry data were acquired at the EPSRC UK National Mass 
Spectrometry Facility at Swansea University. 
  
2.9.2        Nuclear Magnetic Resonance spectroscopy (1-D,2-D NMR)  
 
These were recorded in one of the following solvents CDCl3, MeOD, D2O, 
pyridine-D-5. The instrument used was a Bruker Ultra Shield 400 MHz (1H 
NMR spectra were recorded at 400.1300 MHz, 13C NMR at 100.6126 
MHz, DPX 400 or JEOL ECA 600 (1H NMR at 600.1723 MHz, 13C NMR at 
150.9134 MHz). 
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     Results and discussion, phytochemistry of S. europaea 3
 
3.1       Identification of the lipid fraction of S. europaea  
 
Total lipid fraction of S. europaea was prepared as illustrated in section 
(2.4.1). A total of 1 mg/ml from each sample (total fatty alcohol, total 
hydrocarbon and total fatty acid methyl ester) was dissolved in 1 ml 
dichloromethane and analysed on GC/MS instrument (section 2.6).  
   
 
Table 3.1  Compounds identified in alcohols fraction via GC-MS. 
 
No Compounds Molecular 
formula 
RT(min.) Relative % 
1 Heptacosane C27H56 25.96 43.02 
2 Octacosane C28H57 27.26 45.62 
   Total 88.64 
 
 
Table 3.2  Compounds identified in hydrocarbon fraction of S. 
europaea via GC-MS. 
No Compounds Molecular 
formula 
RT(min.) Relative % 
1 β – Selinene C15H24 13.37 76.09 
2 Caryophyllene oxide C15H24O 14.5 4.20 
3 Pentadecanone C18H36O 17.2 2.23 
   Total 82.52 
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Table 3.3  Compounds identified in fatty acids ester fraction of S. 
europaea via GC-MS. 
 
No Fatty acids Molecular 
formula 
RT(min.) Relative % 
1 7-Hexadecanoic acid, methyl 
ester 
C17H32O2 13.3 2.23 
2 Nonanedioic  acid, 
dimethylester 
C11H20O4 13.94 1.72 
3 Cyclopropane butanoic acid C25H42O 16 0.43 
4 Caffeine C8H10N4O2 17.2 7.93 
5 Isopropyl  myristate C17H34O2 17.3 1.05 
6 1,2,Benzenedicarboxylic 
acid,bis(2-methyl propyl)ester 
C16H22O4 17.5 1.98 
7 9, 12, octadecatrienoic acid C27H52O4 18.049 17.47 
8 Oleic acid, 3-(octadecyloxy) 
propyl ester 
C39H76O3 18.4 1.21 
9 Heptadecanoic acid, 16 
methyl -methylester 
C19H38O2 20 2.68 
   Total 36.7 
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Figure 3.1  GC-MS analysis of alcohol fraction of S. europaea. 
 
 
 
 
    Figure 3.2  GC-MS analysis of hydrocarbon fraction of S. europeae. 
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Figure 3.3  GC-MS analysis of fatty acid methyl ester fraction of S. 
europaea. 
 
 
 
 
 
Figure 3.3 Continued. 
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Table 3.1 and Figure 3.1 show the compounds identified in the total fatty 
alcohols of S. europaea. Although the aim of the work was to identify the 
total fatty alcohols, the results also showed the presence of two 
hydrocarbons with high molecular weight. Table 3.2 and Figure 3.2 show 
the compounds identified in the hydrocarbons mixture of S. europaea. β - 
Selinene and caryophyllene oxide were also  identified in the essential oil 
of S. europaea using GC/MS by (Pavlovic et al., 2006)  as main 
constituents. The GC-MS analysis of total fatty acid methyl esters Table 
3.3,  Figure 3.3 showed the presence of  7-hexadecanoic acid, methyl 
ester (palmitic acid methyl ester) C17H32O2. Palmitic acid (C16H32O2) was 
isolated from the hexane extract of S. europaea (section 3.4.5), and this 
extract also showed the presence of 1 (bis (2-ethylhexyl) phthalate), thus 
providing additional confirmation of the presence of 1 in S. europaea. 
Another interesting peak present in the GC-MS of the Fatty acid esters of 
S. europaea was identified as caffeine (7.93%) on the basis of its mass 
and fragmentation pattern. This finding is surprising and it is possible that 
the caffeine detected was a contaminant and further work needs to be 
carried out in order to confirm or refute the presence of caffeine in S. 
europaea. 
3.2 Preparation and yields of crude glycosides  
 
The crude glycosides extract of S. europaea was prepared according to 
the method mentioned in section (2.4.1.2). Several batches of S. europaea 
L. herb were extracted using different amounts of herb and extraction 
conditions. The yields of crude glycosides obtained are shown in table 
(3.4). 
 
 
3.3      Fractionation of crude glycosides of S. europaea 
 
Fractionation of crude glycosides of S. europaea was carried out by using 
several adsorbent e.g. normal phase silica gel particle size (0.02-0.04 mm 
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- 0.04-0.06 mm), reverse phase silica gel C-18 (LiChropher R 100 RP-18E 
12 μm), preparative TLC, gel filtration (Sephadex LH20 -sigma) and High 
performance liquid chromatography (HPLC).  
  
3.3.1       Normal phase silica gel  
 
200 mg of crude glycosides were chromatographed  on 100 g silica gel for 
thin layer chromatography (section 2.5.1.) using a gradient system of 
CHCl3:MeOH [(100:0), (98:2), (96:4), (94:6), (90:10), (80:20), (70:30), 
(60:40), (50:50), (40:60), (30:70), (20:80), (10:90), (0:100), 200 ml each], 
98 fractions 7 ml each were collected. Similar fractions were combined 
depending on TLC analysis results (silica gel 60 F254  aluminium sheets 20 
× 20 cm   plates) using chloroform: methanol: water (60: 40:10) as mobile 
phase and vanillin sulphuric acid as spray reagent), fraction A(10-12, 20 
mg),  B(13-37, 77 mg), C(38-50, 77 mg), D(60-99, 30 mg).  
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Table 3.4   Yields of crude glycosides obtained with different conditions. 
 
Sample 
number  
Plant 
material 
(g) 
% of 
MeOH 
Solvent 
used  
Amount of 
solvent 
(ml) 
Extraction 
time (h.)  
Amount of 
CHCL3 (ml)  
Amount of  
BuOH ( ml) 
Amount of  
MeOH (ml) 
Amount of  
diethyl 
ether (ml) 
Weight of 
crude 
glycoside 
(g)  
The % of 
crude 
glycoside 
in the 
dried 
herb 
1 75 80 700 23 15(3times) 15(3times) 10 15 0.81 0.607 
2 75 80 1400 16 15(3times) 15(3times) 50 100 1.5 1.125 
3 90 80 1400 24 15(4times) 15(6times) 55 60 1.61 1.449 
4 90 80 1400 37 15(6times) 15(10times) 45 70 1.28 1.152 
5 90 80 1500 16 15(6times) 15(6times) 55 40 1.20 1.08 
6 90 80 1500 16 15(3times) 15(6times) 55 40 1.2 1.08 
7 100 80 1400 23 15(6times) 15(12times) 55 170 1.28 1.28 
8 90 80 1500 17 15(6times) 15(11times) 50 100 1.22 1.06 
9 100 80 1500 24 15(6times) 15(6times) 50 100 0.90 0.70 
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Repeatedly, Fractions A, B, C, D, were further fractionated on a silica gel 
column eluted with CHCl3:MeOH gradient, 36, 101, 68 and 56 fractions (12 
ml) were collected from each column respectively. TLC analysis of the 
fractions was carried out. Although, the saponin mixture of crude 
glycosides was not separated, partial purification of nonpolar compounds 
in the mixture was achieved (purification of the main nonpolar compounds 
is described in (section 3.2.3). Table 3.5 shows the compositions of mobile 
phases which were used for analytical TLC (normal phase silica gel 
plates). A mobile phase of CHCl3:MeOH:H2O, 60:40:10 was found to 
produce the best separation of  crude glycosides constituents on analytical  
TLC plates.  
  
Table 3.5  Mobile phases trialled (analytical TLC with silica gel 
plates). 
 
Mobile phase  % of solvents 
CHCl3:MeOH:H2O 40:60:10 
CHCl3:MeOH:H2O 50:50:10 
CHCl3:MeOH:H2O 60:40:10 
CHCl3:MeOH:H2O 70:30:10 
CHCl3:MeOH:H2O 70:30 
CHCl3:MeOH:H2O 80:20 
CHCl3:MeOH:H2O 90:10:5 
CHCl3:MeOH:H2O 90:10:10 
BuOH:CH3COOH:H2O 50:10:40 
 
 
Use of the normal phase method (section 2.5.1) to purify crude glycosides 
from an extract of S. europaea led to isolation of two nonpolar compounds, 
bis (2-ethylhexyl) phthalate (1), and palmitic acid (2). One disadvantage of 
this method is that some of saponin compounds were bound to the silica 
gel, which was recognized by TLC analysis to the crude glycosides extract 
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before do fractionation on the column chromatography and to the collected 
fractions from the column as few compounds were disappeared from the 
fractions. 
                                                                                        
3.3.2    Sephadex LH20 
 
Another method   applied to purify the crude glycosides extract was the 
use of Sephadex LH20 (section 2.5.4.).  At this time 315 mg crude 
glycosides extract were applied to 100 g Sephadex LH20 (2.5 × 100 m), 
eluting with a CHCl3:MeOH gradient. A total of 116 fractions were 
collected and TLC analysis was carried out for the fractions. Fractions 
were combined depending on their similarity on TLC plates. The column 
conditions are shown in the Table 3.6.  
 
The fractions were combined as  A1(2-23) 10 mg, B1(24-43) 20 mg, 
C1(44-48) 35mg,  D1(49-63) 22mg, E1(64-95) 38mg, F1(96-100) 66mg, 
G1(101-112) 41mg, K1(113-116) 50mg. Fraction  A(24-43) was a mixture 
of less polar compounds, whereas C1, D1, E1, F1, contained saponin 
compounds. Since the Sephadex column was shown to be effective in 
separating less polar compounds from the saponin fraction, this procedure 
was repeated several times in order to collect  a  large quantity of the  
saponins fraction for further purification using preparative TLC.  
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Table 3.6  Solvent conditions for Sephadex column fractionation of 
crude glycosides from S. europaea. 
Mobile phase  % of 
compositions 
Volume 
(ml) 
Collected  
Fractions 
Combined 
fractions 
weights not 
recorded) 
CHCl3 100 100 1  
CHCl3:MeOH 90:10 100 2-6    
CHCl3:MeOH 85:15 100 7-14   
CHCl3:MeOH 70:30 100 15-23 A1(2-23) 
CHCl3:MeOH 60:40 100 24-31 B1(24-43) 
CHCl3:MeOH 50:50 100 32-42 C1(44-48) 
CHCl3:MeOH 40:60 100 43-53 D1(49-63) 
CHCl3:MeOH 30:70 100 54-60 C1(44-48) 
CHCl3:MeOH 20:80 100 61-69 D1(49-63) 
CHCl3:MeOH 10:90 100 70-83  
CHCl3:MeOH 100 100 84-92 E1(64-95) 
CHCl3:MeOH 90:10 100 93-100 F1(96-100) 
CHCl3:MeOH 85:15 100 101-112 G1(101-112) 
CHCl3:MeOH 70:30 100 113  
CHCl3:MeOH 60:40 100 114-115 K1(113-116) 
CHCl3:MeOH 50:50 100 116  
       
 
 
A total of 300 mg crude glycosides were fractionated on a 100 g Sephadex 
LH20 column (2.5 × 100 m), eluted with CHCl3:MeOH (2L) gradient, 166 
fractions 7 ml each collected. TLC analysis was carried out and fractions 
were combined depending on the similarity on TLC plates. Fractions were 
combined as fraction A2 (14-43, 30 mg), B2 (44-67, 76 mg), C2 (68-103, 
35 mg), D2 (119-155, 95 mg). Fractions containing saponins were stored 
at 4oC. 
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 Several mobile phases were used as eluting solvent for crude glycosides 
fractionated on Sephadex LH20 column (5.5 × 58 cm), such as MeOH 
(100%), MeOH:CHCl3 gradient system, MeOH:H2O (50:50) and 
MeOH:H2O:EtoAc (60:40:10).  For the eluting solvent MeOH:H2O (50:50), 
crude glycosides (100 mg) were dissolved in small quantity of MeOH:H2O 
(50:50) and fractionated on 70 g of Sephadex LH20. A total of 30 fractions 
of 14 ml each were collected, TLC analysis of the fractions was carried out  
and fractions were combined depending on the similarity on TLC plates.  
 
A total of 300 mg crude glycosides were fractionated on Sephadex LH20 
column (5.5 × 58 cm), MeOH:H2O:EtoAc, 60:40:10, 88 fractions 7 ml each 
were collected. TLC analysis was carried out for the fractions and fractions 
were combined depending on the similarity on TLC plates. Elution with 
MeOH:H2O:EtoAc, 60:40:10, was repeated two times more with the same 
conditions in order to collect a large  quantity of saponins fraction.  
The gel filtration (Sephadex LH-20) method to separate the saponin 
compounds from crude glycosides of S. europaea was successful in the 
separation of nonpolar compounds from the saponins fraction, but the 
saponins compounds were not separated. The difficulties in separation of 
saponins might be because they have similar molecular weight or they are 
isomers for each other. The saponin fraction was further purified using 
preparative TLC and reverse phase silica gel column.  
 
3.3.3      Preparative Thin Layer Chromatography (PTLC)  
 
 Fraction D2 (119-166, 95 mg), portion of crude glycosides eluted with 
CHCl3:MeOH (85:15, 80:20, 70:30, 60:40, (section 3.2.1.2), was subjected 
to preparative TLC  (silica gel 60 F254  aluminium sheets 20×20 cm   
plates) using chloroform:methanol:water, 60:40:10 as a mobile phase and 
vanillin sulphuric acid as spray reagent ), 17 plates were used, 5 mg of 
fraction D2 was applied on each plates, the sample was firstly dissolved in 
a small quantity of methanol, and a capillary tube (size 5µm) was used to 
apply the sample on silica gel plates. A total of four applications (5 mg) 
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were applied to each plate, the TLC plates were allowed to dry completely, 
then placed in chromatographic tank containing CHCl3:MeOH:H2O, 
60:40:10, after the solvent developed through the plate.  
 
TLC plates were removed from the tank, dried completely then placed 
again in a fresh solvent. The process was repeated three times.  The TLC 
plates were dried and checked under UV, the bands marked by pencil 
then removed by small spatula. The combined bands were collected in 
small vials and extracted with methanol, sonicated for 15 minutes and 
filtered. The methanol was evaporated using rotary evaporator. 
Preparative TLC process was successful in separation one of saponin 
compounds (1 mg), identification of the compound was also achieved 
(saniculaside N).   
The use of preparative TLC to purify the saponins fraction (resulting from 
fractionation of crude glycoside on Sephadex LH-20 column) was effective 
(Saniculoside N) (1 mg), the quantity was enough to do 1H NMR and mass 
analysis. At this time the identification of saponin compound was achieved 
by comparison the 1H NMR data of the saponin compound with the 
literature data. One disadvantages of preparative TLC method is that 17 
plates were used to analysis (85 mg) of  saponins  fraction, but  only (1 
mg) of pure compound was yielded. The preparative TLC method is 
consuming both TLC plates and saponin fraction. Thus, another method to 
purify the saponin fraction with higher yield was required. Four saponin 
compounds are shown on the TLC plate. 
  
3.3.4       Reverse phase silica gel C-18  
 
Crude glycosides fractions C1 + D1 fractionated on a 35 g reverse phase 
silica column (LiChrospher R 100 RP-18E 12 μm) eluting via H2O:MeOH 
gradient starting from 100:0, to 0:100. A total of 67 fractions of 7 ml each 
were collected and the fractions were combined depending on the 
similarity on TLC plates. TLC was achieved using silica gel 60 F254  
aluminium sheets 20×20 cm plates, using CHCl3:MeOH:H2O (60: 40:10) 
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as mobile phase and vanillin sulphuric acid as spray reagent. A total of 15 
main fractions were obtained [A(2-4), B(5-10), C(11-12), D(13-15), E(16-
22), F(23-24), G(25-30), K(33-38), L(39-43), M(44-51), N(54-57).  
 
Fractions C(11-12), D(13-15), E(16-22) were  (20 mg total) were combined 
and further fractionated on a 30 g reversed phase silica gel C18 column 
(5.5 × 58 cm) using CHCl3:MeOH mixture as eluting solvent. This process 
afforded 35 fractions of 7 ml each.  Fractions numbered 13, 14, 15 each 
contained mainly one compound, but the quantity was very small 0.3 mg.  
 
This procedure was repeated after collection fractions F(23-24), G(25-30), 
but the eluting solvent was changed to CHCl3:MeOH:H2O gradient, 83 
fractions 21 ml each were collected, TLC carried out. Table 3.7 the 
compositions of mobile phases which tested for revers phase silica gel 
plates, The mobile phase of MeOH:H2O (85:15) was found produce the 
best separation of  crude glycosides constituents on the analytical TLC 
plates.  
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Table 3.7 Compositions of mobile phases tested for the use with 
revers phase silica gel plates. 
Mobile phase  % of solvents 
MeOH:H2O 100:0 
MeOH:H2O 90:10 
MeOH:H2O 85:15 
MeOH:H2O 80:20 
MeOH:H2O 75:20 
MeOH:H2O 60:40 
MeOH:H2O 50:50 
MeOH:H2O:CHCl3 50:50:1 
MeOH:H2O:CHCl3 60:40:1 
MeOH:H2O:CHCl3 70:30:1 
MeOH:H2O:DCM 50:50:1 
MeOH:H2O:DCM 60:40:1 
MeOH:H2O:DCM 70:30:1 
MeOH:H2O:DEE 50:50:1 
MeOH:H2O:DEE 60:40:1 
MeOH:H2O:DEE 70:30:1 
MeOH:H2O:Hex 50:50:1 
MeOH:H2O:Hex 60:40:1 
MeOH:H2O:Hex 70:30:1 
MeOH : H2O:CH3COOH 60:40:10 
MeOH:H2O:(CH3)2CO 60:40:10 
MeOH:H2O:CH3CN 60:40:10 
MeOH:H2O:BuOH 60:40:10 
MeOH:H2O:Toluene 50:50:1 
MeOH:H2O:Toluene 60:40:1 
MeOH:H2O:Toluene 70:30:1 
MeOH:H2O:EtOH 60:40:10 
MeOH:H2O:EtOAC 70:30:1 
MeOH:H2O:EtOAC 70:30:2 
MeOH:H2O:EtOAC 60:40:2 
MeOH:H2O:EtOAC 60:40:3 
MeOH:H2O:EtOAC 50:50:2 
  
 
 
DCM : Dichloromethane. 
DEE : Diethyl ether. 
Hex : Hexane. 
EtOH : Ethanol. 
EtOAC : Ethyl acetate. 
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The disadvantage of using reverse phase silica gel (particle size 0.02-0.04 
mm, 0.04-0.06 mm) to purify either the crude glycosides extract or 
saponins mixture was the yield of resulting pure compounds. One reason 
for that is that the saponin compounds occur in each sub fraction, in 
addition to by repeating the fractionation method four or three times we 
end up with small quantity of pure compounds.  
 
Use normal phase silica gel, Sephadax LH20, Preparative TLC and 
reverse phase silica gel to do fractionation of crude glycosides of S. 
europaea resulted in isolation of 5 compounds and partially purified 
saponins fractions. Compound 1 was identified as (Bis-2-ethyl hexyl 
phthalate), palmitic acid (2), rosmarinic acid (3), saniculoside N (4) and 
compound (5) was composed from three sugars named sucrose, glucose 
and fructose. Partially purified saponins fractions were combined 
depending on the similarity on TLC into three main fractions A (218.07 
mg), B (363.37 mg) and C (89 mg), to further purify by high performance 
liquid chromatophraphy (HPLC) techniques.  
 
3.4   Natural products isolated from S. europaea 
 
The following section is about the isolation and structure elucidation of the 
compounds isolated from the 80% methanolic extract of S. europaea.  
 
 
 
3.4.1      Isolation of  bis (2-ethylhexyl) phthalate 1 
 
A total of 1 g of crude glycoside extract was dissolved in methanol 10 ml 
and mixed with 20 mg of silica gel (section 2.5.1). The methanol was 
evaporated in vacuo at 45 oC until dryness to give a homogenous 
powdered extract. This powder was transferred to a silica gel column (30 g 
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of silica in 200 ml of chloroform). Fractions of 20 ml each were collected. 
Fractions were monitored using TLC with CHCl3:MeOH:H2O (60:40:10) as 
a developing solvent (section 2.5.5). The data are summarized in the 
Table 3.8. 
 
Table 3.8   Conditions of column chromatography of isolation of 1. 
 
Mobile phase % of compositions Volume (ml) Fraction number 
CHCl3 100 100 1-5 
CHCl3:MeOH 98:2 100 6-15 
CHCl3:MeOH 95:5 100 16-20 
CHCl3:MeOH 90:10 100 21-24 (compound 1) 
CHCl3:MeOH 85:15 100 25-30 
CHCl3:MeOH 70:30 100 31-37(saponin fraction) 
CHCl3:MeOH 60:40 100 38-41 
CHCl3:MeOH 50:50 100 42-45 
CHCl3:MeOH 40:60 100 46-49 
CHCl3:MeOH 30:70 100 50-54 
CHCl3:MeOH 20:80 100 55-59 
CHCl3:MeOH 10:90 100 60-64 
MeOH 100 100 65 
 
 
 
     Further purification of 1  3.4.1.1
 
Fractions (21-24) Table 3.8 eluted with CHCl3:MeOH (90:10) were found 
to contain only one compound with main impurity, so they were combined, 
concentrated to a small volume and further purified using a Sephadex 
column (25 g) in 150 ml methanol. The data were summarized in table 3.6.  
 The fractions 6-10 were found to contain one compound (6 mg). The TLC 
of 1 is Figure 3.4. 
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Figure 3.4 is shown TLC plate (silica gel 60 F254   aluminium sheets 20×20 
cm, chloroform:methanol:water, 60:40:10, vanillin sulphuric acid)  of 1 the 
bands from the left to the right represent bis (2-ethylhexyl) phthalate, 
hexane fraction from methanol extract of S. europaea  and methanol 
extract of S. europaea. 
 
 
Table 3.9  Conditions of sephadex column of further purification of 1. 
 
Mobile phase % of compositions Volume (ml) Fractions (10 ml) 
CHCl3 100 50 1-5 
CHCl3: MeOH 90:10 50 6-10 compound 1 
CHCl3: MeOH 85:15 50 11-15 
CHCl3: MeOH 70:30 50 16-20 
CHCl3: MeOH 60:40 50 21-25 
CHCl3: MeOH 50:50 50 26-30 
CHCl3: MeOH 30:70 50 31-35 
 
 
 
 
 
Figure 3.4  TLC analysis of 1 
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     Structure elucidation of 1  3.4.1.2
 
Compound 1 was isolated as a yellow oil from the crude glycosides extract 
of S. europaea.  TLC analysis of 1 on silica gel 60 F254 showed quenching 
at 254 nm but did not fluoresce at 375 nm and showed a dark blue spot 
after vanillin / sulphuric acid spraying (Figure 3.4). The ES+ mass 
spectrum of 1 Figure 3.5 showed a molecular ion peak [M+H]+ at m/z = 
391.2 suggesting a molecular weight of 390; other peaks were observed at 
m/z = 413.2 (M + Na)+, 804.5 ( 2M + Na )+. 
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                Figure 3.5  ES + mass spectrum of 1. 
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Figure 3.6  Bis (2-ethylhexyl) phthalate 1. 
 
 
The 1H NMR and 13C NMR data is shown in Table 3.10. The 1H NMR (400 
MHz, CDCl3) spectrum of 1 Figure 3.7 showed several signals in the up 
field region between δ 0.7 and δ 1.9 which are characteristic for CH2, CH3 
protons and signals in the downfield region between  δ 7.6 and 7.9 which 
are characteristic for aromatic protons. The signals at δ 0.8 and 0.89 are 
triplet indicates the presence of two methyl groups. The 6H signal at  δ 
1.27 suggest the present of 5 (-CH2-) and 1H signal at δ 1.65 indicates the 
presence of a methine CH. The down field shift suggests that this group is 
attached to an oxygen atom. The peaks in the downfield region of the 1H 
NMR spectrum showed the presence of two aromatic protons at δ 7.50 
(1H, dt, J = 2.2, 6.3 Hz, H-12), 7.65 (1H,  dd, J = 2.2, 6.3 Hz, H-11). 
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Figure 3.7  1H NMR (400 MHz, CDCl3) spectrum of 1. 
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The 13C NMR (400 MHz, CDCl3) spectrum Figure 3.9 showed 12 signals. 
Eight signals were observed in the up field region with chemical shifts 
between δ 11 and 68 ppm; the DEPT spectrum of 1 Figure 3.10 indicated 
the presence of two methyl groups, four methylene groups and one for a 
methine group.  The peak at δ 68 is characteristic for a carbon atom 
bonded to an oxygen atom. In the downfield region of the 13C NMR 
spectrum three aromatic carbons (two methine, one quaternary) and one 
carbonyl carbon were observed.  
 
From the above data a total of 12 carbon signals and signals for 19 
protons are observed. In addition, there is an evidence for two oxygen 
atoms, one carbonyl and one other oxygen. This gives an empirical 
formula for 1 is C12H19O2, The mass of this formula is 195 (12C = 144, 19H 
= 19, 2O = 32). The mass spectrum showed that the molecular weight is 
actually 390; therefore the molecular formula of 1 is C24H38O4. The six 
aromatic carbons suggest that the molecule contains one six member 
atoms ring with four adjacent protons Figure 3.8. Therefore, there are two 
side chains, each one contains two methyl groups four methylene groups, 
one methine group attached to oxygen atom and carbonyl group. 
Moreover, the side chain most be branched on account of two methyl 
groups. 
 
H
H
H
H
X
X
 
 
Figure 3.8  Partial structure of 1.  
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Figure 3.9  13C NMR spectrum (400 MHz, CDCl3) of 1. 
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Figure 3.10  DEPT spectrum (400 MHz, CDCl3) of 1. 
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Table 3.10  13C and 1H NMR chemical shift and DEPT data (400 MHz, 
CDCl3) of 1. 
 
Carbon number  
13
C NMR, δ, PPM DEPT 
1
H NMR, δ, PPM 
1 14 CH3 0.89 (3H, t, H-1) 
2 29 CH2 1.27 (2H, m, H-2) 
3 23 CH2 1.27 (2H, m, H-3) 
4 30 CH2 1.27 (2H, m, H-4) 
5 39 CH 1.65 (1H, m, H-5) 
6 68 CH2 4.12 (2H, m, H-6) 
7 167 O-C=O - 
8 24 CH2 1.27 (2H, m, H-8) 
9 11 CH3 0.80 (3H, t, H-9) 
10 133 C  - 
11 129 Aromatic CH 7.65 (1H,  dd,  J = 
2.2, 6.3 Hz, H-11) 
12 131 Aromatic CH 7.50 (1H, dt,  J = 
2.2, 6.3 Hz, H-12) 
 
 
All the above data are in accordance reported spectral data of  bis (2-
ethylhexyl) phthalate (1) (Kui, 2009). Therefore, it can be concluded that 1 
is bis (2-ethyl hexyl) phthalate (1) Figure 3.6. 
            
Bis (2-ethylhexyl )phthalate is well known plasticizer and it is used in 
manufacturing of many in industrial products such as plastic polymers, 
pharmaceuticals, cosmetics, inks and adhesives. Although, 1 has low 
acute toxicity it is classified as a probable human carcinogen and is 
expected to be a human endocrine disruptor. In animal studies using oral 
dosing for short periods, 1 is well known for its reproductive toxicity, 
especially for its testicular toxicity (Nelson et al., 2013) .   
 
  
69 
 
3.4.2       Occurrence of 1 in nature 
 
     Occurrence of 1 in foods 3.4.2.1
 
Presence of 1 in food (Stilton cheese) was reported by Michael et al 
(2013). In their study they were measured the abundance of radiocarbon 
in 5 samples of 1 isolated from Stilton cheese by accelerator mass 
spectrometry (AMS) to calculate the carbon fraction created from 
contemporary biogenic bases. The aim of this study was to confirm 
whether it’s presence in food as a contaminate from industrially 
synthesized 1 or a naturally inherent compound. Five ≈ 90 μg quantities of  
1 were isolated from 12 Kg of Stilton cheese using silica gel, size 
exclusion and HPLC. Samples masses were measured via GC-MS 
analyses prior to combustion and manometry. The mean 14C-corrected 
contemporary carbon fraction of 1 in the isolated was 0.235 ± 0.073 (1σ 
and ± 0.091 at the 95% confidence level). It was concluded that the high 
percentage of 1 in Stilton cheese results from anthropogenic sources, 
although with a significant naturally occurring component (Nelson et al., 
2013).  
          Occurrence of 1 in water treatment plants 3.4.2.2
 
A type of fungus named Actinomycete was isolated from the leaf litter 
sample from streams. The bioactive components were purified by silica gel 
column chromatography and identified by Gas Chromatography-Mass 
Spectrometry. Ten compounds were identified between them bis (2-
ethylhexyl) phthalate 1  (33.19%). 
 
The plasticizers and their degeneration in streams of a large urban 
sewage treatment plant were studied by   (Johnson et al., 2012). (Barnabe 
et al 2008) The results revealed that 1 is present at high concentrations in 
the process streams, influents, treated effluent and solid residues of the 
treatment plant in Montreal, Canada. Degradation of 1 lead to the 
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formation of  three compounds, 2-ethylhexanal, 2-ethylhexanol and 2 
ethylhexanoic acid. These compounds were earlier reported in laboratory 
work. 1 and it’s three degradation compounds were found in the influent 
and solids that were analysed. The results suggest that the treatment plant 
does not completely remove plasticizer from the influent and may be 
considered to be as an important source of these compounds and their 
degradation products in the environment (Barnabé et al., 2008). 
 
           Occurrence of 1 in marine organisms 3.4.2.3
 
Identification of bioactive components of marine sediment by gas 
chromatography was evaluated by Sudha Srikesavan and Masilamani 
(2012). 1 was found to be one of the marine constituent at percentage 
(14.13%), which also reported to have antibacterial activity 
(SudhaSrikesavan and Selvam, 2012). 
   
           Occurrence of 1 in bacteria organisms 3.4.2.4
             
One of bioactive constituents produced by Nocardia levis MK-VL_113 & 
Streptomyces tendae TK-VL_333 was 1. The cytotoxicity activity of the 
compound was also evaluated IC50 values of 86.21 μg/ml, 119.89 μg/ml  
on cell lines U-937 and HL-60 respectively (Alapati and Muvva, 2013).    
 
3.4.3             Pharmacological actions of 1 
       
Habib and karim (2009) isolated 1 from the flower of Calotropis gigantean. 
They  reported that 1  has been  reported to be present in  Alchornea 
cordifolia (Mavar et al., 2008),  Aloe vera (Lee K. F. et al., 2000),  
Euphorbia cyparissias and Euphorbia  seguieriana (Tothsoma et al., 
1993). Habib and karim were also studied the antimicrobial and cytotoxic 
activity of 1 (Habib and Karim, 2009). 
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 The shed dried plant material of  Calotropis gigantean (1.0 kg) was 
extracted with ethyl acetate (1.5 L) at room temperature to yield (38 g) 
crude ethyl acetate extract of which 10 g was fractionated on normal 
phase silica gel for column chromatography and preparative to yield (98 
mg) of 1 (Habib and Karim, 2009).  
 
The minimum inhibitory concentrations of 1 (MICS) against bacterial 
species, Staphyloccus aureus, Bacillus subtilis, Bacillus megaterium, 
Sarcina lutea, Escherchia coli, Shigella sonnei, Shigella shiga and Shigella 
dysenteriae was 64, 32, (no inhibitory), 32, 64, 64, 64 and 128 
respectively. 
 
The antifungal activity of 1 was carried out against four fungia species. 
The results revealed that 1 has activity against one species (Aspergillus 
flavus), the inhibition zone at doses 100 and 200 μg/disc was 08 and 11 
respectively. Moreover, 1 showed high toxicity against brine shrimp nauplii 
(LC50  9.19 µg/ml).   
 
Habib and karim (2009) stated that the presence of 1 in flowers of 
Calotropis gigantean, was not as a contaminant from solvents, was further 
confirmed by GC-MS analysis (first confirmation was isolation of 1 from 
flowers of Calotropis gigantean,  by  using silica gel chromatography as 
mentioned above). The plant flowers were not preserved in plastic bags, 
so these could be discounted as a source of 1. The authors reported that 
their study could not determine if 1 is synthesized by the plant, absorbed 
by the roots or from the external atmosphere (Habib and Karim, 2009). 
 
Compound 1 was also isolated from  Ricinus communis Linn. 
(Euphorbiaceae) (Pateh, 2009), Nuclea officinalis leaves  (Kui, 2009), 
culture broth of a fungus strain No. 36 Pencillium olsonii (Amade et al., 
1994).   
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Lee et al.  (2000) examined the antitumor effect of 1 which was isolated 
from Aloe vera in human and animal cell lines. 1 was tested at three 
concentrations (100, 10 and 1) µg/ml against three leukaemic cell lines 
K562, HL60 and U937. 1 showed an inhibitory activity of 95, 97 and 95 % 
in K562, HL60 and U937 respectively at concentration of 100 µg/ml.  At 10 
µg/ml of 1, the cells lines K562, HL 60 and U 937 showed growth inhibition 
of 74, 83 and 81 %. While at 1 µg/ml of 1 exhibited an inhibitory activity of 
50, 51 and 52 % in K562, HL 60 and U 937 (Lee et al., 2000).     
 
Zanotelli, et al (2009) investigated the effect of 1 on growth of larva and 
adult of guppy fish less than one week old at the start of the experiment at 
concentration present in nature and under conditions that might emphases 
harmful concerns. Two concentrations of 1 (0.1 and 10 µg/L) were applied 
constantly for 91 days. After 14 days of beginning of experiment the length 
of guppy fish was measured. The results revealed that the guppy fish 
treated with 10 µg/L of 1 undergo significant decrease in body length 
compared with control animals. The body weight was also reduced but this 
was after 91 days of treatment.  The percentage decrease in body length 
was 15% and 40% for concentrations of 1 and 10 µg/L respectively, while 
the percentage of reduction in weight was 40% and 70 %  for the both 
concentration respectively. 1 is widespread used plastic softener; as a 
result it is present in large number of plastic goods. It has the ability to 
transfer into the environment over time leading to universal contamination 
(Zanotelli et al., 2010).  
 
Studies on skin penetration and metabolism of 1 was carried out by Hopf 
et al. 1 is assumed to cause endocrine disruption; it might have low dermal 
absorption. The aim of the study was to determine the permeation 
parameters of 1 and evaluate of skin 1 metabolism in individuals who 
highly unprotected to this lipophilic, low volatile material. Skin removed by 
surgery from patients who undergoing abdominoplasty was directly 
dermatomed (800 µm) and mounted on flow- through diffusion cells. The 
cells were injected into the skin in two forms pure 1 and emulsified in 
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aqueous solution (166  μg/ml). 1 transformed human fessible skin only in 
form of metabolite MEHP (mono-(2-ethyl-5-hydroxyhexyl phathalate). After 
8 h of exposer, 1 permeated through human skin as MEHP only when 
emulsified in aqueous solution (Hopf et al., 2014). 
 
3.4.4      Determination the origin of 1 in S. europaea  
  
HPLC was used in order to quantify the amount of 1 present in different 
extracts of S. europaea. Method for HPLC analysis of 1 was as for the 
methods used for HPLC analysis of crude glycosides of extract of S. 
europaea (section 2.4.1.2). In order to determine the retention time of  1 in 
the HPLC chromatogram two samples (1 mg/ml and 0.1 mg/ml of 1 are 
dissolved in  methanol (HPLC grade) and injected to a reverse phase 
HPLC column (10 × 225 mm, loop 100 μl) eluting with 
CH3CN:H2O:isopropanol, 35:60:5, flow rate 1 ml/min. This mobile phase 
gave a broad peak, therefore, the mobile phase was changed to 
CHCl3:MeOH:H2O (60:45:5) which gave a sharp peak. Several 
concentrations of 1 were run as illustrated in the Table 3.11 is shown 
concentration of 1 vis area of the peak. Figure 3.12 is showing HPLC 
analysis of a standard sample of 1 (0.5 mg/ml). 
   
Table 3.11   Analysis of standard sample of 1 (mg/ml) via HPLC  
 
 
Conc. of 1 
(mg/ml) 
Peak area Average SD 
0.125 9.005 9.532 9.63 9.38 0.33 
0.2 20.033 19.015 20.47 19.84 0.74 
0.25 25.04 21.496 24.98 23.83 2.03 
0.3 28.6 30.446 30.85 29.96 1.20 
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Figure 3.12 HPLC analysis of a standard sample of 1 (0.5 mg/ml), 
peak 2 indicates 1. 
   
 
           Analysis of 1 in total methanol extract of S. europaea 3.4.4.1
 
 
To confirm the presence of 1 in the total methanol extract of S. europaea  
(5 g) of the plant was extracted three times with 80 % methanol (3× 50 ml) 
at room temperature. The methanol extract was concentrated using rotary 
evaporator (yield 89.3 mg). The concentration of 1 in the methanol extract 
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Figure 3.11  Graph showing a relationship between conc. of 1 
and peak area. 
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is expected to be higher than that in the crude glycosides extract, since 
the latter was prepared from the methanol extract after several steps of 
partition with organic solvents such as hexane, chloroform, ethyl acetate, 
butanol (The crude glycosides extract was prepared from the butanol 
extract, therefore it is expected that 1 is extracted within each solvent as it 
is non-polar compound.   
 
A concentration of 0.5mg/ml of methanol extract was analysed by HPLC. 
Using reverse phase silica gel column (10 × 225 mm, flow rate 2 ml/min) 
eluted with CHCl3:MeOH:H2O, 60:45:5,  the concentration and the area of 
the peak of 1 on the chromatogram was recorded as illustrated in the 
Table 3.12. Figure 3.13  chromatogram is showing HPLC analysis of S. 
europaea methanol extract (0.5 mg/ml). Figure 3.14 is shown HPLC 
analysis of S. europaea methanol extract (0. 5 mg/ml) plus 0.2ml of 1 (1 
mg/ml) injection loop 20 µl. 
 
Table 3.12  Analysis of S. europaea methanol extract  for compound 
1. 
 
 
 
 
 
For S. europaea methanol extract, area of the peak of 0.5 mg/ml value fill 
in the area of the peak range of the standard curve Figure 3.8, therefore 
this value can be used to calculate the concentration of 1 in methanol 
extract. Rearrange SC equation. 
 
           X=(y+0.0396)/1.1029  
           X=(23.69+0.396)/1.1029 
           X= 21.5 
 
Conc. of MeOH 
extract mg/ml 
Area of the peak at RT = 5 
min. 
Average SD 
0.5 18.06 33 20 23.68 8.12 
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Factor in for weight of solid per volume of solvent; methanol extract was 
prepared as 15g of material in 150 ml of 80 % methanol. It had a 
concentration of 100 mg/ml. Hence 21 mg of 1.  
 
 
Figure 3.13 HPLC analysis of S. europaea methanol extract (0.5 
mg/ml). 
   
 
Figure 3.14  HPLC analysis of S. europaea methanol extract (0. 5 
mg/ml) plus 0.2 mg/ml of 1. 
 
 
       Analysis of 1 in hexane fraction of S. europaea extract 3.4.4.2
 
A total of 100 g of S. europaea was macerated with (500 ml) of 80% 
methanol at room temperature for 5 days. The methanolic extract was 
concentrated in vacuo at 45 C◦ till dryness to yield (5.49 g), dissolved in 
(50 ml) distilled water. The aqueous phase was extracted with hexane (3 × 
300 ml), followed by chloroform (3 × 300 ml), ethyl acetate (3 × 300 ml) 
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and butanol (3 × 50 ml). Anhydrous sodium sulphate was added to the 
solvents.  
The solvents were filtered and concentrated in vacuo at 50 C°, to yield 
( 15.73 mg), ( 76.74 mg), ( 1.16 g) and ( 3 g) of hexane, chloroform, ethyl 
acetate and butanol extracts respectively. The butanol extract was 
dissolved in (50 ml) of methanol and added to (200 ml) of diethyl ether to 
yield a white precipitate of crude glycosides extract (1.8g). 
 
TLC analysis was carried out for the four extracts, in addition to standard 
sample of bis (2-ethylhexyl) phthalate 1; the results showed that 1 is 
present mainly in the hexane extract, although, a small amount has 
extracted with the chloroform extract. 
(2.5 L) of analytical grade hexane solvent was evaporated to dryness 
using a rotary evaporator. Analytical TLC was carried out for the residue to 
find out whether the 1 is contamination from the solvent or it present 
mainly in the plant. The TLC result showed that the residue did not contain 
any compound; this indicates that 1 is present in the plant and is not 
contaminant from the solvents. 
 
 In order to determine the concentration of 1 in the hexane extract, 2 ml 
(1mg/ml) of hexane extract was run on HPLC reverse phase silica gel 
(C18) column (150 × 10 mm, 100 µL loop, flow rate 2 ml/min.) eluted with 
CHCl3:MeOH:H2O (60:45:5). The HPLC chromatogram showed a small 
peak at retention time of (5.1 min.) which is assigned to 1, this process 
was repeated three times in order to show the reproducibility, retention 
time, area and the concentration were recorded each time, the area 
average was calculated. When three drops of standard 1 added to the 
hexane extract, the peak at retention time (5.2 min.) become sharper. 
Furthermore, a sample of standard 1 (0.5 mg/ml)  was run on HPLC 
column reverse phase silica gel (C18) column (150 × 10 mm, 100 µL loop, 
flow rate 2 ml/min.) eluted with CHCl3:MeOH:H2O (60:45:5), the run time 
and the area of the peak is recorded. the average was calculated as 
shown in the  
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Table 3.13. Figure 3.15  is showing the analysis of hexane fraction on 
HPLC. Figure 3.16 is showing HPLC analysis of hexane fraction  0.1 ml (1 
mg/ml)  plus 0.1ml of 1(1 mg/ml), the peak number 4 in this figure is for 1 
because it be became bigger after addition 0.1 ml (1 mg/ml) of standard 
sample of 1 resulting from increase the concentration of 1.  
 
Figure 3.15 HPLC analysis of hexane fraction (1 mg/ml) of S. 
europaea. 
 
 
Figure 3.16  HPLC analysis of hexane fraction  0.1 ml (1 mg/ml)    plus 
0.1 ml of 1(1 mg/ml). 
  
Table 3.13  Results of HPLC analysis of hexane fraction 0.1 ml (1 mg/ml). 
Sample name Area Average 
Hexane extract 49.23 36.74 
Hexane extract 24.79  
Hexane extract 36.19  
Standard sample of 1 32.52 34.05 
Standard sample of 1 38.13  
Standard sample of 1 36.64  
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Standard sample of 1 32.98  
 
 
The average area of 1 standard sample with concentration (0.5 mg/ml) is 
34.052, while the average area of 1 with concentration (x) in the hexane 
extract is 36.742 therefore X equal to 0.539 mg/ml. So each 1 mg of 
hexane extract contains 0.539 mg of 1, therefore, 15 mg of hexane extract 
prepared from 100 g of S. europaea contains 8 mg of 1. Furthermore, 
each (1g) of S. europaea contains (0.08 mg) of 1 (i.e. 0.0081 %).       
 
 Analysis of 1 in chloroform fraction of S. europaea  3.4.4.3
 
A total of 5 g of S. europaea was extracted at room temperature for two days 
with 80 % MeOH (3 × 50 ml) to yield (62.00 mg) of crude methanol extract 
which dissolved in (2 ml) of distilled water and partitioned three times with 
CHCl3 (3 × 50 ml) to yield (5.3 mg) of CHCl3 extract which dissolved in 5 ml 
of methanol for HPLC grad. 
 
1 ml of chloroform extract (1mg/ml) was run on reverse phase HPLC column 
(10 × 150 mm, flow rate 2 ml/min., run time 30 min eluted with 
CHCl3:MeOH:H2O (60: 45:5), this run was repeated again with the same 
conditions except  addition of 5 drops of 1, therefore the tiny peaks for 1 (RT 
4.88) in the first run become bigger after addition of drops from the standard 
compound in the second run as shown in the chromatogram below. Figure 
3.17 chromatogram is showing HPLC analysis of S. europaea chloroform 
extract (0.5 mg/ml). Figure 3.15 HPLC analysis of S. europaea chloroform 
extract (0.5 mg/ml) plus 0.2 ml of 1(1 mg/ml).       
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Figure 3.17 HPLC analysis of S. europaea chloroform extract (0.5 
mg/ml). 
 
 
 
Figure 3.18  HPLC analysis of S. europaea chloroform extract (0.5 
mg/ml) plus 0.2 ml of 1(1 mg/ml). 
 
 
      Analysis of 1 in crude glycosides of S. europaea 3.4.4.4
    
A samples of crude glycoside (B) was run on reverse phase silica gel 
column (10 × 225 mm, loop 100 μl) eluted with CHCl3: MeOH:H2O 
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( 60:45:5). The concentration of 1 in the crude glycoside extract was found 
to be very small because only a tiny peak at the retention time of (5.1 min) 
was found.  It was not possible to calculate the % 1 in the samples 
because the peaks were too small and also merged with glycoside peaks. 
Figure 3.19 chromatogram showing HPLC analysis of S. europaea crude 
glycosides sample B. 
 
 
Figure 3.19  HPLC analysis of S. europaea crude glycosides sample 
B. 
 
There are 4 possible sources in which 1 is present in the plant material as 
it can be synthesized by the plant itself, absorbed from the atmosphere or 
soil (plant habitat) or, it could be transferred to the plant during the 
extraction procedure (i.e. from the solvents or plastic equipment used to 
prepare the total plant extract) the plastic bags which were used to carry 
the plant to the research laboratory. 
 
Isolation of 1 from the plant species was mentioned in several references 
such as,  Calotropis gigantean (Habib and karim,, 2009), Alchornea 
cordifolia (Mavar et al., 2008),  Aloe vera (Lee K. F. et al., 2000),  
Euphorbia cyparissias and Euphorbia  seguieriana (Tothsoma et al., 
1993). Ricinus communis (Euphorbiaceae) (Pateh, 2009), Nuclea 
officinalis leaves  (Kui, 2009), culture broth of a fungus strain No. 36 
Pencillium olsonii (Amade et al., 1994) and Phyllanthus niruri. Marine 
Sadiment (at percentage 14.13%) (SudhaSrikesavan and Selvam, 2012), 
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Nocardia levis MK-VL_113 & Streptomyces tendae TK-VL_333 (Alapati 
and Muvva, 2013).  
 
In the following species the quantity or percentage of 1 in the plant extract 
was high, Marine macro alga, Ulva fasciata with percentage of 1 (88.42%), 
Calotropis gigantean (1.0 kg of plant material yield 38 g crude ethyl 
acetate extract of which 10 g was fractionated on normal phase silica gel 
for column chromatography and preparative TLC to yield 98 mg of 1).  
Compound 1 can be produced naturally by many types of algae and 
fungus. Chen (2004) reported the biosynthesis of 1 by red algae (Bangia 
atropurpurea) grown in a culture medium containing 14C-labeled sodium 
bicarbonate (Chen, 2004).  
 
Namikoshi et al., (2006) calculated the modern carbon content of 1 
isolated from three different algae (2 of which are edible) to range from 
50% to 87% (Namikoshi et al., 2006).  Amade et al (2009), isolated two 
metabolites from culture broth of a fungus strain No. 36 Pencillium olsonii   
(30 liters of Pencillium olsonii was used, first fraction 1.8 g was loaded on 
a silica gel column, fraction eluted with hexane – EtOAc (900 mg) was 
further purified to yield 725 mg of 1 (Amade et al., 1994). 
  
There is no clear mechanism by which 1 is absorbed from the atmosphere 
or soil (i.e. how much of 1 can be transfer to the plant) therefore it is 
difficult to make the decision about the sources of 1. 
 
In the plant under investigation (S. europaea) it can be eliminate the 
possibility of transfer 1 to the plant during the extraction process is unlikely 
because plastic equipment was not used during the extraction process. 
Also 2.5 L of hexane (analytical grade reagent) was dried using rotary 
evaporator then TLC analysis of the residue and a sample of standard 1 
was carried out. The results revealed that the residue did not contain 1, 
therefore this eliminates the possibility of source of 1 as a solvent 
contamination. Further work needs to be carried out with respect to 
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extraction of a sample of the soil in which the S. europaea is growing (a 
sample of soil in Dr Wright’s Garden). Moreover, growing of S. europaea 
in an a special atmosphere which supplied it only with oxygen then carried 
out the extraction of a sample from this source and producing TLC 
analysis of the total extract and a sample of 1 is required  to make a 
decision about the sources of 1.   
3.4.5         Isolation of   palmitic acid 2. 
 
A total of 74 mg hexane extract was separated on a normal silica gel 
column (G 60 F254 nm, mesh 200-400 μm, 2.5 × 40 cm) eluted with n-
hexane:dichloromethane gradient, followed by increasing the polarity 
using dichloromethane:ethyl acetate gradient as illustrated in Table 3.14.  
 
Table 3.14   Solvent conditions of silica gel column for isolation of 2. 
Mobile phase  % of compositions Volume (ml) Fraction 
Number(weights 
not recorded) 
Hexane 100 100 1-6 
Hexane: Dichloromethane 95:5 100 7-10 
Hexane: Dichloromethane 92:7 100 11-14 
Hexane: Dichloromethane 90:10 100 15-17 
Hexane: Dichloromethane 85:15 100 18-20 
Hexane: Dichloromethane 80:20 100 21-24 
Hexane: Dichloromethane 70:30 100  25-27 
Hexane: Dichloromethane 60:40 100 28-31 
Hexane: Dichloromethane 50:50 100 32-35 
Hexane: Dichloromethane 40:60 100 36-39 
Hexane: Dichloromethane 30:70 100 40-45 
Hexane: Dichloromethane 20:80 100 46-49 
Hexane: Dichloromethane 10:90 100 50-53 
Hexane: Dichloromethane 100 100 54-57 
Dichloromethane:ethyl acetate 90:10 100 58-61 
Dichloromethane:ethyl acetate 80:20 100 62-65 
Dichloromethane:ethyl acetate 70:30 100 66-69 
Dichloromethane:ethyl acetate 60:40 100 70-73 
Dichloromethane:ethyl acetate 50:50 100 74-77 
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        Further purification of 2 3.4.5.1
The TLC results (silica gel 60 F254  aluminium sheets 20× 20 cm   plates, 
chloroform: methanol: water (60:40:10) as a developing solvent and 
vallinin sulphuric acid as a spray reagent)  of fraction (62-73) table (3.14) 
revealed that it has one component plus a small quantity of impurity. 
Therefore it was further purified on normal phase silica gel column. The 
column conditions are summarized in Table 3.15. The TLC analysis of 
collected fractions showed that fractions (34-38) 2 mg have a single spot 
of 2. 
 
Table 3.15  Conditions of silica gel column chromatography of further purification 
of 2. 
Mobile phase  % of solvents Volume (ml) Fractions number 
Hexane 100 100 1-5 
Hexane: Dichloromethane 98:2 100 6-8 
Hexane: Dichloromethane 94:6 100 9-11 
Hexane: Dichloromethane 92:8 100 12-14 
Hexane: Dichloromethane 90:10 100 15-17 
Hexane: Dichloromethane 80:20 100 18-20 
Hexane: Dichloromethane 70:30 400  21-30. 
Hexane: Dichloromethane 60:40 300 31-40 (Compound 2) 
Hexane: Dichloromethane 50:50 100 41—44 
Hexane: Dichloromethane 40:60 100 45-47 
Hexane: Dichloromethane 30:70 100 48-50 
Hexane: Dichloromethane 20:80 100 51-53 
Hexane: Dichloromethane 10:90 100 54-56 
Dichloromethane:ethyl acetate 90:10 400 57-63. 
 
 
TLC analysis (section 2.5.5.) indicated that fractions (34-38, 2mg) have a 
single spot of 2. 
 
        Structure elucidation of 2  3.4.5.2
 
Compound 2 was isolated as oily substance from the hexane extract of S. 
europaea. TLC analysis (section 2.5.5.) of 2 showed no UV absorbtion at 
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254 or 357 nm and a dark blue colour after spraying  with  vanillin 
sulphuric acid and heating the plate  at 200 CO.  
 
The ES- mass spectrum of 2 Figure  3.20 showed a molecular ion peak 
[M-1] at m/z = 255.4, other peaks were observed at 256.4 [M+], 512.6 
[2M+], 537.6 [2M+Na+2H]. Accurate mass spectrum [EPSRC National 
Facility Swansea, LTQ Orbitrap XL] Figure 3.21 showed a significant peak 
at 257.2 [M+1] suggesting the molecular formula C16H32O2. Figure 3.22   
an expansion of accurate mass spectrum of 2.   
 
The 1H NMR and 13C NMR data of 2 are shown in  
Table 3.16. The 13C NMR (400 MHz, CDCl3) spectrum of 2 Figure 3.23 
displayed signals at 179.7 (C-1), 34 (C-2), δ between 28 to 30 are CH2 
type for (C-3 to C-14), 22 (C-15, CH2 α to CH3), 24.5 (C-15 β to CH3), 
14.13 (C-16, CH3). Figure 3.24  an expansion of 
13CNMR (400 MHz, 
CDCl3) spectrum of 2. 
 
The DEPT (400 MHz, CDCl3) spectrum of 2 Figure 3.25 shows peak at δ 
14.13 C-16, CH3), other peaks δ between 28 to 30 are CH2 type for (C-3 to 
C-14), these data are in accordance with reported data (Joshi et al., 2009).   
Figure 3.26 expansion of DEPT (400 MHz, CDCl3) spectrum of 2. 
  
The 1H NMR (400 MHz, CDCl3) spectrum of 2 Figure 3.27 showed signals 
at 2.60 (2H, t, H-2), 1.25-1.30 (24H, m, H-3 to H-14), 1.57 (1H, m, α H-15), 
2.17 (1H,m, β H-15) and 0.84 (3H, t, H-16). Figure 3.28 expansion of 1H 
NMR (400 MHz, CDCl3) spectrum of 2. 
 
 
 
 
  
86 
 
 
Table 3.16  
1
H and 
13
C NMR and DEPT data (400 MHz, CDCl3) of 2. 
Carbon number  
1
H NMR data (400 MHz, 
CDCl3) 
DEPT 
13
C NMR data (400 MHz, 
CDCl3) 
1 - O-C=O 179.7 
2 2.60 (2H, t, H-2) CH2 34 
3-14 1.25-1.30 (24H, m, H-3 to 
H-14).  
12 × CH2 28 to 30 
15 1.57 (1H,m, α H-15) 
2.17 (1H,m, β H-15) 
CH2 22.71 
24.5 
16 0.84 (3H, t, H-16) CH3 14.13 
 
 
 
 
       
Figure  3.20 ES- mass spectrum of 2. 
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Figure 3.21  Accurate mass spectrum of 2. 
                          
 
            
Figure 3.22   Expansion of accurate mass spectrum of 2. 
 
  
88 
 
Hexane nmr data.022.esp
220 200 180 160 140 120 100 80 60 40 20 0 -20
Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
 
Figure 3.23  13CNMR spectrum (400 MHz, CDCl3) of 2. 
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  Figure 3.24  Expansion of 13CNMR spectrum (400 MHz, CDCl3) of 2. 
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Figure 3.25  DEPT spectrum (400 MHz, CDCl3) of 2. 
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Figure 3.26  Expansion of DEPT spectrum (400 MHz, CDCl3) of 2. 
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              Figure 3.27  1H NMR spectrum (400 MHz, CDCl3) of 2. 
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Figure 3.28  Expansion of 1H NMR  spectrum (400 MHz, CDCl3) of 2. 
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Palmitic acid 2 was first isolated from palm oil in 1800 S, it also reported in 
other foods such as cheese, meat, butter, milk and olive oil. 2 is present in 
chocolate beside oleic and stearic acids.  
  
Harada et al (2002) studied the cytotoxic activity of 2 isolated from marine 
red alga. The results revealed that 2 has selective antitumor activity to 
human leukemic cells, but no cytotoxicity to normal HDF cell’s at 
concentrations of 12.5 to 50 µg/ml (Harada et al., 2001). 
 
It has been reported that 2 stimulates glucose incorporation in the 
adipocyte by mechanism likely involving intracellular calcium (Thode et al., 
1989).    
 
Joshi-Barve et al (2007) reported that patients with non-alcoholic 
steatohepatitis (NASH) have elevated serum levels of proinflammatory 
cytokines, such as interleukin-8 (IL-8), which are likely to contribute to 
hepatic injury. Therefore they examined the effect of hepatic steatosis on 
IL-8 PRODUCTION. They induced lipid accumulation in hepatocytes (Hep 
G2, rate primary hepatocytes and human primary hepatocytes) by 
exposing them to pathophysiologically relevant concentrations of palmitic 
acid to simulate the excessive influx of fatty acids into hepatocytes.  
 
Significant fat accumulation was documentd morphologically by Oil Red O 
staining in cells exposed to palmitic acid and it was accompanied by an 
increase in intracellular triglyceride levels. Palmitic acid was found to 
induce significantly elevated levels of biologically active neutrophile 
chemoattractant, IL-8, from steatotic hepatocytes (Joshi‐Barve et al., 
2007). 
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3.4.6 Isolation of Rosmarinic acid 3. 
 
A total of 26 mg of ethyl acetate fraction of the methanolic extract was 
fractionated over Sephadex LH20 (2.5 x 40 cm) (section 2.5.4), eluted with 
(300 ml, MeOH (100%). A total of 22 fractions of 21 ml each were 
collected. TLC analysis of the fractions (section 2.5.5.) revealed that 
fractions (20-21) 10 mg composed from  one compound  with some 
impurities, Sephadex chromatography was repeated for this fraction, 
eluting with (300ml, MeOH (100%) and a total of 19 fractions (21) ml each 
were collected. TLC analysis revealed that sub fractions 12-14 (20-21) 3 
mg and 15-17 (20-21) 1 mg appeared to contain individual compounds. 
Fraction (18-19) 7 mg has a single compound with small impurity; 
therefore it was again subjected to Sephadex chromatography with the 
same conditions. A total of 23 fractions (7 ml each) were collected, sub 
fractions (22-23, 1 mg) and (12-21, 2 mg) have a single spot. TLC analysis 
(section 2.5.5.) were carried out for all the single compounds, they   are 
found the same, and therefore they are collected to yield 7 mg of 3. 
 
   Structure elucidation of 3  3.4.6.1
 
Compound 3 (Rosmarinic acid) was separated as a sticky compound (7 
mg) from the ethyl acetate fraction of the methanolic extract of S. 
europaea TLC analysis (section 2.5.5.) of  3 was visible at 254 nm with a 
dark blue spot before spraying, while a pink spot after spraying. 3 showed 
a dark blue spot after spraying with ferric chloride, which indicates that it is 
a phenolic compound.  3 did not show any colour with Dragendorff’s 
reagent; suggests that it is not an alkaloid.   
    
The ES+ mass spectrum of 3 Figure 3.31 showed a molecular ion peak 
[M+] at m/z = 360.3, another peak was observed at m/z = 383.1 (M + Na)+. 
Figure 3.32 ES- mass spectrum of 3. 
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The 1H NMR and 13C NMR data of 3 are shown in Table 3.17. The 13C 
NMR spectrum (600 MHz, CD3OD) of 3  
Figure 3.33 shows 18 signals, therefore it has 18 carbon atoms, 2 of them 
are carbonyl carbons because they appear at δ ≈ 170 ppm. The most 
important peaks characteristic to C-9a, δ = 166, C-9b, δ = 170.1, other 
peaks were at 125.4 (C-1a), 113.9 (C-2a), 145.6 (C-3a), 146.6 (C-4a), 
115.2 (C-5a), 121.9 (C-6a), 144.8 (C-7a), 113.1 (C-8a), 127 (C-1b), 116.3 
(C-2b), 145.0 (C-3b), 144.0 (C-4b), 115.4 (C-5b), 120.2 (C-6b), 36.6 (C-
7b), 73.4 (C-8b). Figure 3.34 expansion of 13CNMR spectrum of 3 (600 
MHz, CD3OD).  
 
The DEPT spectrum Figure 3.35 shows one (-CH2-) group, nine (-CH-) 
groups (9 × CH = C9H9) and eight carbon atoms (8 × C = C8) two of them 
are carbonyl carbons, therefore this accounts for C18H11, and suggest 5-
OH groups are present. 
  
The 1H NMR (400 MHz, CD3OD) spectrum of 3 Figure 3.36 showed the 
existence of two groups of H-atoms in ABX structure on 1,3,4-
trisubstituted benzene rings [δ 7.03 (1H, d, J = 2.0 Hz, H-2a) / 6.76 (1H, d, 
J = 8.2 Hz, H-5a) / 6.93 (1H, dd, J = 2.0 Hz, H-6a); δ 6.73 (1H, d, J = 2.0 
Hz, H-2b) / 6.65 (1H, d, J = 8 Hz, H-5b) / 6.64 (1H, d, J = 8 Hz, H-6b)]. 
Two benzoic methane signals [δ 7.54 (1H, d, J = 16 Hz, H-7a) / 6.25 (1H, 
d, J = 16 Hz, H-8a)]; two signals for aliphatic protons [δ 3.0 (2H, m, H-7b) / 
5.00 (1H, m, H-8b)] were also observed in the spectrum. Figure 3.36 
expansion of 1HNMR spectrum of 3 (600 MHz, CD3OD). Figure 3.29 part 
of structures of 3 assigned from 1H NMR spectrum.    
 
The correlations between H-2a / H-7a, H-2b / H-7b in the long range 1H-1H 
COSY spectrum Figure 3.38 indicated the linkages of C-1a / C-7a, C-1b / 
C-7b respectively. Figure 3.30 part of structures of 3 assigned from H-H 
Cosy and HMBC spectra. Figure 3.39 shows HMQC NMR spectrum of 3 
(600 MHz, CD3OD). 
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In the HMBC spectrum of 3 Figure 3.40 there is a long rang correlation 
between H-7a and H-8a. Also H-8a is correlated with C-1a which already 
correlated with H-7a indicating that C-7a and C-8a are connected with 
each other.  
 
 
In the HMBC H-7a is correlated with C-9a (quaternary carbon δ 166 also 
H-8a is correlated with the same carbon C-9a his allows the placement of 
the carbonyl group. from the 1H-1H COSY it is indicated that C-1b at δ = 
127.3 is connected to C-7b which has correlation with C-6b (δ = 120.2) / 
C-2b δ = 116.7 and another carbon at δ = 170.1 which theoretically could 
be a carbonyl group, from HMBC spectrum there is a single at (δ = 5.0 m) 
correlated to C-1b and to single at (δ = 170.1 which could be a carbonyl 
group) as long as C-7b is connected to C-1b this confirm that C-7b is 
attached to a newly assigned carbon C-8b and the latter  is attached to the 
carbonyl group at δ = 170.1.  
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Figure 3.29  Partial structures of 3 assigned from 1H NMR spectrum. 
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Figure 3.30  Partial structures of 3 assigned from H-H COSY (bold 
bond) and HMBC (arrows) spectra. 
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Table 3.17   1D and 2D NMR date (600MHz, CD3OD) of 3. 
 
Carbon No. δ 
1
H NMR data (600 MHz, 
CD3OD) 
δ 
13
C NMR data (600 
MHz, CD3OD)  
HMBC 
1 - 125.4 - 
2 7.03 (1H, d, J = 2.0, H-2) 113.9 125.4, 148.6 
3 - 145.6 - 
4 - 146.6 - 
5 6.76 (1H, d, J = 8.2, H-5) 115.8 125.4, 145.6 
6 6.93 (1H, dd, J = 2.0, 8.2, H-6) 121.9 148.6 
7 7.54 (1H, d, J = 16, H-7) 144.8 125.4, 113.9, 
166 
8 6.25(1H, d, J = 16, H-8) 113.1 125.4, 166 
9 - 166 - 
1` - 127 - 
2` 6.73 (1H, dd, J = 2.0, H-2`) 116.3 120.2, 144.0 
3` - 145.0 - 
4` - 144 - 
5` 6.65 (1H, d, J = 8, H-5`) 115.4 127.3, 145.0 
6` 6.54 (1H, d, J = 8, H-6`) 120.2 116.7, 144.0 
7` 3.0 (1H, m, H-7`) 36.6 116.7, 120.1, 
127.3, 170.1 
8` 5.00 (1H, m, H-8`) 73.4 127.3, 170.1 
9` - 170.1 - 
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Figure 3.31  ES+ mass spectrum of 3. 
 
 
                   
Figure 3.32  ES- mass spectrum of 3. 
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Figure 3.33  13CNMR spectrum (600 MHz, CD3OD) of 3. 
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Figure 3.34  Expansion of 13CNMR spectrum (600 MHz, CD3OD) of 3. 
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Figure 3.35  DEPT spectrum (600 MHz, CD3OD) of 3. 
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Figure 3.36  1H NMR spectrum (600MHz, CD3OD) of 3. 
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Figure 3.37  Expansion of 1HNMR spectrum (600 MHz, CD3OD) of 3. 
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Figure 3.37 Continued. 
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Figure 3.37 Continued. 
 
 
 
        Figure 3.38  COSY- NMR spectrum (600 MHz, CD3OD) of 3. 
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Figure 3.39  HMQC spectrum (600 MHz, CD3OD) of 3. 
 
Figure 3.40  HMBC spectrum (600 MHz, CD3OD) of 3. 
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              Pharmacological actions of 3 3.4.6.2
 
Rosmarinic acid 3 is an active compound of many culinary plants (mint, 
meliss, prunella, sage, thyme, rosemary, orange, basil and sweet) 
(Karmokar et al., 2012), (Dubois et al., 2008).  
 
Anusuya and Manoharan in (2011), studied the effect of 3 against 7,12-
dimethylbenz(a) anthracene (DMBA) induced oral carcinogenesis. The 
results showed that 3 completely prevented the tumour formation and 
returned the status of biochemical and molecular markers to almost 
normal range in hamsters treated with DMBA. 3 (100 mg/kg body wt.) was 
found to stimulate detoxification enzymes, downregulate the expression of 
P53 and bcl-2 during DMBA induced oral carcinogenesis and improve the 
status of lipid peroxidation (Anusuya and Manoharan, 2011). 
 
Compound 3 was found to prevent the development of cancer in 
preclinical studies. Therefore this study was aimed to evaluate the effect of 
3 on development of intestinal adenomas. The results were compared with 
levels of 3 in the plasma and gastrointestinal tract. It is concluded that 3 
inhibited the growth of Apc 10.1 cells derived from Apc Min  mouse 
adenomas with IC50 value of 43 μm. The percentage of 3 in intestinal 
mucosa and in the plasma was found 38 nmol/g and 1.1 μm respectively 
(Karmokar et al., 2012). 
 
 The anti-inflammatory activity of rosmarinic acid was investigated in a 
murine model of respiratory allergy (asthma) by Ryan et al (2012). A/J 
mice model were used in thier study. Aspiratory allergy was induced by 
administration of Blomia  tropicalis  (BT) mite. The treatment was carried 
out using 2, 20 or 200 mg/kg of 3. The results showed that treatment of 
animals with 100 mg/kg and 200 mg/kg  of 3 led to a significant reduction 
in the numbers of leukocytes/eosinophils in bronchoalveolar lavage (BAL), 
like eosinophil peroxidas activity of BAL presence of mucus in respiratory 
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tract, histopathological changes in the lung and IL-4 in BAL (Costa et al., 
2012). 
The biological activity of 3 against (cis-diamminedichloroplatinum (II), 
Cisplatin (CP) induced nephrotoxicity was investigated by Rebert et al., 
(2014). Treatment with 3 considerably improved histopathological changes 
and the increase in serum creatinine and blood urea nitrogen (BUN) 
induced by CP. Administration of 3 significantly decreased 
hemeoxygenase (HO-1), cytochrome P450 ZE1, (CYPZE1) and renal 4-
hydroxy nonenal (4-HNE) expression which were induced by CP. 
Furthermore, 3 showed antiapoptotic activity by decrease of P53, 
phosphorylated P53 and active caspase-3-expression in the kidneys 
(Domitrović et al., 2014).      
 
The effect of 3 on atopic dermatitis (AD) was carried out by Jongsung et al 
(2008). In this study 7 men and 14 women aged between 5 to 28 years 
suffering from AD were involved. Emulsion of 3 at concentration of (0.3%) 
was topically applied to the elbow flexures of AD patients twice a day. All 
individuals were evaluated for skin conditions before treatment at the first 
visit and then at 4 and 8 weeks after treatment. According to AD index 
results, the erythema on antecubital fossa was significantly reduced at 4 
and 8 weeks (P < 0.05). Self-questionnaires on effect of 3 indicated that 
dryness, pruritus and general AD symptoms improved; this suggest 
potential of clinical use of 4 as therapeutic agent for AD. 3 and it’s acetyl 
ester derivatives which isolated from Rosmarinus officinalis  were used as 
anti-inflammatory (Lee et al., 2008).   
    
 
The nitration of 3 produced 6`- nitro and 6`,6``-dinitrorosmarinic acids. 
Both derivatives were found to have HIV-1, integrase inhibitors and anti-
viral activity in MT-4 cells with similar selectivity indexes (Dubois et al., 
2008). 
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The effects of 3 on a cultured neuronal cell line, SH-SY5Y in vitro and 
experimental ischemic diabetic stroke in vivo was evaluated by Haiyun etal  
(2013). 3 was incubated with tumour necrosis factor- α (TNF-α) stimulated 
SH-SY5Y cell line in vitro and oxygen-glucose deprived (OGD)-diabetic 
rats were used for an in vivo experiment. The rats were subjected to 
middle cerebral artery occlusion (MACO) for 40 minutes followed by 
reperfusion for 23 h. The results revealed that 3 decreased the OGD-
induced apoptosis and cytotoxicity. In addition, 3 produced a considerable 
neuroprotective activity in rats with ischemia and reperfusion (I/R) at doses 
higher than 50 mg/kg (Luan et al., 2013).  
             
3.4.7            Isolation of saniculoside N 4.  
 
Fraction 11 (section 3.10) was further purified on normal phase silica gel 
column (section 2.5.1.) to yield 4, the column conditions are showed in 
Table 3.18. Normal phase silica gel 30 g (for thin layer chromatography 
particle size 12 µm, section 2.5.1) was suspended in 200 ml chloroform to 
make a paste. Thin layer of sand was place a in the column.  The paste 
was gently poured without disrupting the layer of sand at the bottom of the 
column. The silica allowed to settle and form a compact mass making sure 
that the level of solvent i.e. chloroform is above the surface of silica then 
place another band of sand on the silica mass. Fraction number 11 (284 
mg) was suspended in approximately 5 ml of methanol. The sample was 
gently poured in the prepared column, the side of column washed with 
80:20 chloroform:methanol to make sure the entire sample gets to the 
silica. 
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Table 3.18 Conditions of silica gel column chromatography of 
fraction C2 (section 3.3.2). 
 
 
 
Fractions (17-26) table (3.18) 16 mg contained 4. Preparative TLC (silica 
gel F254 aluminium sheets 20x20 cm plates, chloroform:methanol:water, 
60:40:10 as a developing solvent) was carried out to yield 4 mg of 4. 
 
  Structure elucidation of 4 3.4.7.1
  
Compound 4 was isolated as a white crystal from the crude glycosides 
extract of S. europaea. TLC analysis (section 2.5.5) of 4 showed no UV 
activity at 254 nm and a green spot after vanillin/sulphuric acid spraying. 
The ES- mass spectrum of 4 figure 3.41 showed a molecular ion peak [M-
H]- at m/z = 1099, suggesting a molecular weight of 1100. Another peak 
was observed at m/z = 968 [1101-arabinose]-. Table 3.19 is shown 
comparison of FAB-MS data of saniculoside N with the ES- mass data of 
4.  
 
Mobile phase  % of composition Volume (ml) Fractions (7 ml)  
CHCl3: MeOH 80:20 50 1 
CHCl3: MeOH 70:30 100 2-6 
CHCl3:MeOH 60:40 100 7-13 
CHCl3:MeOH 50:50 100 14-20 compound 4 
CHCl3:MeOH 40:60 100 21-26 compound 4 
CHCl3:MeOH 35:65 100 27-31 
CHCl3:MeOH 30:70 100 32-37 
CHCl3:MeOH 20:80 100 38-43 
MeOH 100 100 44-49 
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Table 3.19   Comparison FAB-MS data of saniculoside N with the ES-
mass data of 4. 
  FAB(-) mass data of  saniculoside N ES-  mass data of 4 
m/z Fragments m/s Fragments 
1099 [M-H]
-
 1101 [M-H]
-
 
967 [1099-arabinose]
-
 968 [1101- arabinose]
-
 
805 [968-glucose]
-
 Not observed - 
587 [805-glucuronic acid 
propyl ester]
-
 
Not observed - 
 
 
1H NMR spectrum (600 MHz, C5D5N) of 4 Figure 3.42 showed 
characteristic features of saponin compounds; therefore a revision of 
saponin compounds which isolated from S. europaea was carried out in 
order to find any matched data. The results revealed that saniculoside N 
was isolated from S. europaea. (Arda et al., 1997) has a molecular weight 
of m/z 1100 the same as 4. A comparison of 1H NMR data (600 MHz, 
C5D5N)  of 4   with both 
1H NMR data (200 MHz, CD3OD)  of saniculoside 
N Table 3.20  and 1H NMR data (200 MHz, CDCl3)  of saniculagenin N 
Table  3.21 revealed that 4 is saniculoside N.     
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Table 3.20 Comparison of 1H NMR data (200 MHz, CD3OD) of 
saniculoside N with 1H NMR data (600 MHz, C5D5N)  of  4. 
 
1
H NMR data (200 MHz, CD3OD)  of 
saniculoside N  
1
H 
 
NMR data (600 MHz, C5D5N) of 4  
5.48 (1H, d, J = 9 Hz, H-1 of glucose) 5.31 (1H, d, H-1 of glucose) 
5.81 (1H, d, J = 10 Hz, H-1 of arabinose) 5.60 (1H, d, H-1 of arabinose) 
4.94 (1H, d, J = 7.6 Hz, H-1 of glucuronic 
acid) 
4.40 (1H, d, H-1 of  glucuronic acid) 
3.00-4.30 (CH2O-CHO of sugars protons) 3.00-4.30 (CH2O-CHO of sugars protons) 
6.06 (1H, q, H-3` of angelic acid ester) 6.20 (1H, dd, H-3`) 
1.92 (3H, d, J = 7Hz, H-4` of angelic acid 
ester) 
1.81 (3H, d, H-4`) 
1.87 (3H, s, H-5` of angelic acid ester) 1.50 (3H, s, H-5`) 
 
Table  3.21 Comparison of 1H  NMR data (200 MHz, CD3OD)  of 
saniculagenin N with 1H NMR data (600 MHz, C5D5N) of 4. 
1
H NMR data  of saniculagenin N (200 
MHz, CDCl3) 
1
H 
 
NMR data of 4 (600 MHz, C5D5N) 
0.79-1.34 (6H, s, H-23 & H-27) 0.79-1.30 (6H, s, H-23 & H-27) 
1.00 (6H, s, H-29 & H-30) 1.08 (6H, s, H-29 & H-30) 
1.72 (3H, s, H-5`) 1.50 (3H, s, H-5`) 
1.83 (1H, bd, J = 7Hz, H-4`) 1.81 (1H, bd, H-4`) 
3.22 (1H, dd, J = 6.0, H-3) 3.00 (1H, dd, H-3) 
3.31 (1H, d, J = 12 Hz, H-28`) 3.30 (1H, d, H-28`) 
3.54 (1H, d, J = 12 Hz, H-28) 3.40 (1H, d, H-28) 
3.92 (1H, d, J = 10 Hz, H-22) 3.69 (1H, d, H-22) 
4.04 (1H, bd, J = 4Hz, H-16) 3.90 (1H, bd, H-16) 
4.31 (1H, bs, H-15) 4.10 (1H, bs, H-15) 
5.37 (1H, bs, H-12) 5.30 (1H, bs, H-12) 
5.40 (1H, d, J = 10 Hz, H-21) 5.45 (1H, bd, H-21) 
6.12 (1H, q, J = 7.0, 1.5 Hz, H-3`) 6.20 (1H, q, H-3`) 
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Figure 3.41  ES- mass spectrum of 4. 
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Figure 3.42  1H NMR (600MHz, C5D5N) spectrum of 4. 
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Figure 3.42 Continued 
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Taking in the account the different in the frequency and solvents in which 
1H NMR analysis of 4 and both saniculoside N and saniculagenin N were 
carried out, it can be concluded that 4 is saniculoside N.  Furthermore, 4 
was also isolated from S. europaea crude glycosides extract using HPLC 
technique (section2.3.6.3).        
  
3.4.8  Isolation of sugar fractions (sucrose, glucose and fructose) 5  
  
70 g of Sephadex LH20 were suspended in 450 ml of chloroform to make 
a suspension. The suspension was poured in the column.  About 3.6 g of 
crude glycoside were dissolved in methanol (30 ml) than concentrated to 
(10 ml) of methanol extract. This extract was transferred to Sephadex 
LH20 column. 40 fractions of 25 ml each were collected. The 
chromatographic fractionation was monitored using silica gel 60 F254  
aluminium sheets 20× 20 cm plates, chloroform:methanol:water, 60:40:10 
as a developing solvent and vallinin sulphuric acid and anisaldehyde as a 
spray reagents.  
 
Fraction number B2(44-67, 76 mg) section 3.3.2 contains two bands with a 
green colour on spraying,  preparative TLC (silica gel 60 F254  aluminium 
sheets 20× 20 cm   plates, chloroform:methanol:water,  60:40:10 as 
developing solvent) was carried out of the fraction, the two bands 
corresponding to the two compounds were collected. 5 was 16 mg was 
contained some impurity, so it was run again on a small TLC grad silica 
gel G6 column using 10 grams. The results are shown in Table 3.22. The 
quantity of other band was small so it discarded. 
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Table 3.22  Conditions of silica gel column chromatography of further 
purification of 5. 
Mobile phase  % of composition Volume (ml) Fractions( 7 ml) 
CHCl3:MeOH 80:20 50 1-7 
CHCl3:MeOH 70:30 100 8-21 
CHCl3:MeOH 60:40 100 22-26 compound 5 
CHCl3:MeOH 50:50 100 27-33 compound 5 
CHCl3:MeOH 40:60 100 34-39 
CHCl3:MeOH 30:70 100 40-43 
CHCl3:MeOH 20:80 100 44-47 
Methanol 100 100 48 
 
 
      Structure elucidation of 5 3.4.8.1
 
Compound 5 was isolated as a white crystal from the crude glycosides 
extract of S. europaea. TLC analysis of 5 on silica gel 60F254 (section 
2.5.1) showed no UV activity at 254 nm and a green spot after 
vanillin/sulphuric acid spraying (2.8.2). In the ES+ mass spectrum of 5 
Figure 3.43  there is an evidence of glucose molecule m/z = 180 [m/z = 
203 (M + Na), m/z = 360 (2M), m/z = 383 (2M + Na)], also there is an 
evidence of sucrose molecule m/z = 412 [m/z = 413 (M + 1), m/z = 334 (M 
- CH2OH)]. 
 
Furthermore, because of sucrose was isolated from Teucrium davaeanum 
(section) therefore a comparison between the ES+ mass spectrum of 5 
and accurate mass of sucrose 9 which isolated from T. davaeanum 
(Figure 4.46) was carried out. The following peaks were appears in both 
spectra (236.2, 245.1, 266, 301, 310, 334, 360.6, 361.4, 413 and 414). 
 
The 13C NMR spectrum of 5 Figure 3.44 (600 MHz, D2O) showed 24 
signals in which 20 were observed in the region between δ = 60 to δ = 80 
which is characteristic to the sugars molecule. In addition to four signals in 
anomeric proton region, but the signal at 101 is for quaternary carbon 
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because it is not appear in the DEPT spectrum Figure 3.45 (600 MHz, 
D2O). From the above data a total of 24 C signals of which three are 
anomeric protons are observed.  
 
The 1H NMR spectrum of 5 Figure 3.46 (600 MHz, D2O) displayed signals 
at δ value in the region between δ = 3.20 to δ = 4.20 which is 
characteristic to sugars molecules, and it is a complex region indicated 
that the sample is composed from more than one sugars. The peaks in the 
downfield region of the 1H NMR spectrum showed signals of three 
anomeric protons at δ 5.20, 4.64 and 4.19. 
 
These data are in accordance with reference data from Gabriel et al  
(2013). The auteurs were identified the sugar fraction which isolated from 
Apple Pomace. It was composed from three sugars (glucose, sucrose and 
fructose) (Gabriel et al., 2013). By comparison of 1H NMR data (600 MHz, 
D2O) of 5  Figure 3.46 with the
1H NMR data of sugar fraction of Apple 
Pomace (200 MHz, D2O) Figure 3.47 it can be concluded that 5 is a 
mixture of three sugars (glucose, sucrose and fructose). TLC using 
standard sugar samples (sucrose, glucose and fructose) with 5 could be 
carried out to confirm the identity of the sample.    
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                     Figure 3.43  ES- mass spectrum of 5. 
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Figure 3.44  13CNMR spectrum (400 MHz, D2O) of 5. 
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Figure 3.45  DEPT spectrum (400 MHz, D2O) of 5. 
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Figure 3.46  1HNMR spectrum (400 MHz, D2O) of 5. 
 
  
120 
 
 
 
Figure 3.46 Continued. 
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Figure 3.47  1HNMR spectrum (D2O) of sugar mixture isolated from 
Apple Poemes. 
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3.5  Isolation of partial purified saponins mixture via HPLC system 
 
In previous chapter open column chromatography, packed with either 
normal or reverse phase silica gel or sephdex LH-20 was used to purify 
the saponin glycosides from the crude glycosides extract of S. europaea L. 
This resulted in partial purification of saponin fractions A, B and C. Whilst 
preparative TLC was successful in purification of one saponin compound 
(4) the quantity was small and the method was time consuming. In this 
chapter, analytical  HPLC was used to separate saponin compounds of a 
crude glycoside extract of S. europaea L, with the preparative HPLC 
technique being used to purify those compounds, to be used in further 
efficacy studies 
   
3.5.1         Separation parameters of S. europaea glycosides 
                                                                                                                                                                                     
 The saponin fractions of S. europaea (all samples prepared as  1 mg/ml) 
were separated by HPLC (section 2.7)  using two types of columns; 
reverse phase silica gel C18 column  and normal phase silica gel column 
(10 × 225 mm) injection loop 20 μl several mobile phases were used, flow 
rate varied between 1 and 7 ml/min. 
 
Reverse phase silica gel column was used to separate the saponin 
fraction of S. europaea several mobile phases were tested on this column 
as illustrated in Table 3.23. The flow rate was also changed between 0.5 
and 1 ml/min and the run time was between 30 and 60 minutes. The aim 
of variation in mobile phases and flow rate was to find out what 
parameters produce a best separation of saponin compounds.  
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Table 3.23  Composition of mobile phases tested for separation of saponins 
fraction B. on reverse phase HPLC column. 
 
 
 Mobile phase  % of composition Flow rate ml/min.  Run time(min.) 
 MeOH:H2O  90:10  1.0  30 
 MeOH:H2O  70:30  1.0  60 
 MeOH:H2O  50:50  1.0  30 
 MeOH:H2O  45:55  1.0  60 
 MeOH:H2O  40:60  1.0  30 
 MeOH:H2O  35:65  1.0  30 
 MeOH:H2O  35:65  0.5  30 
 H2O  100  1.0  30 
 CH3CN:H2O  90:10  1.0  30 
 CH3CN:H2O  70:30  1.0  30 
 CH3CN:H2O  50:50  1.0  30 
 CH3CN:H2O  45:55  1.0  30 
 CH3CN:H2O  40:60  1.0  30 
 CH3CN:H2O  35:65  1.0  30 
 MeOH:H2O:CH3CN  50:50:50  1.0  60 
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Figure 3.48  HPLC analysis of saponin fraction B, eluting CH3CN:H2O 
90:10.   
It can be established from Figure 3.48 that a mobile phase compositions of 
CH3CN:H2O 90:10, flow rate 1 ml/min, did not separate the saponin 
compounds from saponin fraction B (1mg/ml), as the targeted compounds 
eluted from the column as a single peak. TLC analysis of the saponin 
fraction B showed that the fraction comprised at least four compounds. 
Therefore a total of four peaks or more would be expected.   
 
 
Figure 3.49 HPLC analysis of saponin fraction B,  eluting CH3CN:H2O, 
70:30. 
Using  of crude glycosides B (1mg/ml) silica gel C-18, mobile phase of 
CH3CN:H2O, 70:30, flow rate 1 ml/min, Figure 3.49 to separate the 
saponin compounds from saponin fraction B was not successful. Because 
the compounds still eluted from the column as a single peak. Therefore                                                                                                                             
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the next experiment was to increase the polarity of mobile phase till 50:50, 
CH3CN:H2O. 
   
 
Figure 3.50 HPLC analysis of saponin fraction B,  eluting CH3CN:H2O, 
50:50. 
 
The results of separation of the saponins fraction of S. europaea on 
reverse phase silica gel column connected to the analytical HPLC indicate 
that as amount of MeOH and CH3CN in MeOH:H2O and CH3CN:H2O  
decreased the separation is improved. The best chromatographs were 
resulted on using mobile phases compositions of 50:50 and 35:65 for both 
solvents MeOH:H2O and CH3CN:H2O.  
 
Therefore, the next step was to use a new column (normal phase silica gel 
column 10 × 225 mm, loop 100 µl) a polar stationary phase which may 
produce a better separation to the saponin fraction B because the 
saponins will adsorb to the silica gel, so by increasing the polarity of 
mobile phase the less polar compounds will elute from the column first and 
the more polar compounds will elute at the end by increasing the polarity 
of mobile phase. Changes in both composition of mobile phase 
CH3CN:H2O, 50:50 and flow rate between 1, 2, 3, 5 and 7 ml/min were 
also suggested to improve the separation. Inclusion of a third mobile 
phase such as isopropanol and acetic acid was also recommended. The 
reason of changing in the percentage of compositions of mobile phase and 
the flow rate was to find out which parameters produce the best 
separation. Table 3.24 illustrates the compositions of mobile phases which 
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used to separate the saponins fraction B of S. europaea on normal phase 
silica gel column connected to HPLC technique. 
 
At this step it can be concluded that two parameters could produce a 
better separation of saponins on normal phase silica gel column, increase 
the polarity of mobile phase and decrease the flow rate to 3 or 2 ml/min. 
 
Table 3.24  Composition of mobile phases which tested for 
isolation of saponins fraction B on normal phase column  
 
 Mobile phase  % of 
Composition 
 Flow rate 
ml/min 
 Notes 
 CH3CN:MeOH:Isprop-ol  35:60:5  5 Poor 
separation 
 CH3CN:MeOH:Isprop-ol  35:55:10  5  Poor separation 
 CH3CN:MeOH:Isprop-ol  35:55:10  3  Improved separation 
 CH3CN:MeOH:Isprop-ol  35:60:5  3  Improved separation 
 CH3CN:MeOH:Isprop-ol  35:60:5  7  Poor separation 
 CH3CN:MeOH:Isprop-ol  40:55:5  5  Poor separation 
 CH3CN:MeOH:Isprop-ol  35:60:5  2  Improved separation 
 CHCl3:EtoAC:MeOH:H2O 75:10:14:1  3  Poor separation 
 CHCl3:EtoAC:MeOH:H2O  75:10:14:1  5  Poor separation 
 CHCl3:EtoAC:MeOH:H2O  75:10:14:1  7  Poor separation 
 CHCl3:MeOH: ACOOH 60:45:5  3  Poor separation 
 CHCl3:MeOH: ACOOH  60:45:5  5  Poor separation 
 CHCl3:MeOH: ACOOH  60:45:5  7  Poor separation 
 CHCl3:MeOH:H2O: ACOOH  60:45:4:1  3  Poor separation 
 CHCl3:MeOH:H2O: ACOOH  60:45:4:1  5  Poor separation 
 CHCl3:MeOH:H2O: ACOOH  60:45:4:1  7  Poor separation 
 CHCl3:MeOH:H2O  15:1:0  2 Poor eparation 
 CHCl3:MeOH:H2O  8:1:0.1  1.0  Poor separation 
 CHCl3:MeOH:H2O  60:40:10  5  Improved separation 
 CHCl3:MeOH:H2O  60:45:5  5  Improved separation 
 CHCl3:MeOH:H2O:Isopropanol  60:45:5: 5  5  Improved separation 
 CHCl3:MeOH:H2O:Isopropanol  60:45:5:10  5  Poor separation 
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Figure 3.51 HPLC separation of saponin fraction B, eluting 
CH3CN:H2O:Isopropanol, 35:60:5. 
 
 
 
 
Figure 3.52  HPLC analysis of saponin fraction C, eluting 
CHCl3:MeOH:H2O,  60:45:5. 
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Figure 3.53 HPLC analysis of saponin fraction C eluting 
CHCl3:MeOH:H2O,  60:45:5. 
 
 
The best two mobile phases for fractionation of saponins fraction of S. 
europaea on analytical HPLC column connected to normal phase silica gel 
column were CH3CN:H2O:Isopropanol, 35:60:5, flow rate 3 ml/min, and 
CHCl3:MeOH:H2O, 60:45:5, flow rate 1 ml/min because with decrease the 
flow rate, the saponins will have enough time to adsorb to silica gel, and 
the saponins will separate into several peaks instead of single peak. 
Therefore the less polar compounds will elute from the column first 
followed by more polar compounds.   
 
The flow rate has a significant effect on purification of saponins fraction of 
S. europaea on normal phase silica gel column, as the flow rate 
decreased as the peaks well separated on normal phase silica gel  column 
figure (3.51), because the saponins separated into two distinguish peaks.  
Therefore the next step was fractionation of saponins using one of these 
two mobile phases. 
 
3.5.2     Purification of saponins fraction via preparative HPLC 
system 
 
Separation of saponins from S. europaea on analytical HPLC was best 
achieved using the mobile phase compositions of CH3CN:H2O: 
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Isopropanol, 35:60:5 at a flow rate 3 ml/min.  A gradient system of 
CH3CN:H2O:0.1% formic acid was used as a mobile phase to do 
purification of the saponins fraction of S. europaea on a preparative HPLC 
system connected to C-18 silica gel column. 
  
Four different gradient systems were used to purify the saponins fraction B 
(the purest sample) via preparative HPLC system connected to normal 
phase silica gel column. The sample was prepared by dissolving 6 mg in 1 
ml distilled water (6mg/ml), the injection loop was 100 µl (injection of 0.1 
mg each time), a luna C-18 column was used, the flow rate was 3 ml/min. 
Solvent A was composed from 5 % CH3CN + 0.1 % formic acid, solvent B 
was composed from 95% CH3CN + 0.1 % formic acid. The system was 
washed and equilibrated at the end of each run.    
 
In the first method 100% solvent A was run for the first 10 minutes Table 
3.25, followed by gradient to 40 % solvent B at 50 minutes, held for 50 
minutes. The wash started at 65 minutes. In order to established at what 
UV wavelength region the saponin compounds absorb UV light, the 
preparative HPLC system (PDA) was set to 200 and 290 nm. The DAD 
spectral analysis showed that most of the polar compounds (hydrophilic 
peak) absorbed the UV light at three wavelengths 220 Figure 3.54, 290 
Figure 3.55  and 330   
Figure 3.56. While nonpolar compounds (hydrophobic) absorbed the UV 
light at one wavelength. Therefore, by using these methods there were 
two targets can be collected, a major peak eluted at 43 minutes and a 
number of nonpolar compounds eluted at 40 % CH3CN.  
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Table 3.25  Gradient system applied in method 1 to purify saponins 
fraction B. 
 Time Flow %A %B Curve 
1 0.01 3.00 100.0 0.0 6 
2 10.00 3.00 100.0 0.0 6 
3 50.00 3.00 60.0 40.0 6 
4 65.00 3.00 60.0 40.0 6 
5 67.00 3.00 95.0 5.0 6 
6 79.00 3.00 95.0 5.0 6 
7 82.00 3.00 100.0 0.0 6 
8 97.00 3.00 100.0 0.0 6 
 
 
 
Figure 3.54  Compounds have absorption at 220 nm method 1. 
    
 
Figure 3.55  Compounds have absorption at 290 nm method 1. 
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Figure 3.56  Compounds have absorption at 330 nm method 1. 
 
The second method started at 10 % solvent B for the first 5 minutes              
Table 3.26, then gradients to 40 % solvent B at 35 minutes, held for 20 
minutes then column wash was started at 55 minutes.  There were two 
aims of the second method, reduced the run time and to improve the 
response from nonpolar compounds at a new wavelength 330 nm. The 
results showed that collection of the major polar peaks can be achieved by 
16 minutes. Also, the separation of the non-polar compounds was 
improved. Figure 3.57 compounds which have a single maxima at 220 nm 
(method 2). Figure 3.58 compounds which have a single maxima at 290 
nm (method 2). Figure 3.59 compounds which have a single maxima at 
330 nm (method 2). 
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             Table 3.26  Gradient system applied in method 2  
 
 Time Flow %A %B Curve 
1 0.01 3.00 90.0 10.0 6 
2 5.00 3.00 90.0 10.0 6 
3 35.00 3.00 60.0 40.0 6 
4 55.00 3.00 60.0 40.0 6 
5 57.00 3.00 95.0 5.0 6 
6 69.00 3.00 95.0 5.0 6 
7 72.00 3.00 90.0 10.0 6 
8 87.00 3.00 90.0 10.0 6 
 
 
  
 
 
Figure 3.57  Compounds have absorption at 220 nm method 2. 
 
    
 
Figure 3.58  Compounds have absorption at 290 nm method 2. 
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Figure 3.59  Compounds have absorption at 330 nm method 2. 
 
The third method was started at 25 % solvent B for 5 minutes then 
gradient to 40 % B at 35 minutes followed by held for 20 minutes              
Table 3.27. The column wash was started at 55 minutes. The aim of 
method 3 was to attempt to resolve the major hydrophilic peak in the 
shortest time possible.  
Figure 3.60 compounds which have a single maxima at 220 nm.  
Figure 3.61 compounds which have a single maxima at 290 nm.  
Figure 3.62 compounds which have a single maxima at 330 nm. 
 
The results showed that at 330 nm all the early eluted polar compounds 
were combined into a single peak. Another peak was observed from 
approximately 10 minutes. The major peak was eluted at 13.5 minutes. 
While the later nonpolar compounds were eluted at 28 minutes. Table 3.28 
and  
Table 3.29 the gradient system applied in method three with reduce the 
run time. Table 3.30 is shown the gradient system applied in method three 
to purify the saponins fraction B with 25 % with 25 % solvent B for the first 
35 minutes. 
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             Table 3.27  Gradient system applied in method 3  
 
 Time Flow %A %B Curve 
1 0.01 3.00 75.0 25.0 6 
2 5.00 3.00 75.0 25.0 6 
3 17.00 3.00 69.0 31.0 6 
4 18.50 6.00 5.0 95.0 6 
5 24.50 6.00 5.0 95.0 6 
6 26.00 6.00 75.0 25.0 6 
7 30.00 6.00 75.0 25.0 6 
8 32.00 3.00 75.0 25.0 6 
9 34.00 3.00 75.0 25.0 6 
 
 
Table 3.28  Gradient system applied in method 3 with reduce run 
time. 
 
 Time Flow %A %B Curve 
1 0.01 3.00 75.0 25.0 6 
2 5.00 3.00 75.0 25.0 6 
3 17.00 3.00 69.0 31.0 6 
4 18.50 6.00 5.0 95.0 6 
5 24.50 6.00 5.0 95.0 6 
6 26.00 6.00 75.0 25.0 6 
7 30.00 6.00 75.0 25.0 6 
8 34.00 3.00 75.0 25.0 6 
 
 
Table 3.29  Gradient system applied in method 3 with more reduce 
the run time. 
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 Time Flow %A %B Curve 
1 0.01 3.00 75.0 25.0 6 
2 5.00 3.00 75.0 25.0 6 
3 17.00 3.00 60.0 31.0 6 
4 20.00 3.00 5.0 95.0 6 
5 32.00 3.00 5.0 95.0 6 
6 34.00 3.00 75.0 25.0 6 
7 46.00 3.00 75.0 25.0 6 
 
 
Table 3.30  Gradient system applied in method 3 with 25 % solvent B 
for the first 35 minutes. 
 
 Time Flow %A %B Curve 
1 0.01 3.00 75.0 25.0 6 
2 5.00 3.00 75.0 25.0 6 
3 35.00 3.00 60.0 40.0 6 
4 55.00 3.00 60.0 40.0 6 
5 57.00 3.00 95.0 5.0 6 
6 69.00 3.00 95.0 5.0 6 
7 72.00 3.00 75.0 25.0 6 
8 87.00 3.00 75.0 25.0 6 
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Figure 3.60  Compounds have absorption at 220 nm method 3. 
 
 
 
Figure 3.61  Compounds have absorption at 290 nm method 3. 
    
 
 
Figure 3.62  Compounds have absorption at 330 nm method 3. 
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The fourth method was held at 40 % solvent B Table 3.31 the purpose of 
this method was to significantly decrease the elution time for the major 
nonpolar compounds peaks which eluted at 18 minutes. The results 
showed that, the separation of both polar and nonpolar degraded 
compared to the previous method as illustrated in chromatogram 220 nm 
and 330 nm. Figure 3.63  compounds which have absorption at 220 nm. 
Figure 3.64 compounds which have absorption at 290 nm. Figure 3.65 
compounds have absorption at 330 nm. 
 
            Table 3.31  Gradient system applied in method 4  
 
 Time Flow %A %B Curve 
1 0.01 3.00 60.0 40.0 6 
2 55.00 3.00 60.0 40.0 6 
3 57.00 3.00 95.0 5.0 6 
4 69.00 3.00 95.0 5.0 6 
5 72.00 3.00 60.0 40.0 6 
6 87.00 3.00 60.0 40.0 6 
 
 
 
 
Figure 3.63  Compounds have absorption at 220 nm method 4. 
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Figure 3.64  Compounds have absorption at 290 nm method 4. 
  
 
 
Figure 3.65  Compounds have absorption at 330 nm method 4. 
 
The purification of a major polar compound peak could be achieved using 
method three, with total run time (including wash) of 30 minutes. 
Therefore, a total of 600 µg (injection loop 100 µl) of saponin fraction B is 
needed per run (0.1 mg per run). Since from the peak area it can be 
expected that the major peak is represented approximately 15-20 % of 
total eluted solids. Therefore, 10 run would yield approximately 1 mg (10 × 
0.1 mg) pure compound (the major compound). Hence 20 run programme 
is recommended required 10 hours of practical work.       
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2.3.6.3 Purification of two glycoside compounds from saponins 
fraction B via preparative HPLC connected to normal phase silica gel 
column  
 
The aim of the work was to use the method three (section 3.5.2) to purify 
the saponin fraction B of S. europaea L. The sample was prepared by 
dissolving 6 mg saponin fraction B in 1 ml distilled water, flow rate was 3 
ml/min, injection loop 100 µl (lead to inject of 0.1 mg of physical sample 
each run), run time was 30 minutes. 20 runs were applied total practical 
work was 10 hours. At each run the follows peaks were collected in 
individual vials. The peaks at RT 5, 6.60, 7.40, 8.20, 10.40, 13 and 20 
minutes. 
 
The TLC results (silica gel 60 F254  coated aluminium sheets 20 × 20 cm) 
using chloroform:methanol:water, 60:40:10 as a mobile phase and vanillin 
sulphuric acid as a spray reagent, of collected fractions showed that, the 
fraction collected at 20 minutes was contained a pure compound 
(saniculaside N 4) with a small impurity. The other fractions did not 
showed any constituents, which could be related to a very small quantity 
of these fractions. 
 
the quantity of fraction eluted at 20 minutes was small (0.3 mg) and was 
sufficient only to do mass spectrometry and  1HNMR measurements but 
other 1D and 2D NMR spectroscopy measurements and test the 
compound for treatments of wounds were not carried out because of the 
time shortage. Figure 3.66 shows mass spectrum of saniculoside N 
isolated from saponin fraction B via preparative HPLC. Figure 3.68  
illustrates 1H NMR spectrum of saniculoside N (400MHz, CD3OD) isolated 
from saponin fraction B via preparative HPLC.  
 
 
 
 
  
140 
 
 
 
Figure 3.66  ES- mass spectrum of saniculoside N isolated from 
saponin fraction B via preparative HPLC. 
 
Figure 3.67  Expansion of ES- mass spectrum of saniculoside N 
isolated from saponin fraction B via preparative HPLC. 
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Figure 3.68  1H NMR spectrum (400MHz, CD3OD) of saniculoside N 
isolated via PHPLC. 
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Figure 3.69  Expansion of 1H NMR spectrum (600 MHz, CD3OD) of 
saniculoaside N  isolated via PHPLC. 
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The purification of saponins fraction B was finally successfully achieved 
via preparative HPLC connected to C-18 column. Six prominent peaks 
could be collected. A compound elute at 20 minutes (saniculoside N) was 
twice isolated from the saponins glycoside of S. europaea by (Arda et al., 
1997)  and in section (3.3.7) via preparative TLC. Further work needs to 
be carried out by repeating method 3 several times in order to collect a 
sufficient amount of compounds eluted  at RT 5, 6.60, 7.40, 8.20, 10.40, 
13  for 1D & 2D NMR measurements and test the identified compounds for 
treatment of wounds. Figure 3.70 Compounds isolated from 80% methanol 
extract of S. europaea.  
   
 
 
 
Figure 3.70  Compounds isolated from 80% methanol extract of S. 
europaea  
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 Results and discussion, phytochemistry of T. davaeanum 4
4.1 Identification of the lipid constituents of T. davaeanum  
 
Total lipid fraction of T. davaeanum  was prepared as shown  in section 
(2.4.1.). A total of 1 mg/ml from each sample (total fatty alcohol, total 
hydrocarbon and total fatty acid methyl ester) was dissolved in 1 ml 
dichloromethane and analysed on GC/MS instrument (section 2.6).  
 
Table 4.1    Compounds identified in fatty alcohols ester of  T. 
davaeanum via GC-MS. 
No Alcohols Molecular 
formula 
RT(min.) Relative % 
1 Heptacosane C27H56 25.60 4.5 
2 Octacosane C28H58 27.26 35.4 
3 Tetratetracontane C44H90 28.48 51.0 
   Total 90.9 
 
 
Table 4.2   Compounds identified in hydrocarbons of T. davaeanum 
via GC-MS. 
 
No Hydrocarbons Molecular 
formula 
RT(min.) Relative % 
1 Caryophyllene C15H24 12.48 0.96 
2 Spathulenol C15H24O 14.43 4.41 
3 Caryophyllene oxide C15H24O 14.52 3.66 
4 Teu-Muurolol C15H26O 15.16 3.34 
5 α - Bisabololoxide B C15H26O2 15.30 11.12 
6 α – Bisabolol C15H26O 15.59 4.57 
7 2-pentadecanone C18H36O 17.25 1.66 
8 Phytol C20H40O 19.81 6.79 
   Total 36.51 
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Table 4.3   Compounds identitied in fatty acids esters of T. 
davaeanum via GC-MS. 
No Fatty acids Molecular 
formula 
RT(min.) Relative % 
1 Decanoic acid methyl ester C11H22O2 11.11 0.35 
2 14-octadecenal C18H34O 12.2 1.07 
3 Dimethyl phthalate C10H10O5 12.84 3.0 
4 Dodecanoic acid methylester C13H26O2 13.67 8.27 
5 Cyclopropaneoctanoic acid C20H38O2 13.93 1.03 
6 Methyl tetradecanoate C15H30O2 15.95 7.12 
8 Hexadecanoic acid methyl ester C17H34O2 18.04 14.56 
    35.4 
 
 
 
 
Figure 4.1  GC-MS analysis of fatty alcohol esters of T. davaeanum. 
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Figure 4.2  GC-MS analysis of hydrocarbon fraction of T. davaeanum. 
 
 
 
 
  
        Figure  4.3 GC-MS analysis of fatty acid esters of T.  davaeanum. 
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The results of GC-MS analysis of fatty alcohol methyl ester of T. 
davaeanum (Table 4.1 and Figure 4.1) showed the present of three 
hydrocarbons in which tetratetracontane the main one (51.0%), while the 
GC-MS analysis of hydrocarbon mixture (Table 4.2 and figure 4.2) 
revealed the present of phytol as main component (6.79%). Hexadecanoic 
acid methyl ester (palmitic acid) showed to be the major constituents of 
total fatty acid methyl ester of T. davaeanum (Table 4.3 and Figure 4.3). 
This compound mentioned in treatment of wound by (Victor R. Preedy et 
al., 2011) . Palmitic acid was isolated from the hexane extract of S. 
europaea (section 3.4.5) and also identified in GC-MS analysis of fatty 
acid methyl ester of S. europaea (section 3.1) therefore the wound healing 
activity of both species could be related to the present of this compound.    
  
4.2     Preparation of crude glycosides extract of T. davaeanum  
 
A total of 2.5 kg dried powdered plant material of T. davaeanum  was 
extracted in a Soxhlet extractor (200 g each time) at 50 oC using 80 % 
methanol yielded 12 g of crude glycosides extract. Therefore each 1 g 
dried plant material of T. davaeanum contains 4.8 mg crude glycosides 
extract. 
 
4.2.1    Fractionation of the crude glycosides of T. davaeanum 
 
The crude glycosides extract of Teucrium davaeanum was fractionated by 
the same methodes that were used to do fractionation to the crude 
glycosides extract of S. europaea (section 2.4.1.2). A total of 5 g of crude 
glycosides of T. davaeanum were dissolved in 10 ml of methanol; 6 g of 
silica gel for thin layer  chromatography (section 2.5.1) was added the 
mixture was ground until the liquid was absorbed. The mixture was 
fractionated on 200g of silica gel for thin layer  chromatography  (column 5 
× 60 cm) under pressure as illustrated in Table 4.4. 
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Table 4.4  Fractionation of crude glycosides extract of T. davaeanum. 
 
Mobile phase Composition Volume 
(ml) 
Fr. 
number 
Combined fractions 
(weight is not 
recorded) 
CHCl3:MeOH 100:0 200 1-5  
CHCl3:MeOH 95:5 200 6-8 1-12 
CHCl3:MeOH 90:10 200 9-12  
CHCl3:MeOH 80:20 200 13-15 13-15 
CHCl3:MeOH 70:30 200 16-18 17-18 
CHCl3:MeOH 60:40 200 19-21 19-20 
CHCl3:MeOH 50:50 200 22-24 23, 24, 25 
CHCl3:MeOH 40:60 200 25-27 26-27(compounds 7&8)  
CHCl3:MeOH 30:70 200 28-30 28, 29-30 
CHCl3:MeOH 20:80 200 31-33 31-32 
CHCl3:MeOH 10:90 200 34-36 33-34 compound 6, 
35-36(Sucrose + 
Saponin) 
CHCl3:MeOH 0:100 400 37-42 37-38, 39-40 (Saponin 
comp.), 41-42 
 
 
4.2.2         Isolation of compound 6 
 
The results of TLC plates (section 2.5.5) of fractions (33-34, 256 mg) 
Table 4.4 showed they are composed of one compound and traces of 
impurity, therefore, 64 mg of these fractions were further purified using 
Sephadex LH20 (column dimensions 40 × 2 cm), methanol was used as 
eluting solvent, 19 fraction were collected subfractions 17 till 19 were in 
pure form (16 mg). Another three samples 64 mg each of fractions (33-34) 
were purified again on Sephadex LH20. The total pure quantity of 6 was 
70 mg.       
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               Structure elucidation of compound 6  4.2.2.1
 
Compound 6 was isolated as a brown powder from the crude glycosides 
extract of Teucrium davaeanum. TLC analysis of 6 (silica gel 60 F254, 
CHCL3:MeOH:H2O, 60: 40:10), vanillin sulphuric acid as spraying reagent) 
showed UV activity at 254 nm with a dark spot and  a green spot after 
spraying Rf = 0.39, Figure (4.72). Compound 6 showed a positive colour 
with ferric chloride solution which indicates that it is a phenolic compound.  
 
Compound 6 has the molecular formula C35H46O19 (m/z = 770) as 
determined by an accurate mass measurement, the measured accurate 
mass was 788.2961 and the calculated accurate mass was 788.2972 
corresponding to the molecular ion peak [M + NH4]
 + Figure 4.4. The 
Accurate mass measurement was carried out at the EPSRC UK National 
Mass Spectrometry Facility at Swansea University. The ES- mass 
spectrum Figure 4.5 showed an [M-H]- ion peak at m/z 769 and the ES+ 
mass spectrum Figure 4.6  showed a peak at  m/z 793 [M+Na]+.  
 
Table 4.5 shows the 1H NMR, 13CNMR and HMBC  spectroscopic data of 
6 (600 MHz,CD3OD). The 
13C NMR spectrum of 6 (CD3OD, 600 MHz) 
Figure 4.7 shows 35 signals, which are consistent with the molecular 
formula from the accurate  mass, one of them is  a carbonyl carbon 
because it appears at δ = 166.7 ppm.  The DEPT spectrum of 6 Figure 4.8 
shows 10 (-CH2-) groups, 2 (CH3-) and 20(-CH-) groups amounting 33 
meaning that 6 has six quaternary carbons δ (145.5) C-3 and δ (143.3) C-
4. Figure 4.9 shows an expansion of DEPT spectrum of 6. 
 
The 1H NMR spectrum of 6 Figure 4.10 exhibited two trans olefinic protons 
at δ 6.26 (1H, d, J = 15.75 Hz, H-α`), 7.59 (1H, d, J = 15.87 Hz, H-β`) two 
ABX systems on 1,3,4-trisubstituted benzene rings δ 7.05 (1H, d, splitting 
pattern unclear, H-2````), 6.77 (1H, d, J = 8.19 Hz, H-5````) and 6.94 (1H, d, 
J = 8.06 Hz, H-6````); The signal at 6.67 (2H, d, J = 7.68 Hz, H-2,H-5) 
represent two protons H-2 and H-5;  this was confirmed from the area of 
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the signal as it clearly represents 2 protons compared with other 
neighbouring signals which represent one proton. This consistent with 
the , HMBC spectrum since the signal at 6.67 shows correlations to 5 
carbons, 4 appear to be 2 bond correlations δ 143.3 C-4, 120.0 C-6, 130.1 
C-1, 145.5 C-3 and one carbon is a 3 bond correlation δ 35.4 C-β. From 
the compound structure H-5 is correlated to δ 143.3 C-4 , 120.0 C-6, 2 
bond correlations,  whereas H-2 is correlated to 130.1 C-1, 145.5 C-3 (2 
bond correlations) and δ 35.4 C-β (three bond correlation).  6.67 (2H, d, J 
= 7.68 Hz, H-2 and H-5) and 6.55(1H, d, J = 7.81 Hz, H-6), also two 
aliphatic protons at δ 3.80 (2H, m, H-α) and 2.77 (2H, m, H-β). Figure 4.11  
shows an expansion of 1HNMR spectrum of 6 (600 MHz, CD3OD).     
Figure 4.12 shows the COSY spectrum of 6. 
 
Furthermore, 1H NMR spectrum showed the presence of three anomeric 
protons at δ 4.35(1H, d, H-1`), 5.16(1H, d, H-1``), 4.62(1H, d, H-1```) the 
attachments of three sugars were achieved by comprehensive studies of 
HMQC and HMBC spectra. Figure 4.13 shows the HMQC spectrum of 6, 
Figure 4.14 illustrates an expansion of HMQC spectrum of 6.  
  
The outstanding HMBC cross peaks (Figure 4.15) from the anomeric 
proton of glucose δ 4.35(1H, d, H-1`) to the carbon atom C-α, δ (71.1) of 
the 5, 6-dihydroxy phenyl ethyl group allowed the connection of glucose 
anomeric carbon to that group. The caffeoyl unit was positioned at C-4` of 
glucose δ (69.5) based on the HMBC correlations between glucose proton 
at δ 4.97 (1H, m, H-4`) and carbonyl group at δ (166.7).  
 
The first rhamnose unit is place d at C-3` of the glucose unit based on the 
HMBC correlations between C-3` δ 80.5 and the anomeric proton of the 
first rahmnose unit δ 5.16 (1``H, splitting pattern unclear). The second 
rhamnose unit is connected to C-6` of the glucose unit as shown from 
HMBC correlations between second rahmnose anomeric proton δ 
4.62(1```H, splitting pattern unclear) and C-6` at δ 66.4 of glucose unit. 
 
  
150 
 
The splitting pattern of the two anomeric protons is unclear because both 
protons are shown as singlet at δ 5.17 and 4.62 for H1`` and H1``` 
respectively as shown in figure 4.10 , but theoretically doublets would be 
expected do you to the proton on adjacent carbons as showed from COSY 
data displayed  in Table 4.5 Figure 4.12. This observation could be related 
to the stereochemistry of the two rhamnose anomeric protons.  
 
The other support to this argument is that both anomeric protons of 
rhamnose units at δ  5.17, H1`` and  δ 4.62, H1``` are correlated to the 
carbon atoms at C-2 and C-3 of the two rhamnose units i.e. H1`` δ 5.17 is 
correlated to C-2`` δ 69.33 and C-3`` at 71.04. While H1``` δ 4.26 is 
correlated to C-2``` δ 68.6 and C-3``` δ 71.20. Figure 4.16 expansion of 
HMBC spectrum of 6, Figure 4.17 HMBC correlations of 6.  
 
The linkages between three sugars, caffeoyl moiety and phenylethyl group 
were confirmed by HMBC spectrum. Many but not all the  signals are in 
agreement with those reported for the phenylethanoid glycoside isolated 
from Teucrium chamaedrys L named teucrioside  Figure 4.18  (Bedir et al., 
2003). Structure of 6 is shown in  
Figure 4.19.  
 
 
 
Table 4.6  shows 1H and 13C NMR (600 MHz, CD3OD) spectroscopic data 
comparison of 6 with 1H and 13C NMR (500 MHz, CD3OD) of teucrioside 
isolated from Teucrium chamaedrys L Figure 4.18  (Bedir et al., 2003). 
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Table 4.5  
1
H NMR, 
13
CNMR and HMBC data (600 MHz, CD3OD) of 6. 
No δH (600 MHz, 
CD3OD) of 6 
δC (600 MHz, 
CD3OD) of 6 
HMBC COSY 
Phenethyl 
alcohol 
    
α 3.80  (2H, m) 71.1   
β 2.77 (2H, m) 35.4 115.9/ 130.1/ 120.0  
1 - 130.1 -  
2 6.67 (1H, d, J = 7.68 
Hz)  
117.2 -  
3 - 145.5 -  
4 - 143.3 -  
5 6.67 (1H, d, J = 7.68 
Hz) 
115.9 35.4/ 120.0/ 130.1 / 143.3/ 
145.5. 
 
6 6.55 (1H, d, J = 7.81 
Hz) 
120.0 35.4/ 115.9/ 143.3  
Glu /1′ 4.35 (1H, d, J = 7 Hz) 103.0 80.5/73.23 3.38 
2′ 3.38 (1H, m) 73.23 103.01/80.5  
3′ 3.80 (1H, m) 80.5 69.1 3.38 
4′ 4.98 (1H,  m) 69.1 66.4/ 73.23/ 166.7-80.5 3.80/3.65 
5′ 3.65 (1H, m) 74.13 - 3.45 
6′ 3.45 (1H, dd, J = 9.6 
Hz)   
66.4 -  
Rha at Cglu-3`     
1′′ 5.17 (1H) 102 69.33/ 71.04/ 80.5. 1.07 
2′′ 3.91 (1H, m) 69.33 102/ 71.04 5.17 
3′′ 3.68 (1H, m) 71.04 - 3.32 
4′′ 3.32 (1H, m) 72.53 71.0 3.68 
5′′ 3.58 (1H, m) 69.24 - 1.07 
6′′ 1.07 (3H, d, J = 6.2 
Hz) 
17.2 69.24/ 72.53. 3.58 
Rha at Crha-2``     
1′′′ 4.61(1H) 101 66.4/ 68.6/ 71.20.  
2′′′ 3.83 (1H, m) 68.6 72.86/71.04 4.62 
3′′′ 3.57 (1H, m) 71.20 72.86 3.28/3.31/4.62 
4′′′ 3.28 (1H, m) 72.86 71.20/69.24/16.8  
5′′′ 3.31 (1H, m) 69.24 -  
6′′′ 1.18 (3H, d, J = 6.2 
Hz) 
16.8 69.24/ 72.86. 4.62 
Caffeoyl 
moiety 
    
C=O - 166.7 -  
α` 6.26 (1H, d, J= 15.75 
Hz) 
114.0 126.3/ 166.7.  
β` 7.59 (1H, d, J = 
15.87 Hz) 
147.5 114.0/ 122.0/ 166.7.  
1′′′′ - 126.3 -  
2′′′′ 7.05 (1H, d,) 115.2 122.0/ 146.8/ 149.7/ 147.5.  
3′′′′ - 146.8 -  
4′′′′ - 149.7 -  
5′′′′ 6.77 (1H, d, J = 8.19 
Hz) 
115.3 126.3/ 146.8/ 149.7.  
6′′′′ 6.94 (1H, d, J= 8.06 
Hz) 
122.0 114.0/ 146.8/ 149.7.  
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Table 4.6  
1
H and 
13
C NMR (600 MHz, CD3OD) spectroscopic data comparison of 6 
with 
1
H and 
13
C NMR (500 MHz, CD3OD) of teucrioside isolated from Teucrium 
chamaedrys L. 
 
No δH (600 MHz, CD3OD) of 6 δC (600 MHz, 
CD3OD) of 6 
δH (500 MHz, CD3OD) 
of teucrioside 
 δC (500 MHz, 
CD3OD) of  
teucrioside 
Phenethyl 
alcohol 
    
α 3.80  (2H, m) 71.1 4.05 (2H, m) 72.3 t 
β 2.77 (2H, m) 35.4 2.80 (2H, t, J = 7.0) 36.6 t 
1 - 130.1 - 131.5 s 
2 6.67 (1H, d, J = 7.68 Hz)  117.2 6.70 (1H, d, J = 1.8) 
overlapped with H-5  
116.3 d 
3 - 145.5 - 146.2 s 
4 - 143.3 - 144.7s 
5 6.67 (1H, d, J = 7.68 Hz) 115.9 6.67 (1H, d, J = 8.0)  117.2 d  
6 6.55 (1H, d, J = 7.81 Hz) 120.0 6.56 (1H, d, J = 8.0, 
1.8) 
121.3 d  
Glu 4.35 (1H, d, J = 7 Hz) 103.0   
1′ 3.38 (1H, m) 73.23 4.37 (1H, d, J = 7.9) 104.3 d 
2′ 3.80 (1H, m) 80.5 3.42 (1H, dd, J = 7.9, 
9.2) 
76.2 d 
3′ 4.98 (1H,  m) 69.1 3.78 (1H, t, J = 9.2) 82.0 d 
4′ 3.65 (1H, m) 74.13 4.92 (1H, t, J = 9.2) 70.6 d 
5′ 3.45 (1H, dd, J = 9.6 Hz)   66.4 3.53 (1H, m) 76.1 d 
6′   3.63 (2H, dd, J  = 11.5, 
2.5) 
62.4 d 
Rha at Cglu-3` 5.17 (1H) 102   
1′′ 3.91 (1H, m) 69.33 5.40 (1H, d, J  = 1.8) 101.9 d 
2′′ 3.68 (1H, m) 71.04 3.95 ( 1H, dd, J = 1.8, 
3.1)   
80.5 d 
3′′ 3.32 (1H, m) 72.53 3.67 (1H, dd,  J = 3.1, 
9.7) 
72.0 d 
4′′ 3.58 (1H, m) 69.24 3.28 (1H, dd, J = 9.7, 
9.8)  
74.1 d 
5′′ 1.07 (3H, d, J = 6.2 Hz) 17.2 3.53
a
  70.5 d 
6′′   1.07 (3H, d, J = 6.1) 18.6 q 
 
Rha at Crha-2`` 
4.61(1H) 101   
1′′′ 3.83 (1H, m) 68.6 4.88 (1H, d, J = 3.7) 104.3 
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2′′′ 3.57 (1H, m) 71.20 3.85 (1H, dd, J = 3.7, 
3.6) 
71.5 
3′′′ 3.28 (1H, m) 72.86 3.71 (1H,dd, J = 3.6, 
8.0) 
72.6 
4′′′ 3.31 (1H, m) 69.24 3.74
a
 69.0 
5′′′ 1.18 (3H, d, J = 6.2 Hz) 16.8 3.68
a
, 3.56
a
 65.0 
6′′′   - - 
Caffeoyl 
moiety 
- 166.7   
C=O 6.26 (1H, d, J= 15.75 Hz) 114.0 - 168.3 
α` 7.59 (1H, d, J = 15.87 Hz) 147.5 6.29(1H, d, J = 15.9) 114.7 d 
β` - 126.3 7.59 (1H, d, J = 15.9) 148.1 d 
1′′′′ 7.05 (1H, d,) 115.2 - 127.7 
2′′′′ - 146.8 7.05 (1H, d, J = 2.0) 115.3 
3′′′′ - 149.7 - 146.9 
4′′′′ 6.77 (1H, d, J = 8.19 Hz) 115.3 - 149.8 
5′′′′ 6.94 (1H, d, J= 8.06 Hz) 122.0 6.79 (1H, d, J = 8.2) 116.6 
6′′′′   6.97 (1H, dd, J = 8.2, 
2.0) 
123.3 
 
a ( The signal pattern was unclear due to  overlapping). 
 
The 1H & 13C NMR data comparison of  6 with the phenylethanoid 
glycoside isolated from Teucrium chamaedrys L named teucrioside  Figure 
4.18  Bedir et al (2003)  
 
 
 
Table 4.6 indicate that both are almost the same except the following δ 
values, in 6 the δ 4.62 ( 1H, d, J = 3.7, H-1```), 3.73 (1H, m, H-3```), 3.38 
(1H, m, H-4```) and 3.31 (1H, m, H-5```) are shifted up field because of 
shielding effect resulting from the presence of an extra methyl group (CH3-
) which belongs to the second rhamnose unit, whereas in teucrioside  
Figure 4.19 these values are as follows 4.88 (1H, d, J = 3.7, H-1```), 3.71 
(1H, dd, J = 3.6, H-3```), 3.74 (signal pattern was unclear due to 
overlapping) and 3.68 (signal pattern was unclear due to overlapping). 
Furthermore, in 6 there is an extra methyl group (CH3-) at δ 1.18 (3H, d, J 
= 6.2, H-6```) for the second rhamnose unit which does not occur in the 
phenylethanoid glycoside isolated from Teucrium chamaedrys L named 
teucrioside  Figure 4.18 (Bedir et al., 2003). 
 
From the best of my knowledge compound 6 is a novel glycoside for which 
the name davaeanuside A is proposed [2-(3,4-dihydroxyphenethyl)-O-α-L-
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rhamnopyranosyl-(1→6)-α-L-rhamnopyranosyl-(1→3)-4-O-trans-caffeoyl-
β-D-glucopyranoside]. The chemical name of 6 was similar to that of 
teucrioside isolated from Teucrium chamaedrys L because most of signals 
in 6 are identical to those in teucrioside. It would be worthy if X-ray 
crystallography analysis of 6 carried out in order to have 3D structure of 6. 
 
 
 
 
 
Figure 4.4  Accurate mass spectrum of 6 
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Figure 4.4   Continued. 
 
 
 
 
 
Figure 4.4 Continued 
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Figure 4.5  ES- mass spectrum of 6. 
 
 
 
 
Figure 4.6  ES+ mass spectrum of 6. 
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Figure 4.7  13CNMR spectrum of 6 (600 MHz, CD3OD). 
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Figure 4.7  Continued. 
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Figure 4.7 Continued. 
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Figure 4.8  DEPT spectrum of 6 (600 MHz, CD3OD). 
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Figure 4.9  Expansion of DEPT spectrum of 6. 
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Figure 4.10  1HNMR spectrum (600 MHz, CD3OD) of 6. 
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Figure 4.11  Expansion of 1HNMR spectrum (600 MHz, CD3OD) of 6. 
 
 
cww140606-1.jdf
4.1 4.0 3.9 3.8 3.7 3.6 3.5 3.4 3.3 3.2 3.1
Chemical Shift (ppm)
0
0.05
0.10
0.15
0.20
N
or
m
al
iz
ed
 In
te
ns
ity
3.
97
3.
96 3
.9
5
3.
93
3.
91 3.
84
3.
80
3.
79
3.
77
3.
73
3.
71
3.
70
3.
68 3
.6
7
3.
66
3.
61
3.
60
3.
59
3.
58
3.
58
3.
57
3.
56
3.
56
3.
54 3.
53
3.
53
3.
52
3.
51
3.
45 3.
44 3.
43
3.
38
3.
37
3.
35
3.
33 3.
32
3.
32
3.
30
3.
28
3.
27
 
 
Figure  4.11 Continued. 
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Figure 4.11 Continued. 
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                                     Figure 4.11 Continued. 
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            Figure 4.12  COSY spectrum (600 MHz, CD3OD) of 6. 
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Figure 4.13  HMQC spectrum (600 MHz, CD3OD) of 6. 
 
 
Figure 4.14  Expansion of HMQC spectrum (600 MHz, CD3OD) of 6. 
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Figure 4.15  HMBC spectrum (600 MHz, CD3OD) of 6. 
 
 
Figure 4.16  Expansion of HMBC spectrum (600 MHz, CD3OD) of 6. 
  
165 
 
 
 
Figure 4.16 Continued. 
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                     Figure 4.17  HMBC correlations of 6. 
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Figure 4.18 Structure of teucrioside isolated from Teucrium 
chamaedrys L (Bedir et al., 2003). 
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Figure 4.19  Proposed Structure of 6 isolated from T. davaeanum L. 
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4.2.3                    Isolation of compounds 7 and 8  
 
Fractions 26 and 27 Table 4.4 120 mg showed two coloured bands  (green 
+ pink) on TLC plate after spraying Figure 4.75  therefore, the fractions 
were mixed together and fractionated on a silica gel column as illustrated 
in Table 4.7. 
  
Table 4.7   Fractionation of fractions 26-27 which contains 7 & 8. 
Mobile phase composition Volume (ml) Fr. 
Number 
Combined 
fractions  
CHCl3:MeOH 100:0 200  2-3 1-20, 21 
CHCl3:MeOH 95:5 200 4-13  
CHCl3:MeOH 90:10 200 14-23 22-26 
CHCl3:MeOH 80:20 200 24-33 27-29, 30-31 
CHCl3:MeOH 70:30 200 34-43  
CHCl3:MeOH 60:40 200 44-53 42-49 
CHCl3:MeOH 50:50 200 54-63 50-70 
CHCl3:MeOH 40:60 200 64-73  
CHCl3:MeOH 30:70 200 74-83 71-94 
CHCl3:MeOH 20:80 200 84-93  
CHCl3:MeOH 10:90 200 94  
CHCl3:MeOH 0:100 200 100  
 
 
Fractions [ 21, 22-26, 27-29, 31-41] after TLC analysis (plate conditions 
see section) they showed two bands with green and  pink colours they 
were further purified using preparative TLC plates  20 plates were used to 
yield 77mg of compound 7 and 18 mg of compound 8. 
  
      Partial structure elucidation of 7  4.2.3.1
 
Compound 7 was isolated as a sticky substance from the crude glycosides 
extract of T. davaeanum. The TLC analysis of 7 (plate conditions see 
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section 2.5.5) showed no UV activity at 253 nm and a green spot (Rf = 
0.56) after spraying with vanillin sulphuric acid reagent (2.8.2). 
 
The accurate mass spectrum of 7 is shown in 4.22 , which suggested a 
molecule of formula C7H14O6  and molecular weight 184 due to the 
observation of [+NH4]
+ and [+Na]+ adducts at m/z 212 and 217 
respectively. The molecular ion peak at m/z 411 is corresponding to 
[2M+Na] which also present in ES+ mass spectrum of 7 Figure 4.24. ES- 
spectrum of 7 Figure 4.25 the peak at m/z 229 could be [M+Cl]-.  
                      
The 1HNMR, 13CNMR, DEPT and HMBC data of 7 are shown in Table 4.8. 
The 13CNMR spectrum of 7 (600 MHz, CD3OD) Figure 4.26 showed the 
presence of 15 signals indicating that the molecule is composed from 15 
carbon atoms, Figure 4.27 is shown expansion of 13C NMR spectrum of 7. 
The DEPT spectrum of 7 (600 MHz, CD3OD)                                
Figure 4.28 showed a peak at 48 which is due to the solvent (CD3OD).                        
                      Figure 4.29 is shown expansion of DEPT spectrum of 7. The 
spectrum showed the presence of 4 methylene (-CH2-) groups, one 
belonging to the glucose at δ 61.5  C-6` and the other three are belonging 
to the aglycone part. The spectrum showed the presence of 5 methine (-
CH-) carbons for the sugar part, in which four are in δ region between 
69.75 to 70.90 and one anomeric carbon C-1` at δ value of 100.1. The 
DEPT spectrum of 7 also gave evidence to presence of quaternary carbon 
because the peak at δ 103.1 (C-8) in 13CNMR spectrum of 7 is absent in 
the DEPT spectrum.  
 
 The 1HNMR spectrum of 7 (600 MHz, CD3OD) Figure 4.30 showed the 
presence of an anomeric proton at δ 4.64 (1H, d, J = 3.72, H-1`). The 
other sugar proton signals are overlapped in δ region between 3.50 to 
3.83. The proton signals belonging to the aglycone part appear at δ values 
of 4.05 (1H, d, J = 8.13, H-6), 3.88 (1H, t, H-5), 3.49 (2H, t, H-3) and 3.30 
(2H, s, H-10). The H-3`, H-5` signals are overlapped with the other sugar 
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proton signals.   Figure 4.31 is shown expansion of 1HNMR spectrum of 7 
and HMQC spectrum is shown in Figure 4.32.  
 
The HMBC spectrum of 7 (600 MHz, CD3OD) Figure 4.33 showed a 
correlations between δ 3.74 (1H, t, H-1) and the anomeric carbon C-1`  at  
δ 100.1 which allowed the connection between the glucose anomeric 
carbon and C-1 of aglycone part at δ 82.1. The H-3 proton at δ 3.49 (2H, t, 
H-3)  is correlated to C-4 at δ 63.06 which allowed the connection between 
C-4 at δ 63.06 and C-3 at δ 63.44. The H-4 at δ 3.58 (2H, d, H-4) is 
correlated to C-5 at δ 76 and to another carbon C-3 at δ 63.44 this 
permitted the position of C-4. The resonance of H-7 at δ 3.64  (1H, d, J = 
3.32, H-7) is correlated to two carbon atoms at δ 103.1 C-8 and δ 76 C-5 
which confirm the position of C-7 between C-8 and C-5.  
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Figure 4.20  Suggested HMBC correlations of 7. 
 
 
The accurate mass spectrum of 7 4.22 indicated the presence of 7 carbon 
atoms, while the 13CNMR Figure 4.26 showed the existence of 15 carbon 
atoms, therefore the C7H14O6 could be the main fragment. Furthermore, 
the suger proton signals were overlapped which made the structure 
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elucidation of 7 more complicated. The glucose molecule is definitely a 
part of the molecule. The compound could be belonging to iridoid 
glycoside compounds. Further work needs to be carried out with regarding 
to collect a pure quantity in order to have a good 1D & 2D spectra.    
Table 4.8  1HNMR, 13CNMR, DEPT and HMBC data (600 MHz, CD3OD) 
of 7 
No 
 
δ
1
H NMR (600 MHz, CD3OD) δ
13
C NMR (600 MHz, 
CD3OD) 
DEPT (600 MHz, 
CD3OD) 
HMBC 
1 3.74 (1H, t, H-1)  82.1 CH 60.48- 76-103.1-72.5 
2 - - -O- - 
3 3.49 (2H, t, H-3) 63.44 CH2 63.06-54.4 
4 3.58 (2H, d, H-4) 63.06 CH2 82.1-63.44-103.1-72.5-
76-78 
5 3.88 (1H, t, H-5) 76 CH 78-63.44-82.1 
6 4.05 (1H, d, J = 8.13 H-6)  78 CH 76-60.21-103.1 
7 3.64 (1H, d, J = 3.32, H-7) 72.5 CH 103-78-63.31 
8 - 103.1 Q - 
9 3.44 (1H, d, H-9) 54.4 CH 100.1 
10 3.30 (2H, s, H-10) 60.21 CH2 103.1 
1` 4.64 (1H, d, J = 3.72, H-1`)  100.1 CH 54.4-70.30-71.43 
2` 3.65 (1H, t, H-2`)  71.43 CH - 
3` 3.87( the signal overlapped) 69.75 CH 69.96-70.28 
4` 3.69 (1H, t, H-4`) 72.56 CH 69.96-70.93 
5` 3.70 ( the signal overlapped) 69.96 CH - 
6` 3.68 (1H, d, J = 2.75, H-6`) 61.46 CH2 69.79 
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Figure 4.21  Suggested structure of 7. 
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Figure 4.22 An accurate mass spectrum of 7. 
 
 
                   Figure 4.23  Expansion of accurate mass spectrum of 7. 
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Figure 4.23  Continued. 
 
 
                        
                            Figure 4.24  ES+ spectrum of 7. 
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Figure 4.25  ES- mass spectrum of 7. 
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               Figure 4.26  13C NMR spectrum (600 MHz, CD3OD) of 7. 
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   Figure 4.27 Expansion of 13C NMR spectrum (600 MHz, CD3OD) of 7. 
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Figure 4.28  DEPT spectrum of 7. 
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                      Figure 4.29  Expansion of DEPT spectrum of 7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.30  1H NMR spectrum (600 MHz, CD3OD) of 7. 
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  Figure 4.31  Expansion of 1H NMR spectrum  (600 MHz, CD3OD) of 7. 
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        Figure 4.32  HMQC spectrum (600 MHz, CD3OD) of 7. 
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Figure 4.32  Continued. 
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Figure 4.33  HMBC spectrum of 7. 
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          Structure elucidation of compound 8 (pink compound) 4.2.3.2
 
Compound 8 was isolated as a brown sticky substance from the crude 
glycosides extract of T. davaeanum. The TLC analysis of 8 (2.5.5) showed 
UV activity at 253 nm and a pink spot (Rf = 0.64) after spraying with 
vanillin sulphuric acid reagent (section 2.8.2). Compound 8 has the 
molecular formula C17H28O11 (m/z = 406.1) as determined by an accurate 
mass measurement, the measured accurate mass was 424.1813 and the 
calculated accurate mass was 424.1813 corresponding to the molecular 
ion peak [M + NH4]+ Figure 4.35 . The ES+ spectrum of 8 Figure 4.36 
showed a peak at m/z = 429.1 [M + Na]+ . The ES- spectrum of 8 Figure 
4.37 displayed a peak at 441.0 [M + Cl]-. 
 
The 1HNMR, 13CNMR, DEPT and HMBC data of 8 are shown in Table 4.9. 
The 13CNMR spectrum of 8 (600 MHz, CD3OD) Figure 4.38 showed the 
presence of 17 signals indicated the molecule has 17 carbon atoms. The 
up field region of the spectrum showed a presence of two methyl groups at 
δ 20.9 C-10  and δ 21.2 C-12, also there are two methylene groups of 
aglucone part (-CH2-) of C-6 and C-7 at δ 29.5, 44.8 respectively.  The 
methine group appears at δ 54.1 C-9. The sugar –CH- carbons displayed 
at δ values of 70.9 C-3`, 73.8 C-5`, 76.3 C-2` and 76.9 C-4`, while the –
CH2- appears at δ 61.7 C-6` and the anomeric carbon at δ 98.1 C-1`. The -
HC=CH- carbons displayed at  δ 142.6 C-3 and δ 105.5 C-4 and, while the 
carbonyl carbon was shown at δ 172.1 C-11. 
 
The DEPT spectrum of 8 (600 MHz, CD3OD) Figure 4.39 showed a 
presence of three methylene groups (-CH2-), two are belonging to 
aglycone part,  appears in upfield region at δ 29.5 C-6 and 44.8 C-7, and 
the third one is belonging to sugar part displayed in downfield region at δ 
61.7 C-6`.  
 
The 1HNMR spectrum of 8 (600 MHz, CD3OD) Figure 3.39 showed  
signals of two methyl groups at δ 1.37 (3H, s, H-10) and at δ 1.94 (3H, s, 
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H-12). Also two methylene (-CH2-) groups at δ 1.27 (2H, t, H-6) and 2.10 
(2H, t, H-7). The H-9 proton appears at δ 2.81 (1H, s, H-9), while signals 
for the sugar protons were found at δ 3.18 to 3.85. The down field region 
of the spectrum showed the presence of two (-CH-) groups one of the 
anomeric proton at δ 4.56 (1H, d, J = 7.84, H-1`) and the second is 
connected to the C-1 at δ 6.04 (1H, d, H-1), Figure 4.41 is shown 
expansion of 1HNMR spectrum of 8. The H-3 proton appears at δ 6.36 
(1H, d, J = 6.35, H-3), H-4 proton showed at δ 4.89, the signal is hidden 
under the signal of hydroxyl; two evidence indicated the presence of this 
signal, in the COSY spectrum  Figure 4.42 the proton at δ 4.89, H-4 is 
coupled to the proton at δ 6.36 (1H, d, J = 6.35, H-3) meaning that the two 
protons are adjacent. Therefore the signal at δ 4.89 is expected to be 
doublet, also in the HMQC spectrum Figure 4.43 showed a presence of 
protin at δ 4.89 connected to the carbon atom at δ 105.5. A distinctive 
signal at δ 4.82 is related to the solvent hydroxyl group, also it could be 
related to water hydroxyl group; due to the presence of water in solvent, 
the sample is not completely dried or a damp NMR tube.         
 
The HMBC spectrum of 8 Figure 4.44 showed the following correlations, 
the cross peak from the anomeric proton of glucose δ 4.56 (1H, d, J = 
7.84, H-1`) to the carbon atom C-1 at δ 93.2 of the aglycone part allowed 
the connection of glucose anomeric carbon to C-1 of aglycone part. The 
DEPT spectrum of 8 showed the presence of two quaternary carbons at δ 
72 C-5 and δ 87.4 C-8. The H-1 at δ 6.04 (1H, d, H-1)  has correlation with 
C-3 δ 142.6, C-1` δ 98.1 and C-5 δ 72, also H-3 at δ 6.36 (1H, d, J = 6.35, 
H-3) is correlated to C-5 δ 72 this allowed the positions of C-5. 
Furthermore, the H-12 proton at δ 1.94 (3H, s, H-12) are correlated only to 
the carbon atom at δ 172.1 C=O allowed the connection between C-12 δ 
21.2 and carbonyl group C-11 δ 172.1, the other correlations are 
summarized in Table 4.9. Figure 4.34 is shown HMBC correlations of 8.  
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Figure 4.34  HMBC correlations of 8. 
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Table 4.9  1HNMR, 13CNMR, DEPT and HMBC data (600 MHz, CD3OD) 
of 8. 
No 
 
δ
1
H NMR (600 MHz, 
CD3OD) 
δ
13
C NMR (600 
MHz, CD3OD) 
DEPT (600 
MHz, 
CD3OD) 
HMBC 
1 6.04 (1H, d, H-1) 93.2 -CH- 142.6, 98.1, 72 
2 -  -O- - 
3 6.36 (1H, d, J = 6.35, H-3) 142.6 -CH- 105.5, 93.2, 72 
4 4.89 (hidden under OH 
signal) 
105.5 -CH- 142.6 
5 - 72 Q - 
6 1.27 (2H, t, H-6) 29.5 -CH2- - 
7 2.10 (2H, t, H-7) 44.8 -CH2- 87.4, 72, 54.1 
8 - 87.4 Q 172.1 
9 2.81 (1H, s, H-9) 54.1 -CH- - 
10 1.37 (3H, s, H-10) 20.9 CH3- 87.4, 54.1, 44.8 
11 - 172.1 C=O - 
12 1.94 (3H, s, H-12) 21.2 -OCH3 93.2, 87.4, 72 
1` 4.56 (1H, d, J =7.84, H-1`) 98.1 -CH- 93.2 
2` 3.70 (1H, t, H-2`) 76.3 -CH- - 
3` 3.34 (1H, t, H-3`) 70.9 -CH- 76.9 
4` 3.26(1H, m, H-4`) 76.9 -CH- 76.3 
5` 3.17 (1H, t, H-5`) 73.8 -CH- 98.1, 76.3 
6` 3.84 (2H, d, H-6`) 61.7 -CH2- - 
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Table 4.10 1H and 13C NMR (600 MHz, CD3OD) spectroscopic data 
comparison of 8 with 1H and 13C NMR (400 MHz, DMSO-d6) of 
morroniside isolated from Fructus corni. 
No δH (600MHZ, CD3OD) of 
8 
δC 
(600MH
Z, 
CD3OD) 
of 8  
δH (400 MHz, DMSO-d6) 
of morroniside  
 δC (400 
MHz, 
DMSO-d6) 
of 
morronisi
de   
1 6.04 (1H, d, H-1) 93.2 5.32 (1H, d, H-1) 94.6 
2 -  - -O- 
3 6.36 (1H, d, J = 6.35, H-
3) 
142.6 7.40 (1H, s, H-2) 152.3 
4 4.89 (hidden under OH 
signal) 
105.5 - 109.2 
5 - 72 1.85 (1H, m, H-5) 27.4 
6 1.27 (2H, t, H-6) 29.5 1.85, 1.61 (each, 1H, m, H-
6) 
34.7 
7 2.10 (2H, t, H-7) 44.8 5.32 (1H, m, H-7) 94.6 
8 - 87.4 2.50 (1H, m, H-8) 39.5 
9 2.81 (1H, s, H-9) 54.1 3.74 (3H, s, OCH3-9) 52.0 
10 1.37 (3H, s, H-10) 20.9 1.20 (3H, d, H-10) 20.4 
11 - 172.1 - 166.2 
12 1.94 (3H, s, H-12) 21.2 3.74 (1H, m, H-12) 63.3 
1` 4.56 (1H, d, J =7.84, H-
1`) 
98.1 4.93 (1H,d, H-1`) 98.1 
2` 3.70 (1H, t, H-2`) 76.3 - - 
3` 3.34 (1H, t, H-3`) 70.9 - - 
4` 3.26(1H, m, H-4`) 76.9 - - 
5` 3.17 (1H, t, H-5`) 73.8 - - 
6` 3.84 (2H, d, H-6`) 61.7 - - 
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Table 4.11 1H and 13C NMR (600 MHz, CD3OD) data comparison of 8 
with 1H and 13C NMR (D2O) of 6-epi-8-acetylharpagide isolated from 
Caryopteris x clandonensis. 
No δH (600MHZ, CD3OD) of 
8 
δC 
(600MH
Z, 
CD3OD) 
of 8  
δH (D2O) of 6-epi-8-
acetylharpagide 
 δC (D2O) of 6-
epi-8-
acetylharpagi
de 
1 6.04 (1H, d, H-1) 93.2 5.95 s 95.8 
2 -  -  
3 6.36 (1H, d, J = 6.35, H-
3) 
142.6 6.51 dd(6.4, 1.0) 145.3 
4 4.89 (hidden under OH 
signal) 
105.5  5.11 d (6.5) 
- 
104.0 
- 
5 - 72  74.6 
6 1.27 (2H, t, H-6) 29.5 4.27 dd (12.5, 6.6) 77.8 
7 2.10 (2H, t, H-7) 44.8 1.57 dd (13.5, 12.5) 
2.24 dd (13.5, 6.6) 
46.1 
- 
8 - 87.4 - 86.6 
9 2.81 (1H, s, H-9) 54.1 2.70 s 56.7 
10 1.37 (3H, s, H-10) 20.9 1.44 s 23.5 
11 - 172.1 - 176.8 
12 1.94 (3H, s, H-12) 21.2 2.03 s 24.3 
1` 4.56 (1H, d, J =7.84, H-
1`) 
98.1 4.71 dd (8.0, 1.0) 100.1 
2` 3.70 (1H, t, H-2`) 76.3 3.25 ddd(9.3, 8.2, 1.1) 75.2 
3` 3.34 (1H, t, H-3`) 70.9 3.44 – 3.50 78.1 
4` 3.26(1H, m, H-4`) 76.9 3.38 dd (9.9, 1.0) 72.3 
5` 3.17 (1H, t, H-5`) 73.8 3.44 – 3.50 79.0 
6` 3.84 (2H, d, H-6`) 61.7 3.71 dd (12.4, 5.6) 
3.91 d (12.4) 
63.3 
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Figure 4.35 An accurate mass spectrum of 8. 
 
 
 
 
Figure 4.35 Contaniued. 
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Figure 4.36  ES+ mass spectrum of 8. 
 
 
 
Figure 4.37  ES- mass spectrum of 8. 
  
189 
 
carbon pink.esp
180 160 140 120 100 80 60 40 20
Chemical Shift (ppm)
0
0.005
0.010
0.015
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
1
7
2
.0
7
1
6
9
.0
7
1
4
2
.5
9
1
4
1
.2
5
1
2
9
.6
3
1
1
4
.8
1
1
0
7
.0
9
1
0
5
.5
9
9
8
.6
0
9
8
.0
5
9
6
.9
1 9
1
.8
9
8
7
.3
6
7
6
.8
8
7
6
.2
2
7
3
.1
9
7
1
.1
5
7
0
.4
5
6
1
.4
9
5
8
.2
5
5
4
.1
5 4
5
.9
2
4
4
.7
7
2
9
.4
9
2
3
.6
4
2
2
.8
9
2
1
.2
0
2
0
.9
1
 
Figure 4.38  13CNMR spectrum (600 MHz, CD3OD) of 8. 
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Figure 4.39  DEPT spectrum (600 MHz, CD3OD) of 8. 
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Figure 4.40  1HNMR spectrum (600 MHz, CD3OD) of 8. 
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Figure 4.41  Expansion of 1HNMR spectrum (600 MHz, CD3OD) of 8. 
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Figure 4.41  Continued. 
proton new pink.esp
6.5 6.0 5.5 5.0 4.5
Chemical Shift (ppm)
0.005
0.010
0.015
0.020
0.025
0.030
0.035
0.040
0.045
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
6
.3
6
6
.0
5
4
.8
9
4
.5
7
 
Figure 4.41  Continued. 
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 Figure 4.42  COSY NMR spectrum (600 MHz, CD3OD) of 8. 
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Figure 4.43  HMQC spectrum (600 MHz, CD3OD) of 8. 
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Figure 4.44  HMBC spectrum (600 MHz, CD3OD) of 8. 
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From the best of my knowledge compound 8 isolated from Teucrium 
davaeanum appears to be a novel glycoside for which the name 
davaeanuside B is proposed. It has comparable 1H and 13C NMR data and 
the same molecular weight of morroniside (m/z = 406.1) isolated from 
Fructus corni  but they are different in chemical structure (Lui et al., 2009) . 
8 appears to be an isomer of the iridoid glycoside named acetylharpagide 
isolated from Caryopteris x clandonensis. Table 4.10 and Table 4.11 show 
a comparison of 1H and 13C NMR data of 8 with 1H and 13C NMR data of 
morroniside and acetylharpagide.  The stereochemistry of 8 has not been 
confirmed; it could be achieved via X-ray crystallography method and with 
the help of nuclear overhauser effect NMR spectroscopy (NOE). Figure 
4.45 shows the structures of compound 8, morroniside and 6-epi-8- 
acetylharpagide. Iridoid glycosides are common in many genera of the 
Lamiaceae: Prostantheroideae, Ajugoideae, Prasioideae, Scutellarioideae, 
Stachydoideae-Marrubieae and St.-Stachydeae (Kooiman, 1972), as well 
as in species of Teucrium: Teucrium polium (Jaradat, 2015), (Rizk et al., 
1986), Teucrium arduini (Ruhdorfer and Rimpler, 1981), (Çakir et al., 
2006). 
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Figure 4.45  Structure of 8, morroniside and 6-epi-8-acetylharpagide. 
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4.2.4    Procedure for isolation compounds 9 & 10  
 
The results of TLC analysis of fractions (35-36) Table 4.485 mg (section 
2.5.5) showed that it composed mainly from two bands (compound 9 & 
10), therefore, preparative TLC plates was carried out to purify these two 
compounds (section 2.5.3). 12 plates were used; the bands corresponding 
to two compounds were collected in small vials using a spatula, then 
dissolved in methanol, filtered by filter paper to remove the silica gel then 
dried under nitrogen gas. Compound 9 was 16 mg while 10 was 25 mg.  
 
Fractions (39-40) Table 4.4 755 mg were also contained the compound 10 
therefore, they were further purified using reverse phase silica gel column 
(40 × 3.5 cm) (secton 2.5.2). The fractionation process illustrated in Table 
4.12.     
 
Table 4.12  Process to purify a further quantity of compound 10. 
Mobile phase Composition Volume 
(ml) 
Fr. 
number 
Combined the 
fraction 
CHCl3 100 100 1 (1-16)  discarded 
CHCl3:MeOH 90:10 100 2-6 (17-19) compound 6 
pure 
CHCl3:MeOH 70:30 100 7-26 20-25 
CHCl3:MeOH 60:40 100 27-34 26-28 
CHCl3:MeOH 95:5 200 35-48 29-30 
MeOH:H2O 90:10 200 49-64 31-40 
MeOH:H2O 80:20 200 65-70 41-43 
MeOH:H2O 70:30 200 71-79 44-79 
 
 
Sub-fraction (41-43) Table 4.12 30 mg contained the compound 10, so it 
was further purified on (25g) reverse phase silica gel column (30 × 2.5 
cm), the silica gel was mixed with methanol and the fractionation was 
carried out with the methanol, 17 fractions (5 ml each) were collected. 
Sub-fractions (10-18) 15 (mg) was in pure form (compound 10).    
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           Structure elucidation of compound 9 (sucrose). 4.2.4.1
 
Compound 9 was isolated as a white solid substance from the crude 
glycosides extract of T. davaeanum. TLC analysis of 9 on silica gel  
showed no UV absorbtion at 254nm or 375 nm and a dark green colour 
spot (Rf = 0.15) after vanillin/sulphuric acid spraying Figure 4.75. 
Compound 9 has the molecular formula C12H22O11 (m/z = 342.1240) as 
determined by an accurate mass measurement, the measured accurate 
mass was 343.1240 and the calculated accurate mass was 343.1235 
corresponding to the molecular ion peak [M + H] + Figure 4.47. The 
Accurate mass measurement was carried out at the EPSRC UK National 
Mass Spectrometry Facility at Swansea University Figure 4.48 is shown 
expansion of accurate mass spectrum of 9. The ES+ mass spectrum of 9 
figure Figure 4.49 displayed a peak at m/z = 365 [M + Na]+ suggesting a 
molecular weight of 342. While the ES- mass spectrum Figure 4.50 
showed a peak at m/z = 341 [M – H]-. 
 
The 1H NMR, 13C NMR and HMBC data of 9 are summarized in Table 
4.13. The 13C NMR (600 MHz, CD3OD) spectrum Figure 4.51 showed 12 
signals, indicates the molecule has 12 carbon atoms. The glucose and 
fructose anomeric carbons appears at δ values of  93 C-1 and 62.1 C-1`, 
Figure 4.52 expansion of 13CNMR spectrum of 9. The DEPT spectrum of 9  
Figure 4.53 showed the presence of 3 (-CH2-) groups, one of glucose at δ 
60.8 C-6 and two of fructose at δ 62.1 C-1` and  62.6 C-6`. 
 
The 1H NMR (600 MHz, CD3OD) spectrum of 9 Figure 4.54 showed 
signals in the region between δ 3.5 and δ 4.5 which is characteristic for a 
sugar molecule. Furthermore, the signal at δ 5.38 (1H, d, J = 3.78, H-1) is 
corresponding to glucose anomeric proton.  While the signal at δ 3.82 (1H, 
d, H-1`) is corresponding to fructose anomeric proton, Figure 4.55 is 
shown expansion of 1HNMR spectrum of 9. Figure 4.56 is illustrated 
HMQC spectrum of 9.     
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In HMBC of 9  
Figure 4.58 cross peaks from the anomeric proton of glucose [ δ5.38 (1H, 
d, J = 3.78, H-1) to the carbon atoms C-2 δ 73.4 and C-3 δ 72.2 of glucose 
and C-2` δ 104 of fructose were observed. Table 4.14 1H and 13C NMR 
(600 MHz, CD3OD) spectroscopic data comparison of 9 with 
1H and 13C 
NMR (500 MHz, H2O) of sucrose used in journal articles (Duker and 
Serianni, 1993). Figure 4.45 is shown HMBC correlations of 9. 
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Figure 4.46  HMBC correlations of 9. 
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Table 4.13  1HNMR, 13CNMR, DEPT and HMBC data (600 MHz, CD3OD) 
of 9. 
No 
1
HNMR 
(600 MHz, CD3OD) of 9 
13
CNMR 
(600 MHz, 
CD3OD) of 9 
DEPT HMBC 
1 5.38 (1H, d, J = 3.78, H-1) 93 CH 73.4, 72.2, 104 
2 3.81 (1H, t, H-2) 73.4 CH 70, 73.6 
3 3.42 (1H, d,  J = 3.78, H-3)   72.2 CH 70, 73.4 
4 3.69 (1H, t, H-4) 73.6 CH 70, 72.2, 73.4 
5 3.33 (1H, t, H-5) 70 CH 60.8, 73.4 
6 Overlapped 60.8 CH2 - 
1` 3.82 (1H, d, H-1`)   62.1 CH2 - 
2` - 104 Q - 
3` 4.07 (1H, d, J = 8.24, H-3`) 78 CH 62.6, 74 
4` 4.00 (1H, t, H-4`) 74 CH 62.6, 78, 82 
5` 3.73 (Overlapped) 82 CH 74 
6` 3.74 (Overlapped) 62.6 CH2 74, 82, 104 
   
Table 4.14  1H and 13C NMR (600 MHz, CD3OD) data comparison of 9 
with 1H and 13C NMR (500 MHz, H2O) of sucrose. 
 
No 
1
HNMR(600 MHz, CD3OD) 
of 9 
13
CNMR (600 
MHz, CD3OD) 
of 9 
1
HNMR(500 
MHz, H2O) of 
sucrose 
(Duker and 
Serianni, 
1993) 
13
CNMR (500 MHz, 
H2O) of sucrose 
(Duker and 
Serianni, 1993) 
1 5.38 (1H, d, J = 3.78, H-1) 93 5.49 94.5 
2 3.81 (1H, t, H-2) 73.4 3.63 73.4 
3 3.42 (1H, d,  J = 3.78, H-3)   72.2 3.83 74.9 
4 3.69 (1H, t, H-4) 73.6 3.54 71.5 
5 3.33 (1H, t, H-5) 70 3.88-3.93 74.7 
6 Overlapped 60.8 3.88-3.93 62.4 
1` - 62.1 3.75 63.6 
2` 3.82 (1H, d, H-1`)   104 - 106.0 
3` 4.07 (1H, d, J = 8.24, H-3`) 78 4.29 78.7 
4` 4.00 (1H, t, H-4`) 74 4.12 76.3 
5` 3.73 (Overlapped) 82 3.96 83.7 
6` 3.74 (Overlapped) 62.6 3.88-3.93 64.7 
   
 
 
 
 
  
201 
 
 
 
                    Figure 4.47  Accurate mass spectrum of 9. 
 
 
Figure 4.48  Expansion of accurate mass spectrum of 9. 
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Figure 4.48  Continued. 
 
 
 
 
                           Figure 4.49  ES+ mass spectrum of 9. 
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Figure 4.50  ES- mass spectrum of 9. 
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Figure 4.51  13C NMR spectrum of 9 (600 MHz, CD3OD). 
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Figure 4.52  Expansion of 13CNMR spectrum (600 MHz, CD3OD) of 9. 
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Figure 4.53  DEPT  spectrum (600 MHz, CD3OD) of 9. 
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                 Figure 4.54  1H NMR spectrum (600 MHz, CD3OD) of 9. 
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Figure 4.55  Expansion of 1H NMR spectrum (600 MHz, CD3OD) of 9. 
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Figure 4.56   HMQC spectrum (600 MHz, CD3OD) of 9. 
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Figure 4.57  Expansion of HMQC spectrum (600 MHz, CD3OD) of 9. 
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Figure 4.58  HMBC spectrum (600 MHz, CD3OD) of 9. 
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Figure 4.59  Proposed structure of 9. 
 
   Partial structure elucidation of compound 10 4.2.4.2
 
Compound 10 was isolated as a white solid substance from the crude 
glycosides extract of T. davaeanum  TLC analysis of 10 on silica gel 
(2.5.5) showed no UV activity at 254 nm  or 375 nm and a green colour  
spot (Rf = 0.25) after vanillin sulphuric acid spraying Figure 4.75 . 
Compound 10 has the molecular formula C71H111O38 (m/z = 1572) as 
determined by an accurate mass measurement, the measured accurate 
mass was 1572.6754 and the calculated accurate mass was 1572.6793 
Figiure 4.60. Figure 4.62 shows the ES- spectrum of 10. ES+ mass 
spectrum of 10 is shown in Figure 4.63. 
 
The 1HNMR, 13CNMR, DEPT and HMBC data (600 MHz, CD3OD) of 10 
are shown in Table 4.15. The 13CNMR spectrum of 10 (600MHz, CD3OD) 
Figure 4.64 showed a signals for 68 carbons indicate the molecule has 68 
carbon atoms. Among them seven correspond to methyl carbons at δ 13.4 
C-24, 16.9 C-25, 17 C-26, 25.9 C-27, 15.9 C-28, 32.1 C-29, 23.7 C-30. 
The signals at δ 122.3 C-12 and 143 C-13 indicated a double bond 
between C-12 and C-13. Six signals in the downfield region at δ 105.1 C-
1`, 99.9 C-1``, 100.2 C-1```, 111 C-1````, 102.2 C-1`````, 103.1 C-1`````` 
indicate the anomeric carbons. Furthermore, three carbonyl carbons were 
appeared further down field region at δ 171 C-31, 180 C-23 and 175.6 (the 
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position is not detected). Figure 4.65 is shown expansion of 13CNMR 
spectrum of 10. 
 
The DEPT spectrum of 10 (600 MHz, CD3OD) Figure 4.66 showed the 
existence of seven methyl groups (-CH3) belonging to the aglycone part, 
C-24, C-25, C-26, C-27, C-28, C-29 and C-30 at δ values of 13.4, 16.9, 
17, 25.9, 15.9, 32.1 and 32.7 respectively. The methylene groups (-CH2-) 
belonging to the triterpene part were exhibited at δ 43 C-1, 20.1 C-6, 29 C-
7, 23.3 C-11. Figure 4.67 is shown expansion of DEPT spectrum of 10. 
The two methylene groups belonging to C-15 and C-16 are not seen in 
13CNMR spectrum, the reason for that could be because of overlapped 13C 
NMR signals. It was reported before during the structure elucidation of 
novel triterpene glycosides isolated from Muraltia heisteria overlapped 
1HNMR signals of H-15 and H-16. In case of 10 overlapped signals 
occurre in both 1HNMR and 13CNMR spectra. Many signals were in 
agreement with a novel triterpene glycosides isolated from Muraltia 
heisteria. 
 
 
The 1HNMR spectrum of 10 (600 MHz, CD3OD) Figure 4.68 showed that 
the aglycone part  has an olean-12-ene skeleton from the signal at δ 5.33 
(1H, t, H-12). In the high field region of the 1HNMR spectrum of 10 signals 
of seven methyl groups appeared at δ 0.75 (3H, s, H-28), 0.85 (3H, s, H-
29), 0.94 (3H, s, H-30), 1.22 (3H, d, J = 6.18, CH3-Rha), 1.25 (3H, s, H-4), 
1.28 (3H, s, H-25). Compound 10 was shown to contain 6 sugar moieties 
from the signals of the anomeric protons at δ 4.50 (1H, d, J = 7.73, H-1`), 
5.02 (1H, d, J = unclear, H-1``), 5.25 (1H, d, J =  H-1```), 5.10 (1H, d, J = 
2.58, H-1````), 4.53 (1H, d, J =  H- 1`````), and 4.42 (1H, d, J = 7.90, H-
1``````). Figure 4.69 is shown expansion of 1HNMR spectrum of 10. Figure 
4.70 is illustrated HMQC spectrum of 10. 
 
With regard to the structure elucidation of the aglycone part of 10 a 
significant HMBC correlations  
  
211 
 
                 Figure 4.71 gave evidence of a triterpene skeleton. The cross 
peak between the anomeric proton of the glucose moiety δ 4.50 (1H, d, J 
= 7.73, H-1`) to C-3 at δ 82 of triterpene part allowed the linkage in 10 
between the aglycone part and the glucose moiety. The H-1 at δ 3.12 (2H, 
s, H-1) has three HMBC correlations, C-5 at δ 51., C-8 at δ 76 and C-9 at 
δ 67. H-2 at δ 4.01 (1H, m, H-2) is correlated to C-31 at δ 171. Also, the 
cross peak between H-3 at δ 3.54 (1H, s, H-3) and C-1 at δ 105.1 and C-2 
at δ 71.1 of the glucose gave another evidence of the linkage between the 
aglycone part and glucose residue.  Figure 4.72 is shown expansion of 
HMBC spectrum of 10. 
 
Other important HMBC correlations Figure 4.73 are between H-24 at δ 
1.25 (3H, s, H-24), and C-10 δ 36.6, C-1 at δ 43, C-4 at δ 52, C-9 at δ 67, 
C-3 at δ 82, C-2 at δ 86  and C-23 at δ 180. Also H-25 at δ 1.28 (3H, s, H-
25) is correlated to C-2 and C-3 at δ 86 and 180 respectively. In addition 
to the HMBC correlations between H- 29 at δ 0.85(3H, s, H-29) and C-20, 
C-22, C-21, C-19 at δ 30.1, 32.6, 35, 46.2 respectively. As well as the 
correlations between H-27 at δ 1.35 (1H, s, H-27) and C-25, C-27, C-18 
and C-13 at δ 16.9, 25.9, 40.8 and 143 respectively. The other HMBC 
correlations are summarized in table 4.15. 
 
 
The linkage between aglycone part and tetrasaccharide moiety was 
confirmed by reverse HMBC correlations between δ 4.50 (1H, d, H-1`) and 
δ at 82.1 C-3, and δ at 71.2 C-2`, this also permitted the position of C-2` 
after C-1` i.e. both carbons are in the same sugar unit. The anomeric 
proton at δ 5.02 (1H, d, H-1``) is correlated to C-2` δ 71.1 this permitted 
the linkage between first two sugar moieties.  
 
Furthermore, the δ at 3.40 (1H, d, H-2``) is correlated to the second 
anomeric carbon at δ 99.9 C-1``. Therefore C-2`` δ 83 is the second 
carbon in this sugar unit. Because of third anomeric proton at δ 5.25 (1H, 
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d, H-1```) is correlated to C-2`` δ 83 this proved the linkage between third 
and second sugar units via (1→2) linkage. 
 
The reverse HMBC correlations between the third anomeric proton at δ 
5.25 (1H, d, H-1```) and fourth anomeric carbon at δ 111 C-1```` and 
between fourth anomeric proton at δ 5.10 (1H, d, H````)and third anomeric 
carbon C-1``` δ 100.2 allowed the linkage between sugar units 3 and 4. 
This linkage was further confirmed as the two anomeric carbons C-1``` δ 
100.1 and C-1```` δ 111 are correlated to the same carbon atom C-2``` δ 
79.1.  
 
The sugar units 5 and 6 are linked together and connected to the aglycone 
part at C-2 δ 86. this was confirmed by the HMBC correlation between 
anomeric proton at δ 4.53 (1H, d, H-1`````) and C-2 δ 86. 
 
 The proposed structure of 10 Figure 4.74 has molecular weight of 1538 
and ES- mass spectrum of 10 figure suggest a molecular weight of 
1574.8[ M-1 = 1573.8].There is evidence of six sugars and agycone part 
could be triterpene. 10 has a comparable 1H and 13C NMR data with a 
mixture of trans and cis-trimethoxycinnamoyl triterpene glycosides isolated 
from Muraltia heisteria (Elbandy et al., 2002). Table 4.16 1H and 13C NMR 
(600 MHz, CD3OD) spectroscopic data comparison of 10 with 
1H NMR 
(600 MHz, C5D5N) and 
13C NMR (150 MHz, C5D5N) of a mixture of trans 
and cis-trimethoxycinnamoyl triterpene glycosides isolated from Muraltia 
heisteria (Elbandy et al., 2002). Further work needs to be carried out 
regarding to structure elucidation of 10.  
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Figure 4.60 An accurate mass spectrum of 10. 
 
 
 
 
Figure 4.61 An expansion of accurate mass spectrum of 10. 
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       Figure 4.62  ES- mass spectrum of 10. 
 
 
 
 
                  Figure 4.63  ES+ mass spectrum of 10. 
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Table 4.15  1HNMR, 13CNMR, DEPT and HMBC data (600 MHz, CD3OD) 
of 10. 
No 
1
H NMR (600 MHz, 
CD3OD) 
13
C NMR 
(600 MHz, 
CD3OD) 
 DEPT (600 
MHz, 
CD3OD) 
HMBC (600 MHz, 
CD3OD) 
1 3.12(2H, s, H-1) 43.3 CH2 51.53, 67.31, 76.36 
2 4.01 86 CH 170 
3 3.54(overlapped) 82 CH 16.9, 71.2, 105 
4 - 52 C  
5 3.30(overlapped) 51 CH 76, 44.81, 67.8, 105.12 
6 ? 20.1 CH2  
7 4.02 29 CH2 - 
8 - 76 C  
9 3.88 67 CH  
10 - 36.6 C  
11 ? 23.3 CH2  
12 5.33(1H, t, H-12) 122.3 CH  
13 - 143 C  
14 - 48 C  
15  20.1 CH2  
16  23.3 CH2  
17  39.8 C  
18 3.05(1H, t, H-18) 40.8 CH  
19 3.27(2H, d, H-9) 46.2 CH2  
20 - 30.1 C  
21 1.16(overlapped) 35 CH2 15.98 
22  32.6 CH2  
23  180 C=O  
24 1.25(3H, s, H-24) 13.4 CH3 36.22, 43.18, 47.59, 
52.23, 67.7, 82.16, 86.3, 
180.2 
25 1.28(3H, s, H-25) 16.9 CH3 180, 86.6 
26 1.21(3H, s, H-26) 17 CH3 - 
27 1.35(3H, s, H-27) 25.9 CH3 39.70, 40.79, 143.40 
28 0.75(3H, s, H-28) 15.9 CH3 32.51, 39.70, 41.79, 
47.36 
29 0.94(3H, s, H-29) 32.1 CH3 30.19, 32.51, 35.30, 
42.02, 46.89 
30 0.85(3H, s, H-30) 23.7 CH3 30.19, 35.53, 46.43 
31 - 171 C=O  
32 3.78 59.9 CH2  
33 3.88 61.2 CH2  
34 3.84 62.7 CH2  
35 3.57 64.2 CH2 73.8, 76.5, 79.3 
36 3.68 65.8 CH2  
37 3.78 65.9 CH  
38 3.88 67.6 CH  
39 3.67 68.6 CH 72.8, 75.2, 103.2 
40 3.48 68.8 CH 45 
41 4.68 69 CH  
42 3.81 70.1 CH 105.1 
43 3.81 70.1 CH 73.3, 82.1 
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Table 4.15  Continued 
No 
1
H NMR 
13
C NMR  DEPT HMBC 
44 3.24 70.3 CH 77.0 
45 3.95 70.7 CH 64.5, 111 
46 - 71 CH  
47 3.32 72.7 CH 16.97, 68.93, 70.5, 
73.8 
48 3.21 72.9 CH 76.59, 103.27 
48 3.93 73.0 CH 73.3, 93.0, 111.1 
50 3.75 73.3 CH  
51 4.75 73.7 CH 73.3, 102, 170 
52 4.45 73.9 CH 42.2  
53 3.29 74.7 CH 83.0 
54 3.43 75.1 CH  
55 - 76.5 CH  
56 3.95 76.6 CH  
57 - 76.9 CH  
58 - 78.2 C  
59 3.69 78.8 CH  
60 - 79.3 CH  
61 3.39 83 CH  
62 5.57  92.8 CH  
1` 4.50 (1H, d, J = 7.73 
Hz)  
105.1 CH 82.1 
1`` 5.02 (1H, d, J = unclear) 99.9 CH 67.54, 70.79, 74.04 
1``` 5.25 (1H, d) 100.2 CH 111.15, 68.4, 70.3, 
79.1, 83  
1```` 5.10 (1H, d, J = 2.58 
Hz) 
111 CH 68.7, 73.8, 79.1, 
100.44 
1````` 4.53 (1H, d) 102.2 CH 86.10, 103.72 
1`````` 4.42(1H, d, J = 7.90 Hz) 103.1 CH 78.4 
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Table 4.16  1H and 13C NMR (600 MHz, CD3OD) data comparison of 10 
with 1HNMR(600 MHz, C5D5N) and 
13C NMR (150 MHz, C5D5N) of a 
mixture of trans and cis-trimethoxycinnamoyl triterpene glycosides 
isolated from Muraltia heisteria (Elbandy et al., 2002). 
 
No 
1
H NMR(600 MHz,CD3OD) 
of 10 
13
C NMR (600 
MHz,CD3OD) of 
10 
1
H NMR(600 
MHz, C5D5N) 
13
C NMR (150 
MHz, C5D5N) 
1 3.12(2H, s, H-1) 43.3 2.19, 1.28 43.9 
2 4.01 86 4.57 70.0 
3 3.54(overlapped) 82 4.50 86.6 
4 - 52 - 53.1 
5 3.30(overlapped) 51 2.21 52.3 
6  20.1 1.85, 1.96 21.0 
7 4.02 29 1.04, 1.28 33.6 
8 - 76 - 40.7 
9 3.88 67 2.27 49.0 
10 - 36.6 - 36.5 
11  23.3 Nd 23.8 
12 5.33(1H, t, H-12) 122.3 5.83 127.8 
13 - 143 - 139.0 
14 - 48 - 47.8 
15  20.1 Nd 24.2 
16  23.3 Nd 24.0 
17  39.8 - 46.8 
18 3.05(1H, t, H-18) 40.8 3.14 41.8 
19 3.27(2H, d, H-9) 46.2 1.27, 1.74 45.1 
20 - 30.1 - 30.8 
21 1.16(overlapped) 35 1.85, 2.3 34.0 
22  32.6 1.73, 1.85 32.0 
23  180 - 180.8 
24 1.25(3H, s, H-24) 13.4 1.86(s) 14.4 
25 1.28(3H, s, H-25) 16.9 1.47(s) 17.2 
26 1.21(3H, s, H-26) 17 1.08(s) 18.7 
27 1.35(3H, s, H-27) 25.9 2.85, 4.12 64.2 
28 0.75(3H, s, H-28) 15.9 - 176.3 
29 0.94(3H, s, H-29) 32.1 0.77(s) 32.7 
30 0.85(3H, s, H-30) 23.7 0.78(s) 23.4 
31 - 171   
32 3.78 59.9   
33 3.88 61.2   
34 3.84 62.7   
35 3.57 64.2   
36 3.68 65.8   
37 3.78 65.9   
38 3.88 67.6   
39 3.67 68.6   
40 3.48 68.8   
41 4.68 69   
42 3.81 70.1   
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Table 4.16   Continued 
 
No 
1
H NMR 
13
C NMR  DEPT HMBC 
43 3.81 70.1 CH 73.3, 82.1 
44 3.24    
45 3.95    
46 -    
47 3.32    
48 3.21    
49 3.93    
50 3.75    
51 4.75    
52 4.45    
53 3.29    
54 3.43    
55 -    
56 3.95    
57 -    
58 -    
59 3.69    
60 -    
61 3.39    
62 5.57     
1` 4.50 (1H, d, J = 7.73 Hz)     
1`` 5.02 (1H, d)    
1``` 5.25 (1H, d, J Hz)    
1```` 5.10 (1H, d, J = 2.58 Hz)    
1````` 4.53 (1H, d, J =  Hz)    
1`````` 4.42(1H, d, J = 7.90 Hz)    
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Figure 4.64  13C NMR spectrum (600 MHz, CD3OD) of 10. 
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Figure 4.65  Expansion of 13C NMR spectrum (600 MHz, CD3OD) of 10. 
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Figure 4.62 Continued. 
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Figure 4.65 Continued. 
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Figure 4.66  DEPT spectrum (600 MHz, CD3OD) of 10. 
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Figure 4.67  Expansion of DEPT spectrum (600 MHz, CD3OD) of 10. 
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         Figure 4.68  1H NMR spectrum 0 (600 MHz, CD3OD) of 10. 
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Figure 4.69  Expansion of 1H NMR spectrum (600 MHz, CD3OD) of 10. 
 
 
 
  
223 
 
 
 
 
130814- 2-1.jdf
2.0 1.5 1.0
Chemical Shift (ppm)
0.005
0.010
0.015
0.020
0.025
0.030
0.035
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
2
.2
5
2
.1
1
2
.0
0
1
.8
8
1
.7
0
1
.6
0
1
.5
2
1
.3
4
1
.2
6
1
.2
2
1
.2
1
1
.1
4
1
.0
1
0
.9
4
0
.8
6
0
.7
5
 
 
                            Figure 4.69 Continued. 
 
130814- 2-1.jdf
4.1 4.0 3.9 3.8 3.7 3.6 3.5 3.4 3.3 3.2 3.1 3.0 2.9
Chemical Shift (ppm)
0.005
0.010
0.015
0.020
0.025
N
o
rm
a
li
z
e
d
 I
n
te
n
s
it
y
4
.0
4
3
.9
6
3
.9
4
3
.9
0
3
.8
5
3
.8
4
3
.8
1
3
.7
9
3
.7
7
3
.7
6
3
.7
3
3
.7
1
3
.6
9
3
.6
7
3
.6
5
3
.6
3
3
.5
9
3
.5
8
3
.5
5
3
.5
3
3
.5
2
3
.4
9
3
.4
8
3
.4
2 3
.4
1
3
.4
0
3
.3
8
3
.3
5
3
.3
3
3
.3
2
3
.3
0
3
.2
8
3
.2
6
3
.2
5
3
.2
3
3
.2
1
3
.1
9
3
.1
8
3
.1
7
3
.1
3
3
.0
3
3
.0
1
 
 
                                         Figure 4.69 Continued. 
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Figure 4.70  HMQC spectrum (600 MHz, CD3OD) of 10. 
 
 
 
                 Figure 4.71  HMBC spectrum (600 MHz, CD3OD) of 10. 
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Figure 4.72  Expansion of HMBC spectrum (600 MHz, CD3OD) of 10. 
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Figure 4.73  HMBC correlations of 10. 
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Figure 4.74  Suggested structure of compound 10. 
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Figure 4.75 Glycosides isolated from the crude glycosides of T. 
davaeanum (The bands from left to right  are compounds 7, 8, 6, 10 
and 9. The last two bands are crude glycosides extract). 
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 Assessment of total polyphenol contents, antioxidant and 5
cytotoxic activities of studied plants extract and/or isolated 
compounds. 
 
5.1          Quantification the total phenol content  
 
5.1.1 Introduction  
 
 
Polyphenols comprise a large class of phytochemicals that have a variety 
of important biological activities. Polyphenols consist of one or more 
aromatic rings attached to one or more hydroxyl groups. In many cases 
one or more sugar moieties are commonly attached (Miniati, 2007, Dai 
and Mumper, 2010). Polyphenols are broadly distributed in plant kingdom 
and more than 8000 phenolic compounds have been discovered (Tsao, 
2010). 
 
Phenolic compounds are distributed among plant foods such as fruits, 
vegetables, olive, chocolate, legumes, cereals  (Dai and Mumper, 2010), 
edible and inedible plants (Wojdyło et al., 2007), derived foods, e.g. juices, 
oils and wines (Miniati, 2007). They are secondary metabolites of plants 
(Dai and Mumper, 2010).  
 
An imbalance in free radicals production may lead to cells damage that 
causes deleterious changes in blood vessels, inflammatory conditions, 
neoplastic diseases, cataract formation and neurodegeneration. Their 
presence in food constituents could reduce the oxidation process and 
prevent free radical activity. The results showed that these diseases can 
be prevented by consuming a sufficient quantity of food which containing 
natural antioxidant such as polyphenols, which are considered to be 
strong antioxidant than antioxidant vitamins. The main properties of 
polyphenols (especially those with hydroxyl group in position ortho or 
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para) is the compounds enter easily into redox reactions.  (Cieślik et al., 
2006). 
 
It has been reported that the total weight of polyphenols which should be 
consumed daily is 1-2 g. (In Poland they considered the weight of 
polyphenols to be consumed daily to 0.032g, while in Finland, Japan and 
USA they are 0.003 g, 0.068 g and 1.1 g respectively) (Cieślik et al., 
2006).  
 
Polyphenols have been  reported to have antioxidant activity and many  
uses such as nutrition, beverages, repellents, cosmetics, medicine, 
flavouring, dyeing, fragrances (Miniati, 2007), antimicrobial, antimutagenic 
effects, anti-inflammatory, hypolipidemic (Wojdyło et al., 2007). Their 
presence in plants acts to protect them from ultraviolet radiation or 
aggression by pathogens, predators and parasites in addition to 
contributing to plant colours (Dai and Mumper, 2010). The natural 
flavonoid (-)-epigallocatechin gallate (EGCG), the major constituent of 
green tea was found to be responsible for the potential green tea in 
prevent of lung cancer (Khan and Mukhtar, 2015).  
 
On reviewing the literature on the phytochemistry of Sanicula europaea 
and Teucrium genus it is found that the species are rich in phenolic 
compounds that are known for their health benefits and antioxidant 
activity.  Therefore the aim of this study was to determine the total phenol 
content of 50% ethanol extract of the aerial parts of   both species using 
Folin-Ciocalteu’s method.  
 
5.1.2      Materials 
 
Agilent 8543 UV/Vis spectrometer and Biochem Anal Software for Agilent 
Chem Station or equivalent were from Sigma, UV/Vis spectroscopy cells 
or equivalent (Multi-Wrist Shaker, Model 3589) obtained from Sigma, 
balance accurate to 0.0001 g, volumetric flasks (size 25ml, 50ml, 100ml) 
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were from Life Technologies, Reusable class B volumetric pipets were 
from Life Technologies. Gallic acid standard, Folin Ciocalteu’s phenol 
reagent, sodium carbonate HPLC grade, water HPLC grade, ethanol 
HPLC grade all were from Sigma. 
  
5.1.3             Extraction method 
 
The determination of total polyphenol content was carried out according to 
Folin Ciocalteu’s method (Waterhouse, 2001). The ethanol extract of S. 
europaea and T. davaeanum was prepared by extracting 15 g of dried 
aerial parts plant materials with 150 ml of 50 % ethanol using sonicator for 
20 minutes then extracted again using a centrifuge for 10 minutes. The 
liquid layer was carefully removed, filtered and air removed with N2 gas (to 
prevent the oxidation of polyphenols) for determination of total polyphenols 
content and antioxidant activity. 
 
5.1.4           Procedure of experimental work  
 
To determine the total polyphenol content of Sanicula europaea and 
Teucrium davaeanum via Folin-Ciocalteu’s method a standard curve of 
gallic acid was first plotted by measuring the absorbance at several 
concentration of gallic acid. The bsorbance of several concentration of 
50% ethanol extract of Sanicula europaea and Teucrium davaeanum were 
measured on the same day.    
 
Gallic acid concentrations of (0, 0.05, 0.15, 0.25 and 0.5) mg/ml were 
prepared by pipetting (0, 1, 2, 3 and 5) ml of gallic acid solution 
(preparation of reagents section) into 100 ml volumetric flasks, separately 
then diluted to volume with distilled water. The volumetric flask which has 
0 ml of diluted gallic acid was the blank solution.  
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From the first concentration of gallic acid (0 mg/ml) 20 µl was pipetted into 
UV cuvette and 1.58 ml water and 50 µl of Folin-Ciocalteu’s phenol 
reagent was added, the cuvette contents then mixed well. After 1 minute 
300 µl of sodium carbonate (20 %) was added. The cuvette contents were 
mixed again, covered with Aluminium foil then left for two hours, this 
solution is called the blank solution. This was repeated for the other 
concentrations of Gallic acid. The absorbance of gallic acid at 734 nm is 
an average of three determinations (0.05, 0.015, 0.25 and 0.5) mg/ml.  
   
An ethanol extract of S. europaea was prepared by extract 15 g of dried 
plant material with 150 ml of  50 % ethanol using sonicate for 20 minutes 
then extracted again using centrifuge instrument for 10 minutes the liquid 
layer was carefully removed and covered with N2 gas to prevent the 
oxidation of polyphenols.  
     
Several volumes were measured out from the extract (0, 1, 2, 3, 5 and 10) 
ml into 10 ml volumetric flasks, and then diluted to volume with distilled 
water. From each solution 20µl was pipette into separate cuvettes and to 
each 1.58 ml water, 100 µl Folin reagent mixed well, after 8 minutes 300 µl 
of 20% sodium carbonate solution was added. After 2 hours the 
absorbance was measured at 760 nm.  
 
This process was repeated for two samples of T. davaeanum, 15 g of 
leaves and flower and 15 g of stem.  
 
 
5.1.5 Results and discussion 
 
The gallic acid standard curve is shown in Figure (5.8). The standard 
curve will be used to determine the total phenol content of Sanicula 
europaea and Teucrium davaeanum according to gallic acid equivalents. 
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Absorbance of 10 mg/ml of S. europaea dried plant  material (0.507) fits in 
the absorbance range of the standard curve (SC), therefore this value can 
be used to calculate the concentration of extract. Therefore, SC equation 
was applied to calculate the percentage of polyphenol in the ethanol 
extract of S. europaea. Figure 5.9 is shown the curve obtained from 
absorbance of several concentrations of S. europaea. 
X=(y+0.0396)/1.1029, 
 Where X = conc. of polyphenols in S. europaea in 10 mg/ml. 
            Y = the absorbance of S. europaea extract 
            X = (0.507 + 0.0396)/1.1029. 
            X = 0.496 mg/ml 
 
         
y = 1.1029x - 0.0396 
R² = 0.9972 
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Figure 5.1  Gallic acid standard curve. 
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Therefore, the total polyphenol content of S. europaea is 49.6 mg/100 ml. 
Factor in for weight of solid per volume of solvent;  ethanol extract was 
prepared as 15g of material in 150 ml of 80 % methanol. It had a 
concentration of 100 mg/ml. hence % of polyphenols per mg of physical 
material = (0.496/10) x 100 = 4.956 %. 
 
 
 
 
 
        Figure  5.2  Conc. vs absorbance of S. europaea extract. 
 
  
Calculation of total phenols content of T. davaeanum  50 % ethanol extract 
by measure the absorbance of several conc. of ethanol extract at 734, and 
draw a curve. Figure 5.10 conc. of T. davaeanum leaves and flowers 
extract vs absorbance. The absorbance of 1 ml (0.235) and 2 ml (0.484) 
values are in the absorbance range of the standard curve, therefore these 
values can be used to calculate the concentration of extract. Rearrange 
SC equation. 
 
           X = (y + 0.0396) / 1.1029  
           X = (0.235 + 0.0396) / 1.1029 =0. 24898 in 10 mg/ml 
y = 0.0369x + 0.1101 
R² = 0.9982 
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Conc. of S. europaea in extract mg/ml. 
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           X = (0.484 + 0.0396) / 1.1029 = 0.47505 in 20 mg/ml 
 
The percentage of total polyphenols was calculated as the average of the 
two values (0.24898 + 0.47505) / 2 = 0.362 this extract was prepared as 
15 g of material in 150 ml of 50 % ethanol. It had a concentration of 100 
mg/ml. hence polyphenol per mg of physical material = (0.362/30) = 0.012 
mg/ml, thus 1.20 %. 
 
 
 
 
Figure 5.3 Conc. of T. davaeanum leaves and flowers vs absorbance. 
 
Calculation of total phenols content of T. davaeanum stem ethanol extract  
by plot experimental data and check the linearity. Figure 5.4 is shown 
conc. of T. davaeanum stem extract vs absorbance. The absorbance of 2 
ml (0.244) and 3 ml (0.394) fill in the absorbance range of the standard 
curve, therefore these values can be used to calculate the concentration of 
extract.  
   
           X=(y+0.0396)/1.1029. 
           X = (0.243 + 0.0396) / 1.1029 = 0.2562 of 20 mg/ml 
           X = (0.394 + 0.0396) / 1.1029 = 0.3931 of 30 mg/ml 
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The percentage of total polyphenols was calculated as the average of the 
two values (0.2562 + 0.3931) / 2 =0.3246 in 50 mg (20+30) dried plant 
material. Factor in for weight of solid per volume of solvent in the extract, 
this extract was prepared as 15 g of material in 150 ml of 50 % ethanol. It 
had a concentration of 100 mg/ml. hence polyphenol per mg of physical 
material (0.325/50) = 0.0065 mg, thus  0.65 %. 
 
 
 
 
Figure 5.4  Conc. of T. davaeanum stem extract vs absorbance. 
 
On reviewing the literature on Sanicula europaea two known phenolic 
acids, rosmarinic acid, and caffeic acid were isolated by Arda et al.  (1997) 
as a major compounds (Figure 1.9). Rosmarinic acid was also isolated 
again during this study (section 3.4.6). These constituents can be counted 
as a part of the total phenol contents. Five known flavonoids, 3,7,3`,4` 
tetra-methoxy, 5-hydroxy flavone,  5,7,3`,4` tetra-hydroxy flavone 
(luteolin), 3.5` dimethyl myricetin,  5-hydroxy, 3`,4`,6,7-tatra-methoxy 
flavone and   Luteolin-7-O-gluco-glucosyl-3`-o-rhamnoside Figure 5.5   
were isolated from Teucrium davaeanum by Talag, A. and Khaled 
Abdelhady Abdelshafeek (2006). Also compound 6 a phenyl propanoide 
glycoside which isolated from T. davaeanum (section 4.2.2) as a major 
constituent as shown from TLC plates are a classes of phenolic 
compounds.  
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Figure 5.5 Structure of flavonoid compounds isolated from T. 
davaeanum. 
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5.2  Measurement of the antioxidant activity  
 
5.2.1 Introduction  
 
Screening for free radical scavenging activity of the two dried plant 
materials and S. europaea and T. davaeanum were according to  ABTS 
radical activity. The plants extracts were prepared in 50% ethanol 
(10g/100ml). The antioxidant activity was measured by ABTS.+ (2.2`-
azinobis(3-ethylbenzothioazoline-6-sulfonic acid) diammonium salt radical 
scavenging assay and determined as the concentration required for the 
50 % inhibition of the radicals (IC50). There are five methods to measure 
the antioxidant activity: 2.2-diphenyl-1-picrylhydrazyl(DPPH), 2,2``-
azinobis(3-ethylbenzothioazoline-6-sulfonic acid) (ABTS), Ferric reducing 
antioxidant potential (FRAP), superoxide dismutase (SOD) and oxygen 
radical absorbance capacity (ORAC) Dudonne et al., (2009) 
 
 
The ABTS radical solution was prepared by reacting ABTS with potassium 
persulfate for 6-12 hours in dark at room temperature. Potassium 
persulfate acts as oxidizing agent. When measuring antioxidant activity 
two factors should be considered; the length of reaction between oxidant 
and plant extract and the concentration of extract. The reaction 
mechanisms includes the immediate formation of the ABTS radical 
monocation with intermediate radical, secondly it is a decolourization 
assay , so the radical cation is formed before addition of antioxidant 
instead of formation of the radical after adding of the antioxidants.  
 
 
5.2.2        Materials  
 
UV spectrophotometer (JENWAY 6305) were from Sigma, volumetric 
pipets (5-50 µl, 100-1000 µl and 5 ml) (Genex Beta) were from Sigma, 
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volumetric flasks (10, 50, 100 and 1000) ml, cuvettes 1 ml size, Aluminium 
foil, para-film and gloves all were from Life Technologies. Trolox (Hoffman-
La Roche) (6-hydroxy-2, 5, 7, 8-tetramethyl chroman-2-carboxylic acid; 
Aldrich chemical was used as an antioxidant standard from Aldrich, 
ABTS.+ (2.2`-azinobis(3-ethylbenzothioazoline-6-sulfonic acid) was 
obtained  from Sigma, Mono-sodium hydrogen phosphate NaH2PO4  was 
obtained from Sigma, Di-sodium hydrogen phosphate Na2HPO4  was 
obtained from Sigma, Analytical grade ethanol from Aldrich, Sodium 
chloride was obtained from Sigma, Potassium per sulphate was obtained 
from sigma. 
 
5.2.3           Extraction method 
 
Determination of the total antioxidant activity was also carried out 
according to Folin Ciocalteu’s method. The same extraction method 
mentioned in section 2.10.2 but the weight of plant material was 10 g 
instead of 15 g.         
 
5.2.4          Preparation of reagents 
 
 The ABTS.+ (2.2`-azinobis(3-ethylbenzothioazoline-6-sulfonicacid) was 
prepared by mixing 0.0481g of ABTS and 0.00825 g of potassium 
persulfate, dissolve each in 5 ml of distilled H2O, combine together and 
then make up to exactly 50 ml with distilled water in volumetric flask. 
Trollex (6-hydroxy-2, 5, 7, 8-tetramethyl chroman-2-carboxylic acid) 
several concentrations (0.025, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.8, 1, 1.1,  
1.2, 1.3, 1.4, 1.5, 2 and 3 Mm) were made in analytical grade ethanol 
50 %. Phosphate buffered saline (PBS) solution was made by mixing 81 
ml of di-sodium hydrogen phosphate Na2HPO4 with 19 ml mono- sodium 
hydrogen phosphate NaH2PO4 and 0.9 g of sodium chloride. Di-sodium 
hydrogen phosphate Na2HPO4 was made by dissolving 0.709 g of it in 1 L 
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distilled water; while mono-sodium hydrogen phosphate NaH2PO4 was 
made by dissolving 0.689 g of it in 1 L distilled water.  
 
5.2.5        Procedure of experimental work 
 
Trolox several concentrations (0.025, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.8, 
1, 1.1, 1.2, 1.3, 1.4, 1.5, 2 and 3 Mm) were made in analytical grade 
ethanol 50 %. The molar concentration of Trolox 1M = 250 g/L, thus, 1mM 
= 0.250 mg /ml, the other concentrations were made from this 
concentration.   
 
The first dilution was made by dissolving 1 ml of stock solution (100 
mg/ml) into 25 ml of 50% ethanol; the new concentration is 4 mg/ml. From 
the first diluted solution (4 mg/ml) volumes of 1, 2, 3 and 5 ml were 
pipetted into 10 ml volumetric flasks separately, to make a concentrations 
of (0.4, 0.8, 1.2 and 2) mg/ml.  
 
5.2.6 Results and discussion  
   
Several concentrations of Trolox were made in analytical grade ethanol 
50 % (0.8, 0.6, 0.5, 0.4, 0.3, 0.2, and 0.1) Mm 2 ml each. The 
spectrophotometer device was blank with 1 ml PBS solution. A permanent 
control solution was prepared by mixing 1 ml of diluted ABTS.+ solution 
(50µl ABTS.+ in 1 ml PBS) with  40 µl of  carrier solution 50%  ethanol. The 
absorbance at 734 nm after 1 minute was recorded, the cuvette was kept 
in the dark and the absorbance was recorded again after each reading for 
the test solution.  Figure 5.12 is shown standard curve of  Trolox.  The test 
solution was prepared by mixing 1 ml of diluted ABTS.+ solution (50µl 
ABTS.+ in 1 ml PBS) with several concentrations of  Trolox  (0.8, 0.6, 0.5, 
0.4, 0.3, 0.2, and 0.1) Mm 40 µl separately. The absorbance at 734 nm 
was recorded each time after 1 minute. For each concentration the 
absorbance was recorded in triplicate. 
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               Figure 5.6  Standard curve of Trolox. 
 
S. europaea extract was prepared by mixing 10 g of small cutting plant 
material into 100 ml of 50% ethanol and sonicated for 20 minutes then 
centrifuged at 1000 rpm for 15 minutes. The plant extract was filtered 
using whatman No 3 filter paper and covered with N2 gas (stock solution 
100 mg/ml). The T. davaeanum extract was prepared within the same 
procedure. 
 
Several concentrations of S. europaea extract per solid plant material 
were made by dissolving 1 ml of stock ethanol solution into 25 ml of 50% 
ethanol (4 mg/ml), second dilution of S. europaea  ethanol extract was 
prepared by pipetting (1, 2, 3 and 5) ml of first diluted solution (4 mg/ml) 
into 10 ml volumetric flasks and completed to volume with distilled water 
(0.4, 0.8, 1.2 and 2 mg/ml) respectively. 8 mg/ml was prepared by 
dissolving 1ml of stock solution into 12.5 ml ethanol (50%). The 
absorbance was recorded for each concentration. Figure 5.13 is shown 
percentage loss of radical by S. europaea extract.  
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    Figure 5.7  Percentage radical scavenging by S. europaea extract. 
 
A total of 1ml of  T. davaeanum  extract was diluted by the same way used 
for  S. europaea. The absorbance was measured  for each concentration. 
Figure 5.14 is shown percentage loss radical by T. davaeanum extract.  
                      
 
  
Figure 5.8  Percentage radical scavenging by T. davaeanum extract. 
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The SC equation of Trolox standard curve was used to calculate the antioxidant capacity of S. europaea  and T. davaeanum the 
results is shown in tables 5.13 and 5.14 respectively   
 
                               
 
Table 5.1    Antioxidant capacity of S. europaea according to Trolox equivalent. 
 
% loss of radical 
by S. europaea 
(y) 
Mg/ml equivalents to Trolox 
 x = (y+15.487)/605.48 
Conversion factor for 1 mg 
equivalent of extract (1/conc.) 
Mg Trolox equivalent per mg 
of extract 
5.954 0.35096388 2.5 0.0877 
11.165 0.04387 1.25 0.0548 
15.182 0.050531043 0.83 0.0421 
31.362 0.07732273 0.5 0.0386 
78.496 0.155340191 0.25 0.0388 
   Average = 0.052=5% 
SD = 0.02 
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Table 5.2    Antioxidant capacity of T. davaeanum according to Trolox equivalent. 
 
% loss of radical by T. 
davaeanum (y) 
Mg/ml equivalents to Trolox 
 x = (y+15.487)/605.48 
Conversion factor for 1 mg 
equivalent of extract (1/conc.) 
Mg Trolox equivalent per 
mg of extract 
16.868 0.0532 2.5 0.132 
25.854 0.0682 1.25 0.085 
42.504 0.0957 0.83 0.079 
68.562 0.1389 0.5 0.0694 
83.913 0.164 0.357 0.0586 
   Average = 0.085 = 8.5% 
SD = 0.028 
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Total polyphenol contents of dried plant material of S. europaea L was 
4.956 mg in 100 mg dried plant material. For T. davaeanum leaves and 
flowers was 1.20 mg in 100 mg dried plant material and the stem 
contained 0.65 mg in 100 mg dried plant material. S. europaea has 
approximately 5% antioxidant capacity of Trolox, while T. davaeanum has 
approximately 8 % antioxidant capacity of Trolox. Table 5.3 comparison 
the values of both total phenol content and antioxidant activity of Sanicula 
europaea and Teucrium davaeanum with the other plants. 
 
Table 5.3 Comparison of total phenol content of S. europaea and T. 
davaeanum with other plants. 
 
 
It can be concluded that both species have a medium amount of total 
phenol content and antioxidant activity.  
 
 
 
 
 
  
 
Plant  Total phenol content  Trolox 
equivalent 
Reference 
Sanicula  europaea 4.956 mg/100 mg 5 - 
Teucrium  davaeanum 1.20 mg /100 mg 8 - 
Yellow tea 
Green tea 
Black tea 
4.116±0.113 g GAE/kg 
2.262±0.113  g GAE /kg 
1.139±0.064   g GAE /kg 
29.345±0.124 
20.738 ± 0.171 
16.356 ± 0.314 
(Kopjar et al., 2015).   
Wissadula periplocifolia 
Sidastrum micranthum 
Sidarhombilfolia 
Herissantia crispa 
 260.46±5.74 mg GAE/g 
177.44±16.21 mg GAE/g 
88.31 ± 2.66 mg GAE/g 
87.07 ± 0.50 mg GAE/g 
 
 
45.71 ±0.07 
2.267 ±0.377 
20.58 ± 0.27 
83.35 ± 0.08 
(Fernandes de 
Oliveira et al., 2012) 
Quercus robur 
Pinus maritime 
Cinnamomum zeylanicum 
397.03 ± 0.05 mg GAE/g 
363.02 ±0.02 mg GAE/g 
309.23 ±0.05 mg GAE/g 
99.80 ±0.07 
83.68 ± 0.80 
64.88 ±3.74 
(Dudonne et al., 
2009) 
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5.3 Cytotoxicity assay 
 
5.3.1                 Introduction 
  
HeLa cell line was the first continuous cancer cell line isolated from the 
aggressive glandular cervical cancer of a young woman (Henrietta Lacks) 
over 100 years ago. The cytotoxic activity of four compounds isolated from 
the crude glycosides extract of T. davaeanum was determined using this 
cell line. The cytotoxic activity was kindly carried out by Dr Amos Fatokun 
University of Bradfrord, according to the method published in (Fatokun et 
al., 2013).  
 
 
5.3.2           Materials 
Minimum Essential Medium (MEM) was purchased from Life technologies. 
Foetal Bovine Serum (FBS) was from Sigma. Phosphate Buffered Saline 
(PBS) was from Sigma. Stocks of L-glutamine and antibiotics were from 
Life Technologies. Trypsin/EDTA (TrypLE™ used) from Life Technologies. 
Alamar blue (AB) from Life Technologies. Molecular Device’s FlexStation 
3. Incubator was from Life Technologies. 96-well black flat-bottom plates 
(micro-clear), plastic ware was from Life Technologies. 
5.3.3    Procedure of experimental work 
 
The growth medium used was Minimum Essential Medium (MEM) 
supplemented with 10% Foetal Bovine Serum (FBS), 2 mM L-glutamine, 
1% antibiotic-antimycotic solution (10,000 units/mL of penicillin, 10,000 
µg/mL of streptomycin and 25 µg/mL of Fungizone® Antimycotic) and 1% 
non-essential amino acids (NEAA). Cultures were maintained at 37oC in a 
humidified atmosphere of 5% CO2. Procedures were carried out on 
cultured cells under aseptic conditions (Class II flow cabinet). Growth 
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medium and other solutions were warmed to 37oC before they were used 
on cultures. 
   
The growth medium was aspirated from the cultures growing in a 75cm2 
flask and the cultures were washed with PBS. PBS was aspirated and 
sufficient volume of TrypLE was added to cover the surface of the dish. 
After 2-3 minutes, TrypLE solution was removed and the flask 
was returned to the incubator for 2-3 minutes, after which it was taken out 
of the incubator and the trypsinised cultures flooded with the growth 
medium. The growth medium was pipetted up and down and squirted 
around the surface of the flask to remove the adherent cells. The cell 
suspension was transferred into a 30 ml tube and cell density was 
determined using the haemocytometer. Cell density was then adjusted to 
the desired density of 1 × 105 cells/ml. A 100 µl aliquot of the suspension 
was then seeded into each well of the required number of 96-well plates 
and the plates were incubated overnight.  
 
5.3.4         Cell viability assay  
 
Dilutions (concentrations) of each test compound were prepared from their 
stock solutions (made up in DMSO) by diluting with MEM. The growth 
medium on the cultures was aspirated and the cultures were incubated for 
48 h with the prepared concentrations of the compounds, making sure that 
the final DMSO concentration did not exceed 0.1% (which is not toxic to 
the cells). Each concentration was added in triplicate. Appropriate controls 
(treated with growth medium alone) were included. After the 48 h 
incubation, the viability dye Alamar Blue (AB) was added to the cultures at 
10% v/v and plates were further incubated for 3 h at 37oC. AB is usually 
added in a single step, and the extent of its reduction is indicated by a 
colour change (blue to red), which is directly proportional to the viability of 
the cell population.  
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After 3 hours incubation with AB, plates were taken out of the incubator 
and left at room temperature for 20 min and the dye’s fluorescence was 
determined on Molecular Device’s Flexstation 3, using, according to the 
manufacturer’s protocol,  an excitation of 530 nm (544 nm used) and an 
emission of 590 nm.   
 
5.3.5 Results and discussion 
 
  
Data were analysed by comparing the average fluorescence value of the 
triplicate wells for each concentration with the average fluorescence value 
of the triplicate control wells. Control average was then set as 100%, to 
which each of the rest averages was normalised. Statistical analysis was 
done using GraphPad Prism (GraphPad Software, CA, USA). Inhibition of 
cell growth (IC50) by glycosides 6, 7, 8 and 10 isolated from T davaeanum 
against Hela cells line (The results are a mine of four separate 
determinations) is shown in table 5.15, Figure 5.15.  
 
   
Table 5.4   Inhibition of cell growth by compounds 6,7,8 and 10.  
 
 
 
Study of cytotoxic activity of four glycoside compounds isolated from T. 
davaeanum crude glycosides extract was kindly carried out by Dr. Fatokun 
according to the method published by Fatokun et al (2013). The results 
Compound  Conc.  µg/ml (IC50) 
12.5 25 50 100 
6 99.5 97.5 95.9 90.3 
8 99.1 98.5 97.2 95.5 
10 93.8 76.5 15.2 6.2 
7 99.8 98.2 96.3 93.1 
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showed that saponin compound 10 reduce Hela cell viability (IC50) at 
concentration 50 µg (P<0.001). 10 has a moderate cytotoxicity compared 
with other saponins which have a high cytotoxicity such as, saponin 
compounds isolated from Sea Cucumber Holothuria ForskalII. The IC50 of 
Holothurinoside A (4) 0.86 µg and Holothurinoside C  0.47 µg (Rodriguez 
et al., 1991). The inhibition % at 50 µg/ml of two saponin compounds 
isolated from Brodiaea California were 12.8 and 54.7 of (25S)-spirost-5-
ene-1β,3β-diol[(25S)-ruscogenin]-1- O- β - D- glucopyranosyl- (1→3) -O- 
α- L-rhamnopyranosyl-(1→3) - β- D- glucopyranoside] (saponin A) 
and(25S)-ruscogenin-1-O-{O-β-D-glucopyranosyl - (1→3) -O- L-
rhamnopyranosyl-(1→2)-O-[β-D- xylopyranosyl-(1→3)]- β -D-  
glucopyranoside} (saponin B)   respectively (Mimaki et al., 1995).     
 
 
 
 
 
 
Figure 5.9  Effects of compounds from T. davaeanum on the viability 
of Hela cells9. The gray colour is refer to compound 6, red (8), blue 
(10) and green (7).   
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5.3.6 Cytotoxic mechanisms of saponins 
 
Some saponins are potential anticancer agents, with diverse mechanism 
of action. Their cytotoxic activity could be related to either apoptosis 
inducement or non-apoptotic cell death stimulation. A number of 
processes resulting in cell death but involving different mechanisms of 
action are recognised, including stimulation of autophagic cell death, 
decrease in NO production in cells, cytoskeleton integrity disassembly, 
angiogenesis or metastasis inhibition and cell cycle arrest. The cytotoxic 
mechanism of some saponins from natural resources will be discussed in 
the following section. The immunosuppressive activity of a triterpene, 
saikosaponin A from Bupleurum falcatum on concanavalin A (Con A) 
stimulated mouse  SD3+ T cells, isolated from the lymph node of BALB/c 
mice, was examined, as well as the underlying mechanism of the action. 
This compound had significant antiproliferative activity, and also potentially 
inhibited the activation of the cells, in a concentration-dependent manner. 
Furthermore, saikosaponin A potently suppressed the production of IL-2, 
IFN-ɤ and TNF-α in T cells stimulated by Con A. The G0/G1 arrest of the 
activated T cells by saikosaponin A was also observed, and the activity 
was due to down-regulation of CDK6 and cyclin D3 proteins  and up-
regulation of P27kip. The apoptosis of the activated T cells, in comparison 
to the non-activated cells, was induced by the compound in a dose-
dependent manner, probably through the mitochondrial pathway (Sun et 
al., 2009) . 
 
The anticancer activities of ardisiacrispin (A + B), a mixture (fixed 
proportion 2:1) of triterpene saponins ardisiacrispin A and B from Ardisia 
crenata, toward a number of human cancer cell lines were studied. The 
highest antiproliferative activity of the tested substance was evaluated on 
human hepatoma Bel-7402 cells. Furthermore, the compound induced 
apoptosis in Bel-7402 cells, which was observed by the changes of the 
mitochondrial membrane depolarization, membrane permeability 
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enhancement and nuclear condensation, and the effects were dose-
dependent (Li et al., 2008). 
 
The cytotoxic activity of a triterpene saponin, tubeimoside 1 (TBMS1) from 
Bolbostemma paniculatum was tested on Hela cells. In the cells treated 
with compound, profound protein alterations were observed, suggesting 
an apoptotic process, with the destruction of mitochondria and 
endoplasmic reticulum. TBMS induced the depletion of mitochondrial 
transmembrane potential, causing the activation of caspase-dependent 
apoptotic cell death. Moreover, the increased expression of 
GADD153/CHOP transcription factor, associated with growth arrest and 
apoptosis in the event of prolonged ER stress, was detected. The results 
of the study indicate that the cytotoxic effect of TBMS1 operates through 
the mitochondrial, but also ER stress cell death pathways (Xu et al., 2009). 
 
5.4 Conclusion 
 
The present thesis includes a study of the chemical constituents of two 
species Sanicula europaea L. belonging to (Apiaceae) and Teucrium 
davaeanum L. belonging to (Labiatae). Both species were traditionally 
used in treatment of wounds. S. europaea and T. davaeanum were 
subjected to phytochemical investigation concerning their lipid fraction as 
well as total crude glycosides extracts prepared from butanol fraction. 
 
The GC-MS analysis of fatty alcohols fraction of S. europaea revealed the 
presence of heptacosane (43.02 %) as a main component. 
 
The unsaponifiable fraction of S. europaea was investigated by GC-MS. 
The results showed that the unsaponifiable fraction consists mainly from a 
mixture of β-selinene (76.09%), caryophyllene oxide (4.20%) and 
pentadecanone (2.23%).   
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The study of total fatty acids of S. europaea was achieved via GC-MS 
analysis of their methyl esters. The obtained results revealed the presence 
of 7-Hexadecanoic acid, methyl ester (2.23%), nonanedioic acid, 
dimethylester (1.72%), cyclopropane butanoic cid (0.43%), Caffeine 
(7.93%), isopropyl  myristate (1.05%), 1,2,Benzene dicarboxylic acid, bis 
(2-methyl propyl) ester (1.98 %), 9, 12, octadecatrienoic acid (17.47%), 
oleic acid, 3-(octadecyloxy) propyl ester (1.21%), heptadecanoic acid, 16 
methyl –methylester (2.68%).   
 
Crude glycoside extracts of S. europaea and T. davaeanum were 
prepared from the methanol extracts (80%) by treating the concentrated 
alcoholic extract with water followed by extraction with organic solvents, 
hexane, chloroform, ethyl acetate and butanol. The dried butanol extract 
was then dissolved in methanol, and dropped slowly into diethyl ether. The 
whitish precipitate obtained from the above procedure was filtered using a 
sintered glass Buchner funnel. The precipitate was dried under vacuum for 
approximately 18 hours. 
 
 Purification of crude glycosides extract of S. europaea was partially 
achieved using open column and preparative TLC chromatography, 
different adsorbents including normal or reverse phase silica gel and 
Sephadex LH-20 were used. Preparative TLC was successful in 
purification of one saponin compound 4 (saniculaside N). 
 
High performance liquid chromatography technique HPLC was used to 
purify the saponin fractions of S. europaea. Analytical HPLC (isocratic 
method) was successful in establishment of isolation parameters of 
saponin fractions. The best two mobile phases for fractionation of 
saponins fraction of S. europaea on analytical HPLC column connected to 
normal phase silica gel column were CH3CN:H2O:Isopropanol, 35:60:5, 
flow rate 3 ml/min, and CHCl3:MeOH:H2O, 60:45:5, flow rate 1 ml/min 
figure(5) because with decreased the flow rate, the saponins will have 
enough time to bind to silica gel, and the saponins will separated into 
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several peaks instead of single peak. Therefore the less polar compounds 
will eluted from the column first followed by more polar compounds.  
  
The flow rate has a significant effect on purification of saponins fraction of 
S. europaea on normal phase silica gel column, as decreasing the flow 
rate improved the separation of the peaks. 
 
Purification of saponin fraction B was successfully achieved using 
preparative high performance liquid chromatography technique (PHPLC) 
using a normal phase silica gel column. Four different gradient systems 
were used to purify the saponins fraction B (the purest sample) via 
preparative HPLC system connected to normal phase silica gel column. 
Four methods were applied, method three was successful in separation of 
glycoside compound  named  saniculaside N (4) (fraction eluted at 20 
minute).  
Four known compounds were isolated from the 80% methanolic extract of 
S. europaea named bis (2-ethylhexyl) phthalate (1), palmitic acid (2), 
rosmarinic acid (3), saniculoside N (4). A mixture of sugars (5) composed 
from sucrose, glucose and fructose was also isolated from S. europaea. 
Compounds 1, 2 and 5 were isolated for the first time from this species. 
Identification of the isolated compounds was achieved through 
spectroscopic measurements including 1-D(1H &13C NMR), 2-D(HMQC, 
HMBC and cosy) and mass spectrometry ES-, ES+ in addition to accurate 
mass measurement. Figure 5.17 structure of compounds isolated from S. 
europaea. 
  
 
Several experiments were carried out in order to determine the origin of 1 
in S. europaea (section 3.4.4). The results revealed that 1 is a constituent 
of S. europaea and not a contaminant from the solvents or plastic 
equipment. Thus further work needs to be carried out to confirm whether it 
is synthesized in the plant itself or absorbed by the plant from the 
atmosphere or the soil.   
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The GC-MS analysis of fatty alcohols fraction of T. davaeanum showed 
the presence of three hydrocarbons named heptacosane (4.5%), 
octacosane (35.4) and tetratetracontane (51.0%).  
 
The unsaponifiable fraction of T. davaeanum showed the presence of 
caryophyllene (0.96%), spathulenol (4.41%), caryophyllene oxide (3.66%), 
teu-Muurolol (3.34%), α-Bisabololoxide B(11.12%), α – bisabolol (4.57%), 
2-pentadecanone (1.66%) and phytol (6.79%).         
    
The study of total fatty acids of T. davaeanum was carried out via GC-MS 
analysis of their methyl esters. The obtained results revealed the presence 
of decanoic acid methyl ester (0.35%), 14-octadecenal (1.07%), dimethyl 
phthalate (3.0%), dodecanoic acid methylester (8.27%), 
cyclopropaneoctanoic acid (1.03%), methyl tetradecanoate (7.12%) and 
hexadecanoic acid methyl ester (14.56%).     
 
Purification of the crude glycosides extract of T. davaeanum was effected 
by applying column chromatography using different adsorbants including 
normal or reverse phase silica gel or Sephadex LH-20. Moreover, further 
purification was achieved using preparative TLC as well as Sephadex LH-
20 column chromatography. 
 
Five compounds were isolated from the crude glycosides extract of T. 
davaeanum. Two among them may be a novel; 6 is phenylethanoid 
glycoside for which the name davaeanuside A is proposed and 8 is an 
iridoid glycoside for which the name davaeanuside B is proposed. Sucrose 
(9) was isolated for the first time from T. davaeanum L. In addition to two 
partially identified compounds, 7 is expected to be an iridoid glycoside and 
10 could be a triterpene glycoside.  Figure 5.18 structure of glycoside 
compounds isolated from T. davaeanum.  
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The total phenol content and antioxidant activity of S. europaea and T. 
davaeanum 50% ethanolic extracts were achieved using the Folin 
Ciocalteu method. The result showed that the total polyphenol content of 
S. europaea L is 4.956 mg per 100 mg dried plant material. For T. 
davaeanum leaves and flowers the phenol content was 1.20 mg per 100 
mg dried plant material, and for T. davaeanum stem was 0.65 mg per 100 
mg dried plant material.  
 
The study of the antioxidant activity of the 50 % ethanol extract of S. 
europaea and T. davaeanum showed that on a mg/mg basis S. europaea 
has approximately 5% antioxidant capacity of Trolox and T. davaeanum 
has approximately 8 % antioxidant capacity of Trolox. These values are 
moderate compared with yellow green and black tea which have 
antioxidant activity according to ABTS radical scavenging of 29.345 ± 
0.124, 20.738 ± 0.171 and 16.356 ± 0.314 µmol/100g respectively (Kopjar 
et al., 2015) .      
 
The study of cytotoxic activity (IC50) of davaeanuside A (6), iridoid 
glycosides (7), davaeanuside B (8) and saponin compound (10) isolated 
from the crude glycosides extract of T.  davaeanum revealed that saponin 
compound (10) has cytotoxicity activity (IC50) against Hela cell lines at  50 
µg/ml, P < 0.001, but the other compounds did not show activities against 
the tested cell lines at 100 µg/ml. 
 
The wound healing activity of S. europaea could be related to presence of 
rosmarinic acid (3), because 3 (the main compound in crude glycoside 
extract of S. europaea as showed on TLC) was reported to has 
antinflammatory activity in many journal articles such as (Domitrović et al., 
2014) (Costa et al., 2012) (Lee et al., 2008). Furthermore rosmarinic acid 
was mentioned to have antimicrobial activity (Bais et al., 2002); (Petersen 
and Simmonds, 2003) (Szabo et al., 1999). Thus the anti-inflammatory 
and antimicrobial activities may contribute to the wound healing activity.    
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In T. davaeanum the potentially novel compound 6 which is the main 
compound in crude glycosides extract (as showed on TLC) has a similar 
skeleton to the rosmarinic acid (main compound in S. europaea methanol 
extract) as both are phenylpropanoids, despite the fact that in rosmarinic 
acid the aglycone does not have a glycoside moiety, therefore the wound 
healing activity of both species could be related to presence of this class 
of compounds. 
     
Hexadecanoic acid methyl ester (palmitic acid) showed to be the major 
constituents of total fatty acid methyl ester of T. davaeanum (Table 4.3 
and Figure 4.3). This compound mentioned in treatment of wound by 
(Victor R. Preedy et al., 2011) . Palmitic acid was isolated from the hexane 
extract of S. europaea (section 3.4.5) and also identified in GC-MS 
analysis of fatty acid methyl ester of S. europaea (section 3.1) therefore 
the wound healing activity of both species could be related to the present 
of this compound.  The unexpected finding of 1 in both plant species and 
the important of this as 1 is common used in plastic manufacture and are 
known to be toxic.  
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5.5 Further work 
 
 Determine the source of 1 in S. europaea by extraction of a 
samples of the soil in which the S. europaea is growing (different 
areas)   or growing of S. europaea in a special atmosphere which 
supplied it only with oxygen then carried out the extraction of a 
sample from this source and producing TLC analysis of the total 
extract and a sample of 1.  
 
 
 Collect sufficient quantity of fraction eluted at 13 minutes (major 
peak) from the saponin glycosides of S. europaea using preparative 
HPLC technique, method three which mentioned in section 3.5.2 
and complete  structure elucidation of the isolated compound using 
1-D & 2-D NMR spectroscopy and mass spectrometry, also carry 
out  the wound healing assay.  
 
 Study the stereochemistry of 6 and 8 isolated from the crude 
glycosides of T. davaeanum using X-ray crystallography in order to 
have 3D structure or by nuclear overhauser effect NMR 
spectroscopy (NOE). 
 
 Complete the structure elucidation of compounds 7 and 10 isolated 
from crude glycosides extract of T. davaeanum using 1-D & 2-D 
NMR spectroscopy. 
 
 Evaluate the cytotoxic activity of compound 10 isolated from crude 
glycosides extract of T. davaeanum against other cell lines such as 
P-388, A-549 and B-16 because the saponin compound isolated 
from Sea Cucumber Holothuria ForskalII has 5 sugar unites (similar 
to 10 which has 6 sugar unites or more) showed cytotoxic activity 
against these cell lines. 
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Appendice 1a HMQC spectrum of 6.  
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Appendice 1b  HMBC spectrum of 6. 
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Appendice 1c Cosy spectrum of 6. 
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Appendice 1c Continued.  
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Appendice 2a HMQC spectrum of 10. 
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Appendice 2b HMBC spectrum of 10. 
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Appendice 2c COSY spectrum of 10. 
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Appendice 3a HMQC spectrum of 8. 
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Appendice 3b HMBC spectrum of 8. 
 
 
 
 
 
